ES2768402T3 - Compositions comprising a triazole compound - Google Patents

Abstract

Compositions comprising 1) as component I compound I-3: 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1- (1,2,4-triazol-1-yl) propan-2 -ol; and 2) as component II, an active ingredient, selected from: azoxystrobin, dimoxystrobin, fluoxastrobin, isofetamid, kresoxim-methyl, picoxystrobin, pyraclostrobin, trifloxystrobin, ciazofamide, benzovindiflupir, bixapuazamid, sedaxamide, fluxanoopyrazamad, fluxanoopyraz cyproconazole, difenoconazole, epoxiconazole, metconazole, propiconazole, prothioconazole, tebuconazole, tetraconazole, triticonazole, fenpropimorph, fenpropidine, metalaxyl, metalaxyl-M (mephenoxam), metraphenone, iprovalicarb, oxathiapiproline, copper oxychloride, triticonazole, mannocozine , Bacillus amyloliquefaciens, B. pumilus, B. subtilis, Paenibacillus polymyxa, T. gamsii, prohexadione-calcium, mepicuat (mepicuat chloride), trinexapac-ethyl, flupiradifuron, thiamethoxam, nitenpyram, in which the ratio of component I to the weight ratio Component II is 4: 1 to 1: 4.

Description

DESCRIPTION

Compositions comprising a triazole compound

The present disclosure relates to compositions comprising,

1) as component I

compound I-3: 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1- (1,2,4-triazol-1-yl) propan-2-ol and

2) as component II, an active ingredient, selected from the following groups A) to O)

A) respiration inhibitors

- Inhibitors of complex III at the Q ⁰ site (for example, strobilurins): azoxystrobin, dimoxystrobin, fluoxastrobin, isofetamide, kresoxim-methyl, picoxystrobin, pyractrostrobin, trifloxystrobin,

- Inhibitors of complex III at the Qi site: ciazofamide: inhibitors of complex II (for example, carboxamides): benzovindiflupir, bixafen, boscalid, fluopiram, fluxapiroxad, isopirazam, sedaxane,

- other respiration inhibitors (eg complex I, uncouplers): fluazinam

B) Sterols biosynthesis inhibitors (SBI fungicides)

- C14 demethylase inhibitors (DMI fungicides): cyproconazole, diphenoconazole, epoxiconazole, metconazole, propiconazole, protioconazole, tebuconazole, tetraconazole, triticonazole,

- Delta14-reductase inhibitors: fenpropimorph, fenpropidine,

C) Inhibitors of nucleic acid synthesis

- acyl amino acids phenylamides or fungicides: metalaxyl, metalaxyl-M (mefenoxam),

D) Inhibitors of cell division and cytoskeleton.

- other inhibitors of cell division: metrafenone,

G) Inhibitors of lipid and membrane synthesis

- phospholipid biosynthesis and cell wall deposition: iprovalicarb,

- fatty acid amide hydrolase inhibitors: oxathiapiproline,

H) Inhibitors with multi-site action

- inorganic active substances: copper oxychloride, sulfur;

- thio- and dithiocarbamates: mancozeb,

- organochlorine compounds: chlorothalonil,

I) Inhibitors of cell wall synthesis

- glucan synthesis inhibitors: triciclazole,

K) Unknown mode of action

picarbutrazox,

L) Biopesticides

L1) Microbial pesticides with activating activity of fungal, bactericidal, viricidal and / or plant defense: Bacillus amyloliquefaciens, B. pumilus, B. subtilis, Paenibacillus polymyxa, T. gamsii,

M) Growth regulators

mepicuat (mepicuat chloride), prohexadione (prohexadione-calcium), trinexapac-ethyl

O) Insecticides

- nicotinic receptor agonist / antagonist compounds: flupirradifurone, thiamethoxam, nitenpiram,

wherein the weight ratio of component I to component II is 4: 1 to 1: 4.

According to one embodiment, the two-component compositions according to the invention have weight ratios of compound I to compound II in the range of 4: 1 to 1: 1 and in particular in the range of 2: 1 to 1 :one.

According to one embodiment, the two-component compositions according to the invention have weight ratios of compound I to compound II in the range of 1: 1 to 1: 4 and in particular in the range of 1: 1 to 1 :two.

The invention further relates to the use of the compositions of the invention to control plant pathogenic fungi as detailed herein and the preparations or compositions comprising them. The invention further relates to seeds comprising the compositions. Furthermore, the invention also relates to methods for controlling plant pathogenic fungi as detailed herein, where the fungi or materials, plants, soil or seed to be protected from fungal attack are treated with a quantity effective composition according to the invention. The invention further relates to processes for preparing the compositions according to the invention.

In order to reduce the application rates and broaden the spectrum of activity of the known compounds, it was an object of the present invention to provide compositions that, with a reduced total amount of applied active compounds, show improved activity against major harmful fungi, particularly for certain indications. It was a further object to provide compositions that are useful for the control of specific pathogens in specific important cultures that are often susceptible to pathogen attack.

Accordingly, the compositions and uses defined at the beginning and in the following description have been found. In particular, the present invention relates to compositions comprising component I and component II and to compositions comprising component I, component II and component III, wherein component III is selected from the compounds of groups A) to O) as defined herein below, with the proviso that all components are different from each other. In addition to the mentioned components I, II and III, the compositions according to the invention may also comprise additional components (for example, component IV or components IV and V), wherein each of the additional components (for example, component IV or components IV and V) is independently selected from the compounds of groups A) to O) defined hereinafter, provided that all components are different from each other.

The compounds of groups A) to O) are selected from:

A) Respiration inhibitors.

- Complex III inhibitors at the Qo site (for example, strobilurins): azoxystrobin, coumethoxy estrobin, cumoxystrobin, dimoxystrobin, enestroburin, phenaminstrobin, phenoxy-estrogen / fluphenoxystrobin, fluoxastrobin, isofetamid, kresoxim-methyl, metominostrobin, methinostrobin pyraclostrobin, pyrametostrobin, pyraxystrobin, trifloxystrobin, 2- [2- (2,5-dimethyl-phenoxymethyl) -phenyl] -3-methoxy-acrylic acid methyl ester and 2- (2- (3- (2,6-dichlorophenyl) ) -1-methyl-allylideneaminooxymethyl) -phenyl) -2-methoxyimino-N-methyl-acetamide, pyribencarb, triclopyricarb / chlorodincarb, famoxadone, fenamidone;

- Qi site complex III inhibitors: ciazofamide, amisulbrom, [(3S, 6S, 7R, 8R) -8-benz-yl-3 - [(3-acetoxy-4-methoxypyridine-2-carbonyl) amino] - 6-methyl-4,9-dioxo-1,5-di-oxonan-7-yl] 2-methylpropanoate, [(3S, 6S, 7R, 8R) -8-benzyl-3 - [[3- (acetoxymethoxy) -4-methoxy-pi ridin-2-carbonyl] amino] -6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S, 6S, 7R, 8R) - 8-benzyl-3 - [(3-isobutoxycarbonyloxy-4-methoxy-pi ridin-2-carbonyl) amino] -6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S, 6S, 7R, 8R) -8-benzyl-3 - [[3- (1,3-benzodioxol-5-ylmethoxy) -4-methoxy-pyridine-2-carbonyl] amino] -6-methyl- 4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate; (3S, 6S, 7R, 8R) -3 - [[(3-hydroxy-4-methoxy-2-pyridinyl) carbonyl] amino] -6-methyl-4,9-dioxo-8- (phenylmethyl) -1, 5-dioxonan-7-yl 2-methylpropanoate;

- complex II inhibitors (for example carboxamides): benodanil, benzovindiflupir, bixafen, boscalid, carboxin, fenfuram, fluopiram, flutolanil, fluxapiroxad, furametpir, isopirazam, mepronil, oxycarboxin, penflufen, penflufen, penflufen , N- (4'-trifluoromethylthiobiphenyl-2-yl) -3-difluoromethyl-1-methyl-1 H-pyrazol-4-carboxamide, N- (2- (1,3,3-trimethyl-butyl) -phenyl) -1,3-dimethyl-5-fluoro-1H-pyrazol-4-carboxamide, 3- (difluoromethyl) -1-methyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1-methyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 1,3-dimethyl-N- (1,1,3-trimethylindan-4- yl) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 1,3,5-trimethyl-N - (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, N- (7-fluoro-1,1,3-trimethyl-indan-4-yl) -1,3-dimethyl-pyrazole- 4-carboxamide, N- [2- (2,4-dichlorophenyl) -2-methoxy-1-methyl-ethyl] -3- (difluoromethyl) -1-methyl-pyraziol-4-carboxamide;

- other respiration inhibitors (eg complex I, uncouplers): diflumethorim, (5,8-difluoro-quinazolin-4-yl) - (2- [2-fluoro-4- (4-trifluoromethylpyridin-2-yloxy ) -phenyl] -ethyl} -amine; nitrophenyl derivatives: binapacryl, dinobuton, dinocap, fluazinam; ferimzone; organometallic compounds: fenthin salts, such as fenthin acetate, phenthine chloride or phenthine hydroxide; amethoctradine and silthiopham;

B) Sterol biosynthesis inhibitors (SBI fungicides)

- C14 demethylase inhibitors (DMI fungicides): triazoles: azaconazole, bitertanol, bromuconazole, cyproconazole, diphenoconazole, diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imibenzol, hexaconazole, imibenzol, , paclobutrazole, penconazole, propiconazole, protioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, 1- [rel- (2S; 3R) -3- (2-chlorophenyl) -2- (2,4-difluorophenyl ) -oxyranylmethyl] -5-thiocyanate-1H- [1,2,4] triazole, 2- [rel- (2S; 3R) -3- (2-chlorophenyl) -2- (2,4-difluorophenyl) -oxyranil -methyl] -2H- [1,2,4] triazol-3-thiol; imidazoles: imazalil, pefurazoate, prochloraz, triflumizole; pyrimidines, pyridines, and piperazines: fenarimol, nuarimol, pyrifenox, triforine; 3- (4-chloro-2-fluoro-phenyl) -5- (2,4-difluorophenyl) isoxazol-4-yl] - (3-pyridyl) methanol;

- Delta14-reductase inhibitors: aldimorph, dodemorph, dodemorph acetate, fenpropimorph, tridemorph, fenpropidine, piperaline, spiroxamine;

- 3-keto reductase inhibitors: fenhexamide;

C) nucleic acid synthesis inhibitors

- acylamino acid phenylamides or fungicides: benalaxil, benalaxil-M, kiralaxil, metalaxil, metalaxil-M (mefenoxam), ofurace, oxadixil;

- others: himexazole, octilinone, oxolinic acid, bupirimate, 5-fluorocytosine, 5-fluoro-2- (p-tolylmethoxy) pyrimidin-4-amine, 5-fluoro-2- (4-fluorophenylmethoxy) pyrimidin-4-amine;

D) Inhibitors of cell division and cytoskeleton.

- tubulin inhibitors, such as benzimidazoles, thiophanates: benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate-methyl; triazolopyrimidines: 5-chloro-7- (4-methylpiperidin-1-yl) -6- (2,4,6-trifluorophenyl) - [1,2,4] triazolo [1,5-a] pyrimidine

- other inhibitors of cell division: dietofencarb, etaboxam, pencicuron, fluopicolide, zoxamide, metrafenone, pyriophenone;

E) Inhibitors of amino acid and protein synthesis.

- inhibitors of methionine synthesis (anilino-pyrimidines): cyprodinil, mepanipyrim, pyrimethanil;

- Protein synthesis inhibitors: blasticidin-S, kasugamycin, kasugamycin hydrochloride-hydrate, mildiomycin, streptomycin, oxytetracycline, polyoxine, validamycin A;

F) Inhibitors of signal transduction.

- MAP / histidine kinase inhibitors: fluoroimide, iprodione, procymidone, vinclozolin, fludioxonil;

- G protein inhibitors: quinoxifene;

G) Inhibitors of lipid and membrane synthesis

- inhibitors of biosynthesis of phospholipids: edifenfos, iprobenfos, pirazofos, isoprotiolano;

- lipid peroxidation: dichloran, fifthcene, technacene, tolclofos-methyl, biphenyl, chloroneb, etridiazol;

- phospholipid biosynthesis and cell wall deposition: dimetomorph, flumorfo, mandipropamid, pyrimorph, bentiavalicarb, iprovalicarb, valifenalate and N- (1- (1- (4-cyano-phenyl) ethanesulfonyl) -but-2-yl) acid carbamic (4-fluorophenyl) ester;

- compounds that affect the permeability of the cell membrane and fatty acids: propamocarb, propamocarb hydrochloride;

- fatty acid amide hydrolase inhibitors: oxathiapiproline, 1- [4- [4- [5- (2,6-difluorophenyl) -4,5-dihydro-3-isoxazolyl] -2-ti azolyl] -1 - piperidinyl] -2- [5-methyl-3- (trifluoromethyl) -1 H-pyrazol-1-yl] ethanone, 2- {3- [2- (l - {[3,5-bis (difluoromethyl-1 H -pirazol-1-yl)] acetyl} piperidin-4-yl) -1,3-thiazol-4-yl] -4,5-dihydro-1,2-oxazol-5-yl} phenyl methanesulfonate, 2- { 3- [2- (1 - {[3,5-bis (difluoromethyl) -1H-pyrazol-1-yl] acetyl} piperidi n-4-yl) 1,3-thiazol-4-yl] -4.5 -dihydro-1,2-oxazol-5-yl} -3-chlorophenyl methanesulfonate;

H) Inhibitors with multi-site action

- inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur;

- thio- and dithiocarbamates: ferbam, mancozeb, maneb, metam, metiram, propineb, tiram, zineb, ziram;

- organochlorine compounds (for example, phthalimides, sulfa drugs, chloronitriles): anilazine, chlorothalonil, captafol, captan, folpet, dichlorofluanide, dichlorophen, flusulfamide, hexachlorobenzene, and its salts, phthalide, tolylfluanide, N- (4- nitro-phenyl) -N-ethyl-4-methyl-benzenesulfonamide;

- guanidines and others: guanidine, dodine, dodine free base, guazatine, guazatine acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris (albesilate), dithianon, 2,6-dimethyl-1H, 5H- [1,4 ] dithine [2,3-c: 5,6-c '] dipyrrole-1,3,5,7 (2H, 6H) -tetraone;

I) Inhibitors of cell wall synthesis

- glucan synthesis inhibitors: validamycin, polyoxin B; melanin synthesis inhibitors: piroquilon, triciclazole, carpropamid, dicyclomet, fenoxanil;

J) plant defense inducers

- acibenzolar-S-methyl, probenazol, isothianil, tiadinil, prohexadione-calcium; phosphonates: fosethyl, fosethyl-aluminum, phosphorous acid and its salts;

K) Unknown mode of action

- bronopol, quinomethionate, cyflofenamide, cymoxanil, dazomet, debacarb, diclomezine, diphenzoquat, diphenzoquatmethylsulfate, diphenylamine, fenpyrazamine, flumetover, flutianin, metasulfocarb, nitrapyrin, nitrotal-isopyl, isropyl-isopyl-isopyl-isopyl, - [3,5-bis (difl uoromethyl) -1 H-pyrazol-1-yl] -1- [4- (4- {5- [2- (prop-2-in-1-yloxy) phenyl] - 4,5-di hydro-1,2-oxazol-3-yl} -1,3-thiazol-2-yl) piperidin-1-yl] ethanone, 2- [3,5-bis (difluoromethyl) -1H- pyrazol-1-yl] -1- [4- (4- (5- [2-fluoro-6- (prop-2-in-1-yloxy) phenyl] -4,5-dihydro-1,2-oxazole -3-yl} -1,3-thiazol-2-yl) piperidin-1-yl] ethanone, 2- [3,5-bis (difluoromethyl) -1 H-pyrazol-1-yl] -1 - [4 - (4- {5- [2-chloro-6- (prop-2-in-1-yloxy) phenyl] -4,5-dihydro-1,2-oxazol-3-yl} -1,3-thiazole -2-yl) piperidin-1-yl] ethanone, tolprocarb, triazoxide, 2-butoxy-6-iodo-3-propylchromen-4-one, N- (cyclopropylmethoxyimino- (6-difluoro-methoxy-2,3-difluoro) -phenyl) -methyl) -2-phenyl acetamide, N '- (4- (4-chloro-3-trifluoromethylphenoxy) -2,5-dimethyl-phenyl) -N-et yl-N-methylformamidine, N '- (4- (4-fluoro-3-trifluoromethyl-phenoxy) -2,5-dimethylphenyl) -N-ethyl-N-methylformamidine, N' - (2-methyl-5-trifluoromethyl -4- (3-trimethylsilanyl-propoxy) -phenyl) -N-ethyl-N-methylformamidine, N '- (5-difluoromethyl-2-methyl-4- (3-trimethylsilanyl-propoxy) -phenyl) -N -ethyl-N-methylformamidine, acetic acid 2-methoxy-6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester, 3- [5- (4-methylphenyl) -2,3 -dimethyl-isoxazolidin-3-yl] -pyridine, 3- [5- (4-chloro-phenyl) -2,3-dimethyl-isoxazolidin-3-yl] -pyridine (pyrisoxazole), N- (6-acid amide) -methoxy-pyridin-3-yl) cyclopropanecarboxylic, 5-chloro-1- (4,6-dimethoxy-pyrimidin-2-yl) -2-methyl-1H-benzoimidazole, 2- (4-chlorophenyl) -N- [ 4- (3,4-dimethoxy-phenyl) -isoxazol-5-yl] -2-prop-2-yloxy-acetamide; ethyl (Z) -3-amino-2-cyano-3-phenyl-prop-2-enoate, tert-butyl N- [6 - [[(Z) - [(1-methyltetrazol-5-yl) -phenylmethylene] amino] oxymethyl] -2-pyridyl] carbamate, pentyl N- [6 - [[(Z) - [(1-methyltetrazol-5-yl) -phenyl-methylene] amino] oxymethyl] -2-pyridyl] carbamate, 2 - [2 - [(7,8-difluoro-2-methyl-3-quinolyl) oxy] -6-fluoro-phenyl] propan-2-ol, 2- [2-fluoro-6 - [(8-fluoro- 2-methyl-3-quinolyl) oxy] phenyl] propan-2-ol, 3- (5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl) quinoline, 3- ( 4,4-Difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl) quinoline, 3- (4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl ) quinolone; 9-fluoro-2,2-dimethyl-5- (3-quinolyl) -3H-1,4-benzoxazepine, ethyl (Z) -3-amino-2-cyano-3-phenyl-prop-2-enoate, picarbutrazox , pentyl N- [6 - [[(Z) - [(1-methyltetrazol-5-yl) -phenyl-methylene] amino] oxymethyl] -2-pyridyl] carbamate, 2- [2 - [(7,8- difluoro-2-methyl-3-quinolyl) oxy] -6-fluoro-phenyl] propan-2-ol, 2- [2-fluoro-6 - [(8-fluoro-2-methyl-3-quinolyl) oxy] phenyl] propan-2-ol, 3- (5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl) quinoline, 3- (4,4-difluoro-3,3- dimethyl-3,4-dihydroisoquinolin-1-yl) quinoline, 3- (4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl) quinoline;

L) Biopesticides

L1) Microbial pesticides with fungicidal, bactericidal, viricidal and / or activating plant defense activity: Ampelomyces quisqualis, Aspergillus flavus, Aureobasidium pullulans, Bacillus amyloliquefaciens, B. mojavensis, B. pumilus, B. simplex, B. solisalsi, B. subtilis , B. subtilis B. subtilis var. amyloliquefaciens, Candida oleophila, C. saitoana, Clavibacter michiganensis (bacteriophages), Coniothyrium minitans, Cryphonectria parasitica, Cryptococcus albidus, Dilophosphora alopecuri, Fusarium oxysporum, Clonostachys rosea f. catenulada (also called Gliocladium catenulatum), Gliocladium roseum, Lysobacter antibioticus, L. enzymagnes, Metschnikowia fructicola, Microdochium dimerum, Microsphaeropsis ochracea, Muscodor albus, Paenibacillus polymyxa, Pntoea vagans, Phlebiopsis gigantea, Pleeapsis gigantea, Pleeapsis gigantea, Pleeapsis gigantea, Pleeaps, Giant anomala, Pythium oligandrum, Sphaerodes mycoparasitica, Streptomyces griseoviridis, S. lydicus, S. violaceusniger, Talaromyces flavus, Trichoderma asperellum, T. atroviride, T. fertile, T. gamsii, T. harmatum, T. harzianum; mix of T. harzianum and T. viride; mix of T. polysporum and T. harzianum; T. stromaticum, T. virens (also called Gliocladium virens), T. viride, Typhula phacorrhiza, Ulocladium oudemansii, Verticillium dahlia, zucchini yellow mosaic virus (avirulent strain);

L2) Biochemical pesticides with fungicidal, bactericidal, viricidal and / or activating plant defense activity: chitosan (hydrolyzed), harpin protein, laminarin, Menhaden fish oil, natamycin, cover protein from plum pox virus, bicarbonate of potassium or sodium, Reynoutria sachlinensis extract, salicylic acid, tea tree oil;

L3) Microbial pesticides with insecticidal, acaricidal, molluscic and / or nematicidal activity: Agrobacterium radiobacter, Bacillus cereus, B. firmus, B. thuringiensis, B. thuringiensis ssp. aizawai, B. t. ssp. israelensis, B. t. ssp. galleriae, B. t. ssp. kurstaki, B. t. ssp. tenebrionis, Beauveria bassiana, B. brongniartii, Burkholderia sp., Chromobacterium subtsugae, Cydia pomonella granulosis virus, Cryptophlebia leucotreta granulovirus (CrleGV), Isaria fumosorumia, Heterorhabditis bacteriophora, Lecanicillium longisporum, Lecanicillium longisporum anisopliae var. acridum, Nomuraea rileyi, Paecilomyces fumosoroseus, P. lilacinus, Paenibacillus popilliae, Pasteuria spp., P. nishizawae, P. penetrans, P. ramose, P. reneformis, P. thornea, P. usgae, Pseudomonas fluorescens, Steinernema carpocapsae, S feltiae, S. kraussei;

L4) Biochemical pesticides with insecticidal, acaricidal, molluscic, pheromone and / or nematicidal activity: L-carvone, citral, (E, Z) -7,9-dodecadien-1-yl acetate, ethyl formate, (E, Z) -2,4-ethyl decadienoate (pear ester), (Z, Z, E) -7,11,13-hexadecatrienal, heptyl butyrate, isopropyl myristate, lavaulyl senecioate, cis-jasmona, 2-methyl 1- butanol, methyl eugenol, methyl jasmonate, (E, Z) -2,13-octadecadien-1-ol, (E, Z) -2,13-octadecadien-1-ol acetate, (E, Z) -3, 13-octadecadien-1-ol, R-1-octen-3-ol, pentatermanone, potassium silicate, sorbitol actanoate, (E, Z, Z) -3,8,11-tetradecatrienyl acetate, (Z, E ) -9,12-tetradecadien-1-yl acetate, Z-7-tetradecen-2-one, Z-9-tetradecen-1-yl acetate, Z-11-tetradecenal, Z-11-tetradecen-1-ol, Black Acacia Extract, Grapefruit Pulp and Seed Extract, Chenopodium ambrosiodae Extract, Nebeda Oil, Neem Oil, Quillay Extract, Tagetes Oil;

L5) Microbial pesticides with reduction of plant stress, regulator of plant growth, activity promoting growth of plants and / or improvement of yield: Azospirillum amazonense, A. brasilense, A. lipoferum, A. irakense, A. halopraeferens, Bradyrhizobium sp., B. elkanii, B. japonicum, B. liaoningense, B. lupini, Delftia acidovorans, Glomus intraradices, Mesorhizobium sp., Paenibacillus alvei, Penicillium bilaiae, Rhizobium leguminosarum bv. phaseoli, R. I. trifolii, R. I. bv. viciae, R. tropici, Sinorhizobium meliloti;

L6) Biochemical pesticides with plant stress reducing activity, plant growth regulator and / or activity that improves plant performance: abscisic acid, aluminum silicate (kaolin), 3-decen-2-one, formononetin , genistein, hesperetin, homobrassinlide, humates, jasmonic acid or salts or derivatives thereof, lysophosphatidyl ethanolamine, naringenin, polymeric polyhydroxy acid, extract of Ascophyllum nodosum (Norwegian algae, brown algae) and extract of Ecklonia maxima (seaweed);

M) Growth regulators

abscisic acid, amidochlor, ancimidol, 6-benzylaminopurine, brasinolide, butraline, chlormequat (chlormequat chloride), choline chloride, cyclanilide, daminozide, dikegulac, dimethipine, 2,6-dimethylpuridine, ethephon, flumetralin, flurpirimidine, flurpyrimidine gibberellic acid, inabenfide, indole-3- acetic acid, maleic hydrazide, mefluidide, mepicuat (mepicuat chloride), naphthaleneacetic acid, N-6-benzyladenine, paclobutrazol, prohexadione (prohexadione-calcium, thidiazuronium, thidiazuronium tributyl, 2,3,5-tri-iodobenzoic acid, trinexapac-ethyl and uniconazole;

N) Herbicides

- acetamides: acetochlor, alachlor, butachlor, dimethachlor, dimethenamide, flufenacet, mefenacet, metolachlor, metazachlor, napropamide, naproanilide, pethoxamide, pretilachlor, propachlor, tenylchlor;

- amino acid derivatives: bilanafos, glyphosate, glufosinate, sulphosate;

- aryloxyphenoxypropionates: clodinafop, cyhalofop-butyl, fenoxaprop, fluazifop, haloxifop, metamifop, propaquizafop, quizalofop, quizalofop-P-tefuril;

- Bipyridyls: dicuat, paracuat;

- (thio) -carbamates: asulam, butylate, carbetamide, desmedipham, dimepiperate, eptam (EPTC), esprocarb, molinate, orbencarb, fenmedipham, prosulfocarb, pyributicarb, thiobencarb, triallate;

- cyclohexanediones: butroxidim, cletodim, cycloxidim, profoxidim, setoxidim, tepraloxidim, tralcoxidim;

- dinitroanilines: benfluralin, etalfluralin, orizaline, pendimethalin, prodiamine, trifluralin;

- diphenyl ethers: acifluorfen, aclonifen, bifenox, diclofop, ethoxyphene, fomesafen, lactofen, oxyfluorfen;

- hydroxybenzonitriles: bomoxynil, diclobenyl, ioxynil;

- imidazolinones: imazametabenz, imazamox, imazapic, imazapir, imazaquin, imazetapir;

phenoxyacetic acids: clomeprop, 2,4-dichlorophenoxyacetic acid (2,4-D), 2,4-DB, dichlorprop, MCPA, MCPA-thioethyl, MCPB, Mecoprop;

- pyrazines: chloridazon, flufenpir-ethyl, flutiacet, norflurazon, pyridate;

- pyridines: aminopiralid, clopiralid, diflufenican, dithiopyr, fluridone, fluroxipir, picloram, picolinafen, thiazopir;

- sulfonylureas: amidosulfuron, azimsulfuron, bensulfuron, chlorimuron-ethyl, chlorsulfuron, cynosulfuron, cyclosulfamuron, ethoxysulfuron, flazasulfuron, flucetosulfuron, flupirsulfuron, sulfur-sulfur, methanesulfuron, methanesulfuron, methasulfuron, methasulfuron, meulsulfuron, sulfur, melosulfuron, sulphonur, melosulfuron, sulphonur, meulsulfuron, meulsulfuron, meulsulfuron, meulsulfuron, meulsulfuron , pyrazulfulfuron, rimsulfuron, sulfometuron, sulfosulfuron, tifensulfuron, triasulfuron, tribenuron, trifloxisulfuron, triflusulfuron, tritosulfuron,

1- ((2-chloro-6-propyl-imidazo [1,2-b] pyridazin-3-yl) sulfonyl) -3- (4,6-dimethoxy-pyrimidin-2-yl) urea;

- triazines: amethrin, atrazine, cyanozine, dimethamethrin, etiozin, hexazinone, metamitron, metribuzin, promethrin, simazine, terbutylazine, terbutrin, triaziflam;

- ureas: chlorotoluron, daimuron, diuron, fluometuron, isoproturon, linuron, metabenzothiazuron, tebutiuron;

- other acetolactate synthase inhibitors: bispiribac-sodium, chlorandulam-methyl, diclosulam, florasulam, flucarbazone, flumetsulam, metosulam, orto-sulfamuron, penoxsulam, propoxycarbazone, piribambenz-propyl, piribenzoxim, pyriftalcid, pyriphthane-pyriftalid, pyrifenzyl, pyrifenzyl, pyrifenzyl, pyrifenzyl, pyrifenzim, pyrifenzyme, pyrifenzim, pyrifenzyme pyroxasulfone, piroxsulam;

- Others: amicarbazone, aminotriazole, anilophos, beflubutamide, benazoline, bencarbazone, benfluresate, benzophenap, bentazone, benzobicyclone, bicyclopyrone, bromacil, bromobutyl, butafenacil, butamiphos, cafenstrole, carfenton, carfenton , dicamba, difenzoquat, diflufenzopir, Drechslera monoceras, endotal, etofumesate, etobenzanid, phenoxasulfone, fentrazamide, flumiclorac-pentyl, flumioxazine, flupoxam, flurochloridone, fludalamol, indanofan, isoxaben, isoxafl, Methyl Arsonic Acid, Naptalam, Oxadiargyl, Oxadiazon, Oxaziclomefone, Pentoxazone, Pinoxaden, Pyrazlonyl, Pyraflufen-Ethyl, Pyrasulfotole, Pyrazoxifene, Pyrazolinone, Thrinoclane, Tetrazonaterone, Sulfentrazone, Tetrafluorin 2-chloro-4-fluoro-5- (3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydro-2H-pyrimidin-1-yl) -phenoxy] -pyridin -2-yloxy) -ethyl acetic acid ester, 6-amino-5-chloro-2-cyclopropyl-pyrimidine-4-carboxylic acid methyl ester, 6-chloro-3- (2-cyclopropyl-6-methyl-phenoxy ) -pyridazin-4-ol, 4-amino-3-chloro-6- (4-chloro-phenyl) -5-fluoro-pyridine-2-carboxylic acid, 4-amino-3-chloro-6 methyl ester - (4-chloro-2-fluoro-3-methoxy-phenyl) -pyridin-2-carboxylic acid and 4-amino-3-chloro-6- (4-chloro-3-dimethylamino-2-fluoro) methyl ester phenyl) -pyridine-2-carboxylic.

O) Insecticides

- organo (thio) phosphates: acetate, azamethiphos, azinphos-methyl, chlorpyrifos, chlorpyriphos-methyl, chlorfenvinphos, diazinon, dichlorvos, dicrotophos, dimethoate, disulfoton, ethion, fenitrothion, fenthion, isoxathion, malathion, methamidophosphomethathione , Monocrotophos, Oxidemeton-methyl, Paraoxon, Parathion, Fentoate, Fosalone, Fosmet, Phosphamidon, Forate, Foxim, Pyrimiphos-methyl, Prophenophos, Protiophos, Sulprofos, Tetrachlorvinphos, Terbufos, Triazophos, Tri-chlorfon;

- carbamates: alanicarb, aldicarb, bendiocarb, benfuracarb, carbaryl, carbofuran, carbosulfan, phenoxycarb, furathiocarb, methiocarb, methomyl, oxamyl, pyrimicarb, propoxur, thiodicarb, triazamate;

- pyrethroids: alethrin, biphentrine, cyfluthrin, cyhalothrin, cyphenothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, zeta-cypermethrin, deltamethrin, sphevalerate, etofenprox, feniphotrine, imiprotrin, feniphotrine, imiprotrine resmethrin, silafluofen, tau-fluvalinate, tefluthrin, tetramethrin, tralometrine, transfluthrin, profluthrin, dimefluthrin;

- insect growth regulators: a) inhibitors of chitin synthesis: benzoylureas:

chlorfluazuron, ciramazine, diflubenzuron, flucicloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron; buprofezin, diofenolan, hexitiazox, etoxazole, clofentazine; b) ecdysone antagonists: halofenozide, methoxyphenozide, tebufenozide, azadirachtin; c) juvenoids: pyriproxyfen, methoprene, phenoxycarb; d) lipid biosynthesis inhibitors: spirodichlophene, spiromesifene, spirotetramat;

- Nicotinic receptor agonist / antagonist compounds: clothianidin, dinotefuran, flupiradifurone, imidacloprid, thiamethoxam, nitenpyram, acetamiprid, thiacloprid, 1,2-chloro-thiazol-5-ylmethyl) -2-nitrimino-3,5-dimethyl- [1 , 3,5] triazinan; - GABA antagonist compounds: endosulfan, etiprol, fipronil, vaniliprol, pirafluprol, piriprol, 5-amino-1- (2,6-dichloro-4-methyl-phenyl) -4-sulfinamoyl-1 H-pyrazol-3-carbothioic amide;

- lactone macrocyclic insecticides: abamectin, emamectin, milbemectin, lepimectin, espinosad, espinetoram; - mitochondrial electron transport inhibitor acaricides (METI) I: fenazaquin, pyridaben, tebufenpirad, tolfenpirad, flufenerim;

- METI II and III compounds: acequinocyl, fluaciprim, hydramethylnon;

- Decouplers: chlorfenapir;

- inhibitors of oxidative phosphorylation: cyhexatin, diafentiuron, fenbutatin oxide, propargite;

- molting disrupting compounds: cryomazine;

- mixed function oxidase inhibitors: piperonyl butoxide;

- sodium channel blockers: indoxacarb, metaflumizone;

- ryanodine receptor inhibitors: chloranraniliprole, cyanraniliprole, flubendiamide, N- [4,6-dichloro-2 - [(diethyl-lambda-4-sulfanilidene) carbamoyl] -phenyl] -2- (3-chloro-2-pyridyl ) -5- (trifluoromethyl) pyrazol-3-carboxamide; N- [4-chloro-2 - [(dietillambda-4-sulfanilidene) carbamoyl] -6-methyl-phenyl] -2- (3-chloro-2-pyridyl) -5- (trifluoromethyl) pyrazol-3-carboxamide; N- [4-Chloro-2 - [(di-2-propyl-lambda-4-sulfanilidene) carbamoyl] -6-methyl-phenyl] -2- (3-chloro-2-pyridyl) -5- (trifluoromethyl) pyrazole-3-carboxamide; N- [4,6-dichloro-2 - [(di-2-propyl-lambda-4-sulfanilidene) carbamoyl] -phenyl] -2- (3-chloro-2-pyridyl) -5- (trifluoromethyl) pyrazole- 3-carboxamide; N- [4,6-dichloro-2 - [(diethyl-lambda-4-sulfanilidene) carbamoyl] -phenyl] -2- (3-chloro-2-pyridyl) -5- (difluoromethyl) pyrazol-3-carboxamide; N- [4,6-dibromo-2 - [(di-2-propyl-lambda-4-sulfanilidene) carbamoyl] -phenyl] -2- (3-chloro-2-pyridyl) -5- (trifluoromethyl) pyrazole- 3-carboxamide; N- [4-Chloro-2 - [(di-2-propyl-lambda-4-sulfanylidene) carbamoyl] -6-cyanophenyl] -2- (3-chloro-2-pyridyl) -5- (trifluoromethyl) pyrazole- 3-carboxamide; N- [4,6-dibromo-2 - [(diethyl-lambda-4-sulfanilidene) carbamoyl] -phenyl] -2- (3-chloro-2-pi ridil) -5- (trifluoromethyl) pyrazol-3-carboxamide ;

- Others: Benclotiaz, Bifenazate, Cartap, Flonicamid, Pyridalil, Pymetrozine, Sulfide, Thiocyclam, Cienopyrafen, Flupirazophos, Ciflumetofan, Amidoflumet, Imiciafos, Bistrifluron, Pirifluquinazon and 1,1 '- [(3S, 4R, 4S, 6 12R, 12aS, 12bs) -4 - [[(2-cyclopropylacetyl) oxy] methyl] -1,3,4,4a, 5,6,6a, 12,12a, 12b-decaidro-12-hydroxy-4,6a , 12b-trimethyl-11 -oxo-9- (3-pyridinyl) -2H, 11H-naphtho [2,1-b] pyran [3,4-e] pyran-3,6-diyl] cyclopropaneacetic acid ester.

Compound I-3 can be obtained by various routes in analogy to known prior art processes (see J. Agric. Food Chem. (2009) 57, 4854-4860; EP 0275 955 A1; DE 4003 180 A1; EP 0 113640 A2; EP 0 126 430 A2). Furthermore, the compound of formula I-3, its preparation, the compositions comprising said compound and its use in crop protection are described in WO 2013/007767 (PCT / EP2012 / 063626). Documents EP 0354 183, WO 2013/024076 (PCT / EP2012 / 065835), WO 2013/024075 (PCT / EP2012 / 065834), WO 2013/024077 (PCT / EP2012 / 065836), WO 2013/024081 (PCT / EP2012 / 065848), WO 2013/024080 (PCT / EP2012 / 065847), WO 2013/024083 (PCT / EP2012 / 065852), WO 2013/010862 (PCT / EP2012 / 063526), WO 2013/010894 (PCT / EP2012 / 063635) WO 2013/010885 (PCT / EP2012 / 063620), WO 2013/024082 (PCT / EP2012 / 065850) describe other azole fungicides and certain compositions thereof with other active compounds. Due to the basic character of its nitrogen atoms, component I, that is, in particular compound I-3, is capable of forming salts or adducts with inorganic or organic acids or with metal ions, in particular salts with inorganic acids.

Examples of inorganic acids are hydrohalic acids, such as hydrogen fluoride, hydrogen chloride, hydrogen bromide, and hydrogen iodide, carbonic acid, sulfuric acid, phosphoric acid, and nitric acid.

Suitable organic acids are, for example, formic acid and alkanoic acids, such as acetic acid, trifluoroacetic acid, trichloroacetic acid and propionic acid, and also glycolic acid, thiocyanic acid, lactic acid, succinic acid, citric acid, benzoic acid and others. arylcarboxylic acids, cinnamic acid, oxalic acid, alkylsulfonic acids (sulfonic acids having straight or branched chain alkyl radicals of 1 to 20 carbon atoms), arylsulfonic acids or aryldisulfonic acids (aromatic radicals, such as phenyl and naphthyl), bearing one or two groups of sulfonic acid), alkylphosphonic acids (phosphonic acids having straight or branched chain alkyl radicals with 1 to 20 carbon atoms), arylphosphonic acids or aryldiphosphonic acids (aromatic radicals, such as phenyl and naphthyl), which carry one or two acids phosphoric radicals), where alkyl or aryl radicals may carry additional substituents, for example acid p-toluenesulfonic, salicylic acid, p-aminosalicylic acid, 2-phenoxybenzoic acid, 2-acetoxybenzoic acid, etc. Suitable metal ions are in particular the ions of the elements of the second main group, in particular calcium and magnesium, of the third and fourth main group, in particular aluminum, tin and lead, and also of the elements of the transition groups of the one to eight, in particular chromium, manganese, iron, cobalt, nickel, copper, zinc and others. Particular preference is given to the metal ions of the elements of the transition groups of the fourth period. Metals can be present in the various valences they can assume.

Component I comprises chiral centers and is generally obtained in the form of racemates. The Ry S- enantiomers of compound I-3 can be separated and isolated in pure form by methods known to the skilled person, for example, by using chiral HPLC. Suitable for use as antimicrobial agents are both enantiomers and their compositions. This applies correspondingly to the compositions. Furthermore, component I may be present in different crystalline modifications, which may differ in biological activity.

In particular, in each case, a racemic composition is present. Furthermore, any other proportion of the (R) enantiomer - and the (S) enantiomer - may be present in accordance with the present invention. This applies to all the compositions detailed in this document.

In accordance with the present invention, component I is compound I-3. Compound I-3 may be present as a racemic composition of the (R) -enantiomer - and the (S) -enantiomer, but the (R) -enantiomer and (S) -enantiomer may also be present in any other ratio, for example , the pure (R) enantiomer or the pure (S) enantiomer of I-3.

According to a specific embodiment, compound I-3 is provided and used as the (R) enantiomer with an enantiomeric excess (ee) of at least 40%, for example, at least 50%, 60%, 70% or 80 %, preferably at least 90%, more preferably at least 95%, even more preferably at least 98% and most preferably at least 99%.

According to a further specific embodiment, compound I-3 is provided and used as the (S) enantiomer with an enantiomeric excess (ee) of at least 40%, for example, at least 50%, 60%, 70% or 80%, preferably at least 90%, more preferably at least 95%, even more preferably at least 98% and most preferably at least 99%.

Compound (R) -I-3: (R) -2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1- (1,2,4-triazol-1-yl) propan-2 -ol; compound (S) -I-3: (S) -2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1- (1,2,4-triazol-1-yl) propan-2 -ol.

The active compounds of component II, component III and any other additional components, selected from groups A) to O) as detailed here, their preparation and their action against harmful fungi are known (cf .: http: // www.alanwood .net / pesticides /) and mainly commercially available. Commercially available active compounds can be found, for example, in The Pesticide Manual, 14th Edition, British Crop Protection Council (2006) and other publications. Fluxapyroxad (N- (3 ', 4', 5'-trifluorobiphenyl-2-yl) -3-difluoromethyl-1-methyl-1 H-pyrazol-4-carboxamide) and its preparation and use are described in WO 2006 / 087343.

In the following, references are given for the active compounds of component II, component III and any other additional components, selected from groups A) to O) as detailed here:

benalaxyl, methyl N- (phenylacetyl) -N- (2,6-xylyl) -DL-alaninate (DE 29 03 612); methyl metaxyl, N- (methoxyacetyl) -N- (2,6-xylyl) -DL-alaninate (GB 1500581); ofurace, (RS) -a- (2-chloro-N-2,6-xylylacetamido) -Y-butyrolactone [CAS RN 58810-48 3]; oxadixyl; N- (2,6-dimethylphenyl) -2-methoxy-N- (2-oxo-3-oxazolidinyl) acetamide (GB 2058059); aldimorph, "4-alkyl-2,5 (or 2,6) -dimethylmorpholine", comprising 65-75% of 2,6-dimethylmorpholine and 25-35% of 2,5-dimethylmorpholine, comprising more than 85% 4-dodecyl-2,5 (or 2,6) -dimethylmorpholine, where "alkyl" also includes octyl, decyl, tetradecyl, and hexadecyl, with a cis / trans ratio of 1: 1 [CAS RN 91315-15-0] ; dodine, 1-dodecylguanidinium acetate (Plant Dis. Rep., Vol. 41, p.1029 (1957)); dodemorph, 4-cyclododecyl-2,6-dimethylmorpholine (DE 1198125); fenpropimorph, (RS) -cis-4- [3- (4-tert-butylphenyl) -2-methylpropyl] -2,6-dimethylmorpholine (DE 27 52 096); phenpropidine, (RS) -1- [3- (4-tert-butylphenyl) -2-methylpropyl] piperidine (DE 27 52 096); guazatine, a mixture of the reaction products of the technical grade iminodi (octamethylene) diamine amidation, comprising various guanidines and polyamines [CAS RN 108173-90-6]; iminoctadine, 1,1'-iminodi (octamethylene) diguanidine (Congr. Plant Pathol. 1, p.27 (1968); spiroxamine, (8-tert-butyl-1,4-dioxaspiro [4.5] dec-2-yl) diethylamine (EP-A 281 842); tridemorph, 2,6-dimethyl-4-tridecylmorpholine (DE 11 64 152); pyrimethanyl, 4,6-dimethylpyrimidin-2-ylphenylamine (DD-A 151 404); mepanipyrim, (4 -methyl-6-prop-1-ynylpyrimidin-2-yl) phenylamine (EP-A 224339); cyprodinyl, (4-cyclopropyl-6-methylpyrimidin-2-yl) phenylamine (EP-A 310 550); cycloheximide, 4 - {(2R) -2 - [(1S, 3S, 5S) -3,5-dimethyl-2-oxocyclohexyl] -2-hydroxyethyl} piperidine-2,6-dione [CAS RN 66 81-9]; griseofulvin, 7-chloro-2 ', 4,6-trimethoxy-6'-methylspiro [benzofuran-2 (3H), 1'-cyclohex-2'-ene] -3,4'-dione [CAS RN 126-07 -8 ]; kasugamycin, 3-O- [2-amino-4 - [(carboximinomethyl) amino] -2,3,4,6-tetradeoxy-aD-arabino-hexopyranosyl] -D-chiro-inositol [CAS RN 6980-18 -3]; natamycin, acid (8E, 14E, 16E, 18E, 20E) - (1R, 3S, 5R, 7R, 12R, 22R, 24S, 25R, 26S) -22- (3-amino-3,6- dideoxy-pD-mannopyranosyloxy) -1,3,26-trihydroxy-12-methyl-10-oxo-6,11,28-tri oxatricyclo [22.3.1.05,7] octacosa-8,14,16,18,20-pentane-25-carboxylic [CAS RN 7681-93-8]; polyoxine, 5- (2-amino-5-O-carbamoyl-2-deoxy-L-xylonamido) -1- (5-carboxy-1,2,3,4-tetrahydro-2,4-dioxopyrimidin-1- acid) yl) -1,5-dideoxy-pD-allophuranuronic [CAS RN 22976-86-9]; streptomycin, 1,1'- {1-L- (1,3,5 / 2,4,6) -4- [5-deoxy-2-O- (2-deoxy-2-methylamino-aL-glucopyranosyl) -3-C-formyl-aL-lixofuranosiloxy] -2,5,6-trihydroxycyclohex-1,3-ylene} diguanidine (J. Am. Chem. Soc. 69, p.1234 (1947)); bitertanol, p - ([1,1'-biphenyl] -4-yloxy) -a- (1,1-dimethylethyl) -1 H-1,2,4-triazol-1-ethanol (DE 2324 020); bromuconazole, 1 - [[4-bromo-2- (2,4-dichlorophenyl) tetrahydro-2-furanyl] methyl] -1H-1,2,4-triazole (Proc. Br. Crop. Prot. Conf. 1990 - Pests Dis. Vol. 1, p. 459); cyproconazole, 2- (4-chlorophenyl) -3-cyclopropyl-1- [1,2,4] triazol-1-ylbutan-2-ol (US 4,664 696); diphenoconazole, 1- {2- [2-chloro-4- (4-chlorophenoxy) phenyl] -4-methyl- [1,3] dioxolan-2-ylmethyl} -1H [1,2,4] triazole (GB - A 2 098 607); diniconazole, (p E) -p - [(2,4-dichlorophenyl) methylene] -a- (1,1-dimethylethyl) -1H-1,2,4-triazol-1-ethanol (Noyaku Kagaku, 1983, Vol 8, p. 575); enylconazole (imazalil), 1 - [2- (2,4-dichlorphenyl) -2- (2-propenyloxy) ethyl] -1 H-imidazole (Fruits 28, p. 545, 1973); epoxiconazole, (2RS, 3SR) -1- [3- (2-chlorophenyl) -2,3-epoxy-2- (4-fluorophenyl) propyl] -1H-1,2,4-triazole (EP-A 196 038 ); fenbuconazole, a- [2- (4-chlorophenyl) ethyl] -a-phenyl-1 H-1,2,4-triazol-1-propaneitrile (Proc. Br. Crop Prot. Conf. 1988 - Pests Dis. Vol. 1, p. 33); fluquinconazole, 3- (2,4-didorophenyl) -6-fluoro-2- [1,2,4] -triazol-1-yl-3H-quinazolin-4-one (Proc. Br. Crop Prot. Conf.- Pests Dis., 5-3, 411 (1992)); flusilazol, 1 - {[bis- (4-fluorophenyl) methylsilanil] methyl} -1H- [1,2,4] triazole (Proc. Br. Crop Prot. Conf.-Pests Dis., 1, 413 (1984)) ; flutriafol, a- (2-fluorophenyl) -a- (4-fluorophenyl) -1H-1,2,4-triazol-1-ethanol (EP 15 756); hexaconazole, 2- (2,4-dichlorophenyl) -1- [1,2,4] triazol-1-ylhexan-2-ol (CAS RN 79983-71-4); ipconazole, 2 - [(4-chlorophenyl) -methyl] -5- (1-methylethyl) -1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentanol (EP 267778), metconazole, 5- ( 4-chlorobenzyl) -2,2-dimethyl-1 - [1,2,4] triazol-1-ylmethylcyclopentanol (GB 857 383); miclobutanil, 2- (4-chlorophenyl) -2- [1,2,4] triazol-1-ylmethylpentanenitrile (CAS RN 88671-89-0); penconazole, 1- [2- (2,4-dichlorophenyl) pentyl] -1H- [1,2,4] triazole (Pesticide Manual, 12th Ed. (2000), S.712); propiconazole, 1 - [[2- (2,4-dichlorophenyl) -4-propyl-1,3-dioxolan-2-yl] methyl] -1H-1,2,4-triazole (BE 835 579); prochloraz, N- (propyl- [2- (2,4,6-trichlorophenoxy) ethyl]) imidazol-1-carboxamide (US 3991 071); protioconazole, 2- [2- (1-chlorocyclopropyl) -3- (2-chlorophenyl) -2-hydroxypropyl] -2,4-dihydro- [1,2,4] triazol-3-thione (WO 96/16048 ); simeconazole, a- (4-fluorophenyl) -a - [(trimethylsilyl) methyl] -1H-1,2,4-triazol-1-ethanol [CAS RN 149508-90-7]; tebuconazole, 1- (4-chlorophenyl) -4,4-dimethyl-3- [1,2,4] triazol-1-ylmethylpentan-3-ol (EP-A 40 345); tetraconazole, 1- [2- (2,4-dichlorophenyl) -3- (1,1,2,2-tetrafluoroethoxy) propyl] -1H-1,2,4-triazole (EP 234242); triadimefon, 1- (4-chlorophenoxy) -3,3-dimethyl-1- (1H-1,2,4-triazol-1-yl) -2-butanone (BE 793 867); triadimenol, p- (4-chlorophenoxy) -a- (1,1-dimethylethyl) -1H-1,2,4-triazol-1-ethanol (DE 23 24 010); triflumizole, (4-chloro-2-trifluoromethylphenyl) - (2-propoxy-1- [1,2,4] triazol-1-ylethylidene) -amine (JP-A 79/119 462); triticonazole, (5E) -5 - [(4-chlorophenyl) methylene] -2,2-dimethyl-1- (1H-1,2,4-triazol-1-ylmethyl) cyclopentanol (FR 26 41 277); iprodione, N-isopropyl-3- (3,5-dichlorophenyl) -2,4-dioxoimidazolidine-1-carboxamide (GB 13 12 536); mylozoline, (RS) -3- (3,5-dichlorophenyl) -5-methoxymethyl-5-methyl-1,3-oxazolidine-2,4-dione [CAS RN 54864-61-8]; procymidone, N- (3,5-dichlorophenyl) -1.2-dimethylcyclopropane-1,2-dicarboximide (US 3,903,090); vinclozolin, 3- (3,5-dichlorophenyl) -5-methyl-5-vinylxazolidine-2.4-dione (DE-A 22 07 576); ferbam, iron (3+) dimethyldithiocarbamate (US 1 972 961); nabam, ethylenebis disodium (dithiocarbamate) (US 2317765); maneb, manganese ethylenebis (dithiocarbamate) (US 2504404); mancozeb, manganese ethylenebis- (dithiocarbamate) polymer complex zinc salt (GB 996 264); metam, methyldithiocarbaminic acid (US 2791 605); metiram, ethylenebis zinc ammonia (dithiocarbamate) (US 3248400); propineb, zinc polymer propylenebis (dithiocarbamate) (BE 611 960); polycarbamate, bis (dimethylcarbamodityoate-S, S ') [| j- [[1,2-ethanediylbis [carbamodi-thioate-S, S']] (2 -)]] di [zinc] [ CAS RN 64440-88-6]; tyram, bis (dimethylthiocarbamoyl) disulfide (DE 642 532); ziram, dimethyldithiocarbamate [CAS RN 137-30-4]; zineb, zinc ethylenebis (dithiocarbamate) (US 2 457 674); anilazine, 4,6-dichloro-N- (2-chlorophenyl) -1,3,5-triazine-2-amine (US 2 720 480); benomyl, N-butyl-2-acetylaminobenzoimidazol-1-carboxamide (US 3631 176); boscalid, 2-chloro-N- (4'-chlorobiphenyl-2-yl) -nicotinamide (EP-A 545 099); carbendazim, methyl (1H-benzoimidazol-2-yl) carbamate (US 3657443); carboxin, 5,6-dihydro-2-methyl-N-phenyl-1.4-oxatiin-3-carboxamide (US 3,249,499); oxycarboxine, 5,6-dihydro-2-methyl-1,4-oxatiin-3-carboxanilide 4,4-dioxide (US 3399214); ciazofamide, 4-chloro-2-cyano-N, N-dimethyl-5- (4-methylphenyl) -1H-imidazol-1-sulfonamide (CAS RN 120116 88-3); dazomet, 3,5-dimethyl-1,3,5-thia-diazinane-2-thione (Bull. Soc. Chim. Fr. 15, p. 891 (1897)); dithianon, 5,10-dioxo-5,10-dihydronaphth [2,3-b] [1,4] ditiin-2,3-dicarbonitrile (GB 857383); famoxadone, (RS) -3-anilino-5-methyl-5- (4-phenoxyphenyl) -1.3-oxazolidine-2,4-dione [CAS RN 131807-57-3]; fenamidone, (S) -1-anilino-4-methyl-2-methylthio-4-phenylimidazolin-5-one [CAS RN 161326-34-7]; fenarimol, a- (2-chlorophenyl) -a- (4-chlorophenyl) -5-pyrimidinomethanol (GB 12 18623); fuberidazole, 2- (2-furanyl) -1H-benzimidazole (DE 12 09 799); flutolanil, a, a, a-trifluoro-3'-isopropoxy-o-toluanilide (JP 1104514); furametpir, 5-chloro-N- (1,3-dihydro-1,1,3-trimethyl-4-isobenzofuranyl) -1,3-dimethyl-1 H-pyrazol-4-carboxamide [CAS RN 123572-88-3 ]; isoprothiolane, diisopropyl 1,3-dithiolan-2-ylidenemalonate (Proc. Insectic. Fungic. Conf. 8. Vol. 2, p. 715 (1975)); mepronil, 3'-isopropoxy-o-toluanilide (US 3,937,840); nuarimol, a- (2-chlorophenyl) -a- (4-fluorophenyl) -5-pyrimidinomethanol (GB 12 18 623); fluopicolide (picobenzamide), 2,6-dichloro-N- (3-chloro-5-trifluoromethylpyridin-2-ylmethyl) benzamide (WO 99/42447); probenazole, 3-allyloxy-1,2-benzothiazole 1,1-dioxide (Agric. Biol. Chem. 37, p. 737 (1973)); proquinazide, 6-iodo-2-propoxy-3-propylquinazolin-4 (3H) -one (WO 97/48684); pyrifenox, 2 ', 4'-dichloro-2- (3-pyridyl) acetophenone (EZ) -O-methyloxime (EP 49 854); pyroquilon, 1,2,5,6-tetrahydropyrrolo [3,2,1-ij] quinolin-4-one (GB 139 43 373) quinoxifene, 5,7-dichloro-4- (4-fluorophenoxy) quinoline (US 5 240 940); siltiofam, N-allyl-4,5-dimethyl-2- (trimethylsilyl) thiophene-3-carboxamide [CAS RN 175217-20-6]; thiabendazole, 2- (1,3-thiazol-4-yl) benzimidazole (US 3017415); tifluzamide, 2 ', 6'-dibromo-2-methyl-4'-trifluoromethoxy-4-trifluoromethyl-1,3-thiazol-5-carboxanilide [CAS RN 130000-40-7]; methyl thiophanate, 1,2-phenylenebis (iminocarbonothioyl) bis (dimethylcarbamate) (DE-A 19 30 540); thiadinil, 3'-chloro-4,4'-dimethyl-1,2,3-thiadiazol-5-carboxanilide [CAS RN 223580-51-6]; tricyclazole, 5-methyl-1,2,4-triazolo [3,4-b] [1,3] benzothiazole [CAS RN 41814-78-2]; triforine, N, N '- (piperazine-1,4-diylbis [(trichlormethyl) methylene]} diformamide (DE 1901421); Bordeaux mixture, CuSO4 x 3Cu (OH) 2 x 3CaSO4 mixture [CAS RN 8011-63 - 0]; copper acetate, Cu (OCOCH3) 2 [CAS RN 8011-63-0]; copper oxychloride, Cu2Cl (OH) 3 [CAS RN 1332-40-7]; basic copper sulfate, CuSO4 [CAS RN 1344 73-6]; binapacryl, (RS) -2-sec-butyl-4,6-dinitrophenyl 3-methylcrotonate [CAS RN 485-31-4]; dinocap, mixture of 2,6-dinitro-4-octylphenylcrotonate and 2,4-dinitro-6-octyl-phenylcrotonate, where "octyl" is a mixture of 1-methylheptyl, 1-ethylhexyl and 1-propylpentyl (US 2 526 660); dinobuton, (RS) -2-sec-butyl- 4,6-dinitrophenyl isopropyl carbonate [CAS RN 973-21-7]; nitrotal-isopropyl, diisopropyl 5-nitroisophthalate (Proc. Br. Insectic. Fungic. Conf. 7., Vol. 2, p. 673 (1973)) ; fenpiclonil, 4- (2,3-dichlorophenyl) -1 H-pyrrol-3-carbonitrile (Proc. 1988 Br. Crop Prot. Conf. - Pests Dis., Vol. 1, p. 65); fludioxonil, 4- (2,2-difluorobenzol [1,3] dioxol-4-yl) -1 H-pyrrole-3-carbonitrile (The Pesti cide Manual, publ. The British Crop Protection Council, 10th ed. (1995), p. 482); acibenzolar-S-methyl, methyl 1,2,3-benzothiadiazol-7-carbothioate [CAS RN 135158-54-2]; flubentiavalicarb (bentiavalicarb), isopropyl {(S) -1 - [(1R) -1- (6-fluorobenzothiazol-2-yl) -ethylcarbamoyl] -2-methylpropyl} carbamate (JP-A 09/323 984); carpropamide, 2,2-dichloro-N- [1- (4-chlorophenyl) ethyl] -1-ethyl-3-methylcyclopropanecarboxamide [CAS RN 104030-54-8]; chlorothalonil, 2,4,5,6-tetrachloroisophthalonitrile (US 3 290 353); Cyflofenamide, (Z) -N- [a- (cidopropilmetoxiimino) -2,3-difluoro-6- (trifluoromethyl) benzyl] -2-phenylacetamide (WO 96/19442); cymoxanil, 1- (2-cyano-2-methoxyiminoacetyl) -3-ethylurea (US 3,957,847); diclomezine, 6- (3,5-dichlorophenyl-p-tolM) pyridazin-3 (2H) -one (US 4 052 395) diclocimet, (RS) -2-cyano-N - [(R) -1- (2 , 4-dichlorophenyl) ethyl] -3,3-dimethylbutyramide [CAS RN 139920-32-4]; dietofencarb, isopropyl 3,4-diethoxycarbanilate (EP 78663); edifenfos, O-ethyl S, S-diphenyl phosphorodithioate (DE 14 93 736) etaboxam, N- (cyano-2-thienylmethyl) -4-ethyl-2- (ethylamino) -5-thiazolecarboxamide (EP-A 639 574); fenhexamide, N- (2,3-dichloro-4-hydroxyphenyl) -1-methylcyclohexanecarboxamide (Proc. Br. Crop Prot. Conf. - Pests Dis., 1998, Vol. 2, p.

327); fenthin acetate, triphenyltin (US 3 499 086); phenoxanil, N- (1-cyano-1,2-dimethylpropN) -2- (2,4-dichlorophenoxy) propanamide (EP 262 393); ferimzone, mepanipyrim, (Z) -2'-metNacetophenone-4,6-dimetNpyrimidin-2-ylhydrazone [CAS RN 89269-64-7]; fluazinam, 3-chloro-N- [3-chloro-2,6-dinitro-4- (trifluoromethyl) phenyl] -5- (trifl uorom eti l) -2-pyridinamine (The Pesticide Manual, publ. The British Crop Protection Council, 10th ed. (1995), p. 474); fosethyl, fosetilaluminio, ethylphosphonate (FR 22 54 276); iprovalicarb, isopropyl [(1S) -2-methyl-1- (1-p-tolylethylcarbamoyl) propyl] carbamate (EP-A 472 996); hexachlorbenzene (C. R. Seances Acad. Agric. P. 31, p. 24, 1945); metrafenon, 3'-bromo-2,3,4,6 '-tetramethoxy-2', 6-dimethylbenzophenone (US 5,945,567); pencicuron, 1- (4-chlorobenzyl) -1-cyclopentyl-3-phenylurea (DE 27 32 257); penthiopirate, (RS) -N- [2- (1,3-dimethylbutyl) -3-thienyl] -1-methyl-3- (trifluoromethyl) -1H-pyrazol-4-carboxamide (JP 10130268); propamocarb, propyl 3- (dimethylamino) propylcarbamate (DE 1567 169); phthalide (DE 1643 347); toloclofosmethyl, O-2,6-dichloro-p-tolyl O, O-dimethylphosphorothioate (GB 1467561); fifthcene, pentachlornitrobenzene (DE 682048); zoxamide, (RS) -3,5-dichloro-N- (3-chloro-1-ethyl-1-methyl-2-oxopropyl) -p-toluamide [CAS RN 156052-68-5]; azoxystrobin, methyl 2- {2- [6- (2-cyano-1-vinylpenta-1,3-dienyloxy) pyrimidin-4-yloxy] phenyl} -3-methoxyacrylate (EP 382 375), dimoxystrobin, (E) - 2- (methoxyimino) -N-methyl-2- [a- (2,5-xyloyloxy) -o-tolyl] acetamide (EP 477 631); Enestroburin, methyl 2- {2- [3- (4-chlorophenyl) -1-methylallylideneaminooxymethyl] phenyl} -3-methoxyacrylate (EP 936 213); fluoxastrobin, (E) - {2- [6- (2-chlorophenoxy) -5-fluoropyrimidin-4-yloxy] phenyl} (5,6-dihydro-1,4,2-dioxazin-3-yl) methanone O- methyloxime (WO 97/27189); kresoxim-methyl, methyl (E) -methoxyimino [a- (o-tolyloxy) -o-tolyl] acetate (EP 253 213); metominostrobin, (E) -2- (methoxyimino) -N-methyl-2- (2-phenoxyphenyl) acetamide (EP 398 692); orystrobin, (2E) -2- (methoxyimino) -2- {2 - [(3E, 5E, 6E) -5- (methoxyimino) -4,6-dimethyl-2,8-dioxa-3,7-diazanone- 3,6-dien-1-yl] phenyl} -N-methylacetamide (WO 97/15552); methyl picoxystrobin, 3-methoxy-2- [2- (6-trifluoromethylpyridin-2-yloxymethyl) phenyl] -acrylate (EP 278 595); pyraclostrobin, methyl N- (2- [1- (4-chlorophenyl) -1H-pyrazol-3-yloxymethyl] phenyl} (N-methoxy) carbamate (WO 96/01256); trifloxystrobin, methyl (E) -methoxyimino- { (E) -a- [1- (a, a, atrifluoro-m-tolyl) ethylideneaminooxy] -o-tolyl} acetate (EP 460 575); captafol, N- (1,1,2,2-tetrachloroethylthio) cyclohex -4-ene-1,2-dicarboximide (Phytopathology, Vol. 52, p. 754 (1962)); captan, N- (trichloromethylthio) cyclohex-4-ene-1,2-dicarboximide (US 2 553 770); dichlorofluanide, N-dichlorofluoromethylthio-N ', N'-dimethyl-N-phenylsulfamide (DE 11 93 498); folpet, N- (trichloromethylthio) phthalimide (US 2553 770); tolylfluanide, N-dichlorofluoromethylthio-N, N'-dimethyl -Np-tolylsulfamide (DE 11 93 498); dimetomorph, 3- (4-chlorophenyl) -3- (3,4-dimethoxyphenyl) -1-morpholin-4-yl-propenone (EP 120 321); flumetover, 2- (3,4-dimethoxyphenyl) -N-ethyl-a, a, a-trifluoro-N-methyl-p-toluamide [AGROW no. 243, 22 (1995)]; flumorfo, 3- (4-fluorophenyl) -3 - (3,4-dimethoxyphenyl) -1-morpholin-4-ylpropenone (EP 860 438); 5-Amino-2-isopropyl-3-oxo-4-o-toli S-allyl ester l-2,3-dihydro-pyrazol-1-carbothioic (CN1939128).

The pesticides described by the IUPAC nomenclature, their preparation and their fungicidal activity are also known (see. Can. J. Plant Sci. 48 (6), 587-94, 1968; EP-A 141 317; EP-A 152031; EP -A 226 917; EP-A 243970; EP-A 256 503; EP-A 428941; EP-A 532022; EP-A 1028125; EP-A 1035122; EP-A 1201648; EP-A 1122244, JP 2002316902; DE 19650197; DE 10021412; DE 102005009458; US 3,296,272; US 3,325,503; WO 98/46608; WO 99/14187; WO 99/24413; WO 99/27783; WO 00/29404; WO 00/46148; WO 00/65913; WO 01/54501; WO 01/56358; WO 02/22583; WO 02/40431; WO 03/10149; WO 03/11853; WO 03/14103; WO 03/16286; WO 03/53145; WO 03/61388; WO 03/66609; WO 03/74491; WO 04/49804; WO 04/83193; WO 05/120234; WO 05/123689; WO 05/123690; WO 05/63721; WO 05/87772; WO 05/87773; WO 06/15866; WO 06/87325; WO 06/87343; WO 07/82098; WO 07/90624, WO 11/028657, WO2012 / 168188, WO 2007/006670, WO 2011/77514; WO13 / 047749, WO 10 / 069882, WO 13/047441, WO 03/16303, WO 09/90181, WO 13/127704, WO 13/024009 and WO 13/024010).

The active compounds of group O) and their pesticidal action and the processes for their preparation are known (see also http://www.hclrss.demon.co.uk/index.html). Commercially available active compounds can be found, for example, in The Pesticide Manual, 14th Edition, British Crop Protection Council (2006) and other publications. Compound BB) of group I)

with the name IUPAC [(3S, 4R, 4aR, 6S, 6aS, 12R, 12aS, 12bS) -3- (cidopropanocarbonyloxy) -6,12-dihydroxy-4,6a, 12btrimethiM1-oxo-9- (pyridin-3- il) -1,2,3,4,4a, 5,6,6a, 12a, 12b-decahydro-11H, 12H-benzo [f] pyran [4,3-b] chromen-4-ylojmethylcidopropane carboxylate and its action Pesticide are described in WO2006 / 129714 and WO2009 / 081851. The additional component (s), i.e. component II, III, IV, V, etc., according to the present invention, are selected from any one of groups A) to O) as stated above, provided that all of the components in a composition are different active ingredients. The described compositions and their preferred uses are further described below. In each case, in accordance with the present disclosure, the use of the composition to control a particular plant pathogenic fungus is also intended to encompass the respective method of controlling the particular plant pathogenic fungi, wherein the fungi or materials, plants, soil or seed who wish to be protected against fungal attacks are treated with an effective amount of a composition as defined in that particular context.

According to one aspect, the present description refers to two-component compositions, that is, compositions comprising component I, that is, compound I-3 and component II selected from groups A) to O) as defined here for component II. According to a specific embodiment thereof, only two active compounds as defined are present in these compositions (also referred to herein as "binary compositions"). The composition can, of course, contain any type of additive or the like as detailed below to provide a formulation suitable for use in agriculture.

The weight ratio of component I to component II generally depends on the properties of the active substances used and is generally in the range of 1: 3 to 3: 1. It may also be preferable that the weight ratio is in the range of 1: 2 to 2: 1.

According to other embodiments of the two-component compositions according to the description, the weight ratio of component I to component II is generally in the range of 4: 1 to 1: 1 and in particular in the range of 2: 1 at 1: 1.

In accordance with still other embodiments of the two-component compositions according to the description, the weight ratio of component I to component is generally in the range of 1: 1 to 1: 4 and in particular in the range of 1 : 1 to 1: 2.

According to an embodiment of the two-component compositions, component I is compound I-3 and component II is selected from any one of groups A) to K) as defined herein for component II.

A specific embodiment refers to two-component compositions, in which component I is compound I-3 and component II is selected from group A) of respiration inhibitors as defined herein for component II. According to an embodiment thereof, component II is selected from the group of complex III inhibitors at the Q ⁰ site, in, for example, strobilurins as defined herein for component II. Specifically, component II is selected from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, picoxystrobin, pyraclostrobin, and trifloxystrobin. According to another specific embodiment, these are binary compositions that, as active compounds, comprise in each case only the two mentioned active components.

According to another embodiment thereof, component II is selected from the group of complex II inhibitors, for example, carboxamides as defined herein for component II. Specifically, component II is selected from the group consisting of benzovindiflupir, bixafen, boscalid, fluopiram, fluxapiroxad, isopirazam, and sedaxane. According to another embodiment, component II is selected from the group of ciazofamide and fluazinam. Of According to another specific embodiment, these are binary compositions that, as active compounds, comprise in each case only the two active components mentioned.

According to a further embodiment of the two-component compositions, component I is compound I-3 and component II is selected from group B) of sterol biosynthesis inhibitors (SBI fungicides) as defined herein for component II. According to an embodiment thereof, component II is selected from the group of C14 demethylase inhibitors (DMI fungicides), selected from cyproconazole, diphenoconazole, epoxiconazole, metconazole, propiconazole, protioconazole, tebuconazole, tetraconazole, and triticonazole. According to a further embodiment thereof, component II is selected from the group of delta14-reductase inhibitors as defined herein for component II, in particular fenpropimorph and fenpropidine.

According to a further embodiment of the two-component compositions, component I is compound I-3 and component II is selected from group C) of nucleic acid synthesis inhibitors as defined herein for component II and particularly selected from metalaxyl and (metalaxyl-M) mefenoxam.

According to a further embodiment of the two-component compositions, component I is compound I-3 and component II is metrafenone, a compound from group D) of cell division inhibitors and the cytoskeleton.

According to a further embodiment of the two-component compositions, component I is compound I-3 and component II is iprovalicarb, a compound from group G) of lipid and membrane synthesis inhibitors.

According to a further embodiment of the two-component compositions, component I is compound I-3 and component II is selected from group H) of the inhibitors with multiple site action as defined herein for component II, in Particular selected from copper oxychloride, sulfur, mancozeb, chlorothalonil.

According to a further embodiment of the two-component compositions, component I is compound I-3 and component II is selected from any one of group L) (antimycotic biological control agents and plant bioactivators) as defined herein for component II, in particular selected from Bacillus subtilis strain NRRL No. B-21661 and Bacillus pumilus strain NRRL No. B-30087.

According to a further embodiment of the two-component compositions, component I compound I-3 and component II are selected from any one of group M) (growth regulators) as defined herein for component II. According to a specific embodiment, it is selected from mepicuat (mepicuat chloride), prohexadione (prohexadione-calcium) and trinexapac-ethyluniconazole.

According to a particular embodiment of the two-component compositions of the invention comprising two fungicides, the composition comprises compound I-3 (component I) and a component II selected from pyraclostrobin, fluxapiroxad, fenpropimorph, protioconazole and chlorothalonil in a ratio by weight as defined above, particularly in the range of 1: 3 to 3: 1. It may also be preferable that the weight ratio is in the range of 1: 2 to 2: 1. In a particular embodiment, these compositions are "binary compositions" which is, within the meaning of the present invention, a composition, in which only said two active compounds are present. The composition can, of course, contain any type of additive or the like as detailed below to provide a formulation suitable for use in agriculture. Said two-component compositions comprising two fungicides as components I and II are particularly suitable as fungicides as detailed below.

According to a specific embodiment thereof, said compositions are used for the control of cereal pathogens. In particular, such compositions are suitable for controlling wheat pathogens. When used in wheat, especially preferred weight ratios of the active ingredients are 2: 1 to 1: 2, where it may be especially preferred if component I to II is present 1: 1 to 2: 1. Said compounds are particularly suitable to control the selected wheat pathogens of Septoria tritici, Stagonospora nodorum, Pyrenophora tritici repentis, Puccinia recondita, Puccinia striiformis and Blumeria graminis. Furthermore, said composition is useful for the control of the selected pathogens of Fusarium culmorum, Fusarium graminearum and Pseudocercosporella herpotrichoides. According to a further specific embodiment, said compositions are used to control barley pathogens. When used in barley, especially preferred weight ratios of the active ingredients are 2: 1 to 1: 2, where it may be especially preferred if component I to II is present 1: 1 to 2: 1. Such compositions are particularly suitable for controlling barley pathogens, selected from Pyrenophera teres, Rhychosporium secalis, Puccinia hordei and Blumeria graminis. Furthermore, such compositions are useful for controlling barley pathogens, selected from Ramularia collo-cygni and Pseudocercosporella herpotrichoides.

According to a further specific embodiment, said compositions are used for the control of soybean pathogens. When used in soybeans, especially preferred weight ratios of the active ingredients are 3: 1 to 1: 3, where it may be especially preferred if component I to II is present 3: 1 to 2: 1. In particular, such compositions are suitable for controlling selected soybean pathogens from Phakopsora pachyrizi, P. meibomiae and Microsphaera diffusa. In soybeans, said compositions can also be used effectively for the control of the so-called FDC (Complex of Foliar Diseases), for example, against Septoria glycines, Cercospora kikuchii, C. sojina, Corynespora cassiicola and / or Alternaria spp.

According to a further specific embodiment, said compositions are used for the control of corn pathogens. When used in corn, especially preferred weight ratios of the active ingredients are 2: 1 to 1: 2, where it may be especially preferred if component I to II is present 2: 1 to 1: 1. In particular, such compositions are suitable for controlling selected maize pathogens from Cercospora zeae-maydis, Puccinia sorghi and Helminthosporium maydis.

According to still another specific embodiment, said compositions are used for the control of sugar beet pathogens. When used in sugar beets, the especially preferred weight ratios of the active ingredients are 2: 1 to 1: 2, where it may be especially preferred if component I to II is present 2: 1 to 1: 1. In particular, said compositions are suitable for controlling selected maize pathogens from Cercospora beticola, Erysiphe betae, Ramularia betae and Uromyces betae.

According to still another specific embodiment, said compositions are used for the control of peanut pathogens, in particular selected from Mycosphaerella arachidis (= Cercospora) and Puccinia arachidis. When used in peanuts, especially preferred weight ratios of the active ingredients are 2: 1 to 1: 2, where it may be especially preferred if component I to II is present 2: 1 to 1: 1.

According to still another specific embodiment, said compositions are used for the control of canola and canola pathogens, in particular selected from Sclerotinia sclerotiorum, Leptosphearia maculans and Alternaria alterna. When used in oilseed rapeseed or canola, the especially preferred weight ratios of the active ingredients are 2: 1 to 1: 2, where it may be especially preferred if component I to II is present 2: 1 to 1: one.

According to yet another specific embodiment, said compositions are used for the control of rice pathogens, in particular selected from Rhizoctonia solani and Pyricularia oryzae. When used in rice, especially preferred weight ratios of the active ingredients are 2: 1 to 1: 2, where it may be especially preferred if component I to II is present 2: 1 to 1: 1.

Said compositions of components I and II are also suitable for the control of pathogens in specialized crops, such as turf, potato, tomato, cucurbits, grapes, apples, ornamental plants and bananas. Lawn pathogens that can be controlled in accordance with the present invention are selected from Sclerotinia homeocarpa and Rhizoctonia solani. When used on turf, especially preferred weight ratios of the active ingredients are 2: 1 bis 1: 2, where it may be especially preferred if component I to II is present 1: 1 to 1: 2. Potato and tomato pathogens that can be controlled according to the present invention are selected in particular from Alternaria solani, A. alternata and Rhizoctonia solani. A cucurbit pathogen that can be controlled in accordance with the present invention is in particular Sphaerotheca fuliginea. A grape pathogen that can be controlled in accordance with the present invention is in particular Uncinula necator and Botrytis cinerea. An apple pathogen that can be controlled in accordance with the present invention is in particular Podosphaera leucotricha and Venturia inaequalis. Ornamental pathogens that can be controlled in accordance with the present invention are selected in particular from Sphaerotheca fuliginea, Diplocarpon spp., Alternaria spp. and Sclerotinia spp. Banana pathogens that can be controlled according to the present invention are selected in particular from Mycosphaerella fijiensis and Mycosphaerella musicola.

A specific embodiment of the above embodiment refers to the composition, which comprises component I and fluxapyroxad as component II in a weight ratio of 3: 1 to 1: 3, more specifically 2: 1 to 1: 2. Surprisingly, this composition exhibits synergistic effects and the components are used in particular in synergistically effective amounts.

A further specific embodiment of the above two-component compositions relates to the composition, which comprises component I and component II pyraclostrobin in a weight ratio of 3: 1 to 1: 3, more specifically 2: 1 to 1: 2 . Surprisingly, this composition exhibits synergistic effects and the components are used in particular in synergistically effective amounts.

A further specific embodiment of the above two-component compositions refers to the composition, which comprises component I and as a proppropylene of component II in a weight ratio of 3: 1 to 1: 3, plus specifically 2: 1 to 1: 2. Surprisingly, this composition exhibits synergistic effects and the components are used in particular in synergistically effective amounts.

A further specific embodiment of the omissions of two previous components refers to the composition, which comprises component I and as component II chlorothalonil in a weight ratio of 3: 1 to 1: 3, more specifically 2: 1 to 1: 2 . Surprisingly, this composition exhibits synergistic effects and the components are used in particular in synergistically effective amounts.

According to a further embodiment of the two-component compositions, component I is compounds I-3 and component II is selected from any one of group O) (insecticides) as defined herein for component II. According to a specific embodiment, the insecticide is thiamethoxam. According to a preferred embodiment of the invention, component II is selected from the following fungicidal compounds:

Accordingly, particularly preferred two-component compositions are compiled in Table B, where each row corresponds to an embodiment of the compositions according to the invention, i.e. a specific individualized composition. According to a specific aspect, these are binary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table B: Two-component compositions comprising a component I and a component II, in particular binary compositions containing the respective components I and II as only active ingredients.

According to an additional preferred embodiment of the invention, component II is selected from the following fungicidal compounds:

Accordingly, other particularly preferred two-component compositions are compiled in Table B1, where each row corresponds to an embodiment of the compositions according to the invention, i.e. a specific individualized composition. According to a specific aspect, these are binary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table B1: Two-component compositions comprising a component I and a component II, in particular binary compositions containing the respective components I and II as only active ingredients.

According to a further preferred embodiment of the invention, component II is selected from the following fungicidal compounds:

Accordingly, other particularly preferred two-component compositions are compiled in Table B2, where each row corresponds to an embodiment of the compositions according to the invention, i.e. a specific individualized composition. According to a specific aspect, these are binary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table B2: Two-component compositions comprising a component I and a component II, in particular binary compositions containing the respective components I and II as active ingredients only.

According to still another preferred embodiment of the invention, component II is:

II-101 copper oxychloride

Accordingly, other particularly preferred two-component compositions are compiled in Table B2a, where each row corresponds to an embodiment of the compositions according to the invention, i.e. a specific individualized composition. According to a specific aspect, these are binary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table B2a: Two-component compositions comprising a component I and a component II, in particular binary compositions containing the respective components I and II as only active ingredients.

As detailed above, component I contains chiral centers and therefore may be present as racemic mixtures, as pure enantiomers, or in the two enantiomers of component I may be present in any ration (S) :( R) .

In accordance with particular embodiments of the invention, the respective component I is present as the (S) enantiomer. The specific two-component compositions comprising the respective component I enantiomer (S) are compiled in Table Bs, in which each row corresponds to an embodiment of the compositions according to the invention, i.e. a specific individualized composition. According to a specific aspect, these are binary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table Bs: Two-component compositions comprising a component I as the (S) enantiomer (abbreviated as (S) -I-3 for the (S) enantiomer of I-3) and a component II, in particular binary compositions containing the respective component I as enantiomer (S) and II as only active ingredients.

According to particular embodiments of the invention, the respective component I is present as the (R) enantiomer. The specific two-component compositions comprising the (R) enantiomer of the respective component I are compiled in Table Br, where each row corresponds to an embodiment of the compositions according to the invention, i.e. a specific individualized composition. According to a specific aspect, these are binary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table Br: Two-component compositions comprising a component I as the (R) enantiomer (abbreviated as (R) -I-3 for the (R) enantiomer of I-3) and a component II, in particular binary compositions containing the respective component I as enantiomer (R) and II as only active ingredients.

According to a further embodiment, component II is selected from the following fungicides:

According to still another embodiment, component II is selected from the following fungicides:

In accordance with a further preferred embodiment of the invention, component II is selected from the following growth regulators:

Accordingly, particularly preferred two-component compositions are compiled in Table B3, where each row corresponds to an embodiment of the compositions according to the invention. According to a specific aspect, these are binary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table B3: Two-component compositions comprising a component I and a growth regulator as component II, in particular binary compositions containing the respective components I and II as active ingredients only.

As detailed above, component I contains centers of chirality, and therefore may be present as racemic mixtures, as pure enantiomers, or in the two enantiomers of component I may be present in any ratio (S) :( R) .

In accordance with particular embodiments of the invention, the respective component I is present as the (S) enantiomer. The specific two-component compositions comprising the respective component I enantiomer (S) are compiled in Table B3s, where each row corresponds to an embodiment of the compositions according to the invention, i.e. a specific individualized composition. According to a specific aspect, these are binary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table B3s: Two-component compositions comprising a component I as the (S) enantiomer (abbreviated as (S) -I-3 for the (S) enantiomer of I-3) and a component II, in particular binary compositions containing the respective component I as enantiomer (S) and II as only active ingredients.

According to particular embodiments of the invention, the respective component I is present as the (R) enantiomer. The specific compositions of two components comprising the (R) enantiomer of the respective component I are compiled in Table B3r, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition. According to a specific aspect, these are binary compositions that each only contains these two components as active compounds.

Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table B3r: Two-component compositions comprising a component I as the (R) enantiomer (appreciated as (R) -I, for example, (R) -I-3 for the (R) enantiomer of I-3) and a component II, in particular binary compositions containing the respective component I as the (R) enantiomer and II as only active ingredients.

In accordance with another preferred embodiment of the disclosure, component II is selected from the following insecticides:

II-30cnitenpiram

II-42ctiametoxam.

Accordingly, particularly preferred two-component compositions are compiled in Table B5, where each row corresponds to an embodiment of the compositions according to the description, i.e. a specific individualized composition. According to a specific aspect, these are binary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present disclosure.

Table B5: Two-component compositions comprising a component I and an insecticide as component II, in particular binary compositions containing the respective components I and II as active ingredients only.

As detailed above, component I contains centers of chirality, and therefore may be present as racemic mixtures, as pure enantiomers, or in the two enantiomers of component I may be present in any ratio (S) :( R) . In accordance with particular embodiments of the disclosure, the respective component I is present as the (S) enantiomer. The specific two-component compositions comprising the respective component I enantiomer (S) are compiled in Table B5s, where each row corresponds to an embodiment of the compositions according to the description, i.e. a specific individualized composition. According to a specific aspect, these are binary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table 5s: Two-component compositions comprising a component I as the (S) enantiomer (abbreviated as (S) -I-3 for the (S) enantiomer of I-3) and a component II, in particular binary compositions containing the respective component I as enantiomer (S) and II as only active ingredients.

In accordance with particular embodiments of the description, the respective component I is present as the (R) enantiomer. The specific two-component compositions comprising the (R) enantiomer of the respective component I are compiled in Table B5r, where each row corresponds to an embodiment of the compositions according to the description, that is, a specific individualized composition. According to a specific aspect, these are binary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present disclosure.

Table 5r: Two-component compositions comprising a component I as the (S) enantiomer (abbreviated as (R) -I-3 for the (R) enantiomer of I-3) and a component II, in particular binary compositions containing the respective component I as enantiomer (R) and II as only active ingredients.

In accordance with another aspect, the present description refers to three-component compositions, that is, compositions comprising component I, in particular compound I-3, a component II selected from groups A) to O) as defined here for component II and a component III selected from groups A) to O), where components II and III are not identical. In particular, component II in each case is selected from the preferred groups or preferred active compounds as indicated above for component II and component III is selected from groups A) to O), in particular from the preferred active compounds used as component III as defined in the following.

According to a specific embodiment thereof, exactly three active compounds as defined are present in these compositions (also referred to herein as "ternary compositions"). The composition can, of course, contain any type of additive or the like as detailed below to provide a formulation suitable for use in agriculture.

In the three-component compositions, the weight ratio of component I to the first additional active compound (component II) depends on the properties of the active compounds in question. It may be preferable that the weight ratio is in the region of 1: 3 to 3: 1, in particular 1: 2 to 2: 1. The weight ratio of component I to the second additional active compound (component III) can be particularly 1000: 1 to 1: 1000, specifically 500: 1 to 1: 500. It is preferably in the range of 1: 100 to 100: 1, preferably in the range of 1:50 to 50: 1, and in particular in the range of 1:20 to 20: 1. It may be preferable that the weight ratio is in the region of 1:10 to 10: 1, preferably 1: 3 to 3: 1, in particular 1: 2 to 2: 1. The weight ratio of the first additional active compound (component II) to the second additional active compound (component III) is preferably in the range of 1: 100 to 100: 1, frequently in the range of 1:50 to 50: 1, preferably in the 1:20 to 20: 1 range, and in particular in the 1:10 to 10: 1 range. It may be preferable that the weight is in the range of 1: 3 to 3: 1, particularly 1: 2 to 2: 1.

In accordance with one embodiment, the present disclosure relates to three-component compositions, comprising a component I, in particular compound I-3, a component II selected from the groups of groups A) to K) as defined herein for component II and a component III selected from groups A) to K).

A specific embodiment refers to three-component compositions, where component I is compound I-3 and component II is selected from group A) of complex III respiration inhibitors at site Q ⁰ as defined herein for component II and component III it is selected from group B) of sterols biosynthesis inhibitors (SBI fungicides). According to a specific embodiment thereof, component II is select from the group of strobilurins as defined here for component II. Specifically, component II is selected from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, picoxystrobin, pyraclostrobin, and trifloxystrobin. According to a further specific embodiment thereof, component III is selected from the group of C14 demethylase inhibitors (DMI fungicides), in particular selected from cyproconazole, diphenoconazole, epoxiconazole, fluquinconazole, flusilazole, flutriafol, metconazole, miclobutanil, penconazole, propiconazole, protiozole, triadimefon, triadimenol, tebuconazole, tetraconazole, triticonazole, and prochloraz. According to a further specific embodiment, these are ternary compositions which, as active compounds, comprise in each case only the three mentioned active components I, II and III.

A further specific embodiment relates to three-component compositions, where component I is compound I-3 and component II and component III are selected from the complex III respiration inhibitors at the Q ⁰ site as defined here for component II and component III respectively, where components II and III are not the same. In particular, components II and III are selected from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, picoxystrobin, pyrazlostrobin, and trifloxystrobin. According to a specific embodiment, these are ternary compositions that, as active compounds, comprise in each case only the three mentioned active components I, II and III.

Still another specific embodiment relates to three-component compositions, wherein component I is compound I-3, component II is selected from sterols biosynthesis inhibitors (SBI fungicides) as defined herein for component II and Component III is selected from complex II respiration inhibitors. According to a specific embodiment thereof, component II is selected from the group of C14 demethylase inhibitors (DMI fungicides) as defined herein for component II, in particular selected from cyproconazole, diphenoconazole, epoxiconazole, metconazole, propiconazole, protioconazole, tebuconazole, tetraconazole, and triticonazole. According to a further specific embodiment, component III is selected from the group of carboxamides, in particular selected from benodanil, benzovindiflupir, bixafen, boscalid, carboxin, fenfuram, fluopiram, flutolanil, fluxapiroxad, furametpir, isopirazam, mepronil, oxycarfenin, , pentiopirate, sedaxane, tecloftalam, tifluzamide, N- (4'-trifluoromethylthiobiphenyl-2-yl) -3-difluoromethyl-1-methyl-1H-pyrazol-4-carboxamide, N- (2- (1,3,3- trimethyl-butyl) -phenyl) -1,3-dimethyl-5-fluoro-1H-pyrazol-4-carboxamide, 3- (difluoromethyl) -1-methyl-N- (1,1,3-trimethylindan-4-yl ) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1-methyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 1,3-dimethyl-N- (1,1 , 3-trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1,5-dimethyl-N- (1, 1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (difluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide and 1,3,5-trimethyl-N- (1,1,3-trimethylindan- 4-yl) pyrazol-4-carboxamide, in particular, is se It includes benzovindiflupir, bixafen, boscalid, fluopiram, fluxapiroxad, isopirazam, penflufen, pentiopirad and sedaxane. According to a further specific embodiment, these are ternary compositions which, as active compounds, comprise in each case only the three mentioned active components I, II and III.

Still another specific embodiment relates to three-component compositions, where component I is compound I-3, component II is selected from the complex III respiration inhibitors at site Q ⁰ as defined herein for component II and component III is selected from complex II respiration inhibitors. In particular, component II is selected from the group of strobilurins as defined herein for component II. Specifically, component II is selected from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, picoxystrobin, pyraclostrobin, and trifloxystrobin. In accordance with a further specific embodiment, component III is selected from the group of carboxamides, in particular selected from benodanil, benzovindiflupir, bixafen, boscalid, carboxin, fenfuram, fluopiram, flutolanil, fluxapiroxad, furametpir, isopirazam, mepronil, oxycarfenin, pen , pentiopirate, sedaxane, tecloftalam, tifluzamide, N- (4'-trifluoromethylthiobiphenyl-2-yl) -3-difluoromethyl-1-methyl-1H-pyrazol-4-carboxamide, N- (2- (1,3,3- trimethyl-butyl) -phenyl) -1,3-dimethyl-5-fluoro-1H-pyrazol-4-carboxamide, 3- (difluoromethyl) -1-methyl-N- (1,1,3-trimethylindan-4-yl ) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1-methyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 1,3-dimethyl-N- (1,1 , 3-trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (difluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide and 1,3,5-trimethyl-N- (1,1,3-trimethylindan- 4-yl) pyrazol-4-carboxamide, in particular, is se It includes benzovindiflupir, bixafen, boscalid, fluopiram, fluxapiroxad, isopirazam, penflufen, pentiopirad and sedaxane. According to a further specific embodiment, these are ternary compositions which, as active compounds, comprise in each case only the three mentioned active components I, II and III.

Still another specific embodiment relates to three-component compositions, wherein component I is compound I-3, component II selects complex III respiration inhibitors at site Q ⁰ as defined herein for component II and component III is selected from Sterol biosynthesis inhibitors (SBI fungicides), in particular Delta14-reductase inhibitors. In a specific embodiment, component II is selected from the group of strobilurins as defined herein for component II. Specifically, component II is selected from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, picoxystrobin, pyraclostrobin, and trifloxystrobin. In a further specific embodiment, component III is fenpropimorph. According to a further specific embodiment, these are ternary compositions which, as active compounds, comprise in each case only the three mentioned active components I, II and III.

Still another specific embodiment relates to three-component compositions, wherein component I is compound I-3, component II selects complex III respiration inhibitors at site Q ⁰ as defined herein for component II and component III is selected from inhibitors of cell division and the cytoskeleton. In a specific embodiment, component II is selected from the group of strobilurins as defined herein for component II. Specifically, component II is selected from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, picoxystrobin, pyraclostrobin, and trifloxystrobin. In a further specific embodiment, component III is selected from tubulin inhibitors such as carbendazim. In a further specific embodiment, component III is selected from sales division inhibitors such as tubulin inhibitors such as metrafenone. According to a further specific embodiment, these are ternary compositions which, as active compounds, comprise in each case only the three mentioned active components I, II and III.

Still another specific embodiment relates to three-component compositions, where component I is compound I-3, component II is selected from the complex III respiration inhibitors at site Q ⁰ as defined herein for component II and component III is selected from inhibitors with multisite action. In a specific embodiment, component II is selected from the group of strobilurins as defined herein for component II. Specifically, component II is selected from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, picoxystrobin, pyraclostrobin, and trifloxystrobin. In a further specific embodiment, component III is selected from captan, Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, copper sulfate, sulfur, copper (tri) basic sulfate, mancozeb, maneb, metiram, propineb, tiram, captafol, folpet, chlorothalonil, dichlorofluanide, dithianon, dodine and 2,6-dimethyl-1H, 5H- [1,4] dithinoin [2,3-c: 5,6-c '] dipyrrol-1, 3,5,7 (2H, 6H) -tetraone, in particular captan, Bordeaux mixture, copper hydroxide, copper oxychloride, copper sulfate, copper (tri) basic sulfate, mancozeb, maneb, metiram, folpet, chlorothalonil , dithianon, dodine and 2,6-dimethyl-1H, 5H- [1,4] dithinoin [2,3-c: 5,6-c '] dipyrrole-1,3,5,7 (2H, 6H) - tetraone. In a particular embodiment, component III in said compositions is chlorothalonil. According to a further specific embodiment, these are ternary compositions which, as active compounds, comprise in each case only the three mentioned active components I, II and III.

Still another specific embodiment relates to three-component compositions, where component I is compound I-3, component II is selected from sterols biosynthesis inhibitors (SBI fungicides), in particular from demethylase inhibitors C14 (DMI fungicides) as defined here for component II, and component III is selected from inhibitors with multiple site action. In a specific embodiment, component II is selected from cyproconazole, metconazole, propiconazole, and protioconazole. Component III is specifically selected from captan, Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, copper sulfate, sulfur, copper (tri) basic sulfate, mancozeb, maneb, metiram, propineb, tiram, captafol , folpet, chlorothalonil, diclofluanide, dithianon, dodine and 2,6-dimethyl-1H, 5H- [1,4] dithinoin [2,3-c: 5,6-c '] dipyrrole-1,3,5,7 (2H, 6H) -tetraone, in particular captan, Bordeaux mixture, copper hydroxide, copper oxychloride, copper sulfate, copper (tri) basic sulfate, mancozeb, maneb, metiram, folpet, chlorothalonil, ditianon, dodine and 2,6-dimethyl-1H, 5H- [1,4] dithinoin [2,3-c: 5,6-c '] dipyrrole-1,3,5,7 (2H, 6H) -tetraone.

Still another specific embodiment relates to three-component compositions, where component I is compound I-3, component II is selected from sterols biosynthesis inhibitors (SBI fungicides), in particular from demethylase inhibitors C14 (DMI fungicides) as defined herein for Component II, and Component III is selected from signal transduction inhibitors. In a specific embodiment, component II is triticonazole and component III is fludioxonil.

In accordance with one embodiment, the present invention relates to three-component compositions, comprising a component I, that is, compound I-3, a component II selected from groups of groups A) to K) as defined herein for component II and a component III selected from groups A) to K).

According to a particular embodiment of the three-component compositions comprising three fungicides, the composition comprises compound I-3 as component I, fluxapyroxad as component II and pyraclostrobin or fenpropimorph as component III. In a further specific embodiment of the present invention, the three-component compositions of the invention comprise compound I-3 as component I, protioconazole as component II and fluxapiroxad, bixafen, pyraclostrobin, dimoxystrobin, picoxystrobin, fluoxastrobin, fluopyram or penflufen as component III. In such three-component compositions, the weight ratio of component 1 to component II is preferably from 1: 3 to 3: 1, in particular from 1: 2 to 2: 1. The weight ratio of component I to component III is in the range of 1:20 to 20: 1. It may be preferable that the weight ratio is in the region of 1:10 to 10: 1, preferably 1: 3 to 3: 1, in particular 1: 2 to 2: 1. The weight ratio of component I component III it is in the range of 1:20 to 20: 1, and in particular in the range of 1:10 to 10: 1. It may be preferable that the weight is in the range of 1: 3 to 3: 1, particularly 1: 2 to 2: 1. Said three-component compositions comprising two fungicides as components I and II are particularly suitable as fungicides as detailed below.

According to another embodiment, the present invention relates to the use of said compositions for the control of cereal pathogens, where the components are used in the aforementioned weight ratios. According to a specific embodiment, said compositions are used to control wheat pathogens, where the wheat pathogens are selected in particular from Septoria tritici, Stagonospora nodorum, Pyrenophora tritici repentis, Puccinia recondita, Puccinia striiformis and Blumeria graminis. Furthermore, said compositions are useful for the control of the selected wheat pathogens of Fusarium culmorum, Fusarium graminearum and Pseudocercosporella herpotrichoides. According to another specific embodiment, said compositions are used to control barley pathogens, selected from Pyrenophera teres, Rhychosporium secalis, Puccinia hordei and Blumeria graminis. Furthermore, said compositions are suitable for the control of selected barley pathogens of Ramularia collo-cygni and Pseudocercosporella herpotrichoides.

According to yet another specific embodiment, said compositions are used to control soybean pathogens, in particular selected from phakopsora pachyrizi, P. meibomiae and Microsphaera diffusa. In soybeans, said compositions can also be used effectively for the control of the so-called FDC (Complex of Foliar Diseases), for example, against Septoria glycines, Cercospora kikuchii, C. sojina, Corynespora cassiicola and / or Alternaria spp.

According to still another specific embodiment, said compositions are used to control corn pathogens, in particular selected from Cercospora zeae-maydis, Puccinia sorghi and Helminthosporium maydis.

In accordance with yet another specific embodiment, said compositions are used to control sugar beet pathogens, in particular selected from Cercospora beticola, Erysiphe betae, Ramularia betae and Uromyces betae.

According to yet another specific embodiment, said compositions are used for the control of peanut pathogens, in particular selected from Mycosphaerella arachidis (= Cercospora) and Puccinia arachidis.

According to still another specific embodiment, said compositions are used for the control of canola and canola pathogens, in particular selected from Sclerotinia sclerotiorum, Leptosphearia maculans and Alternaria alterna.

According to yet another specific embodiment, said compositions are used for the control of rice pathogens, in particular selected from Rhizoctonia solani and Pyricularia oryzae.

According to still another specific embodiment, said compositions are used for the control of pathogens in special crops, such as for example in grass, potatoes, tomatoes, cucurbits, grapes, apples, ornamental plants and bananas. Lawn pathogens that can be controlled using such compositions according to the present invention are selected in particular from Sclerotinia homeocarpon and Rhizoctonia solani. Potato and tomato pathogens that can be controlled according to the present invention are selected in particular from Alternaria solani, A. alternata and Rhizoctonia solani. A cucurbit pathogen that can be controlled using such compositions according to the present invention is in particular Sphaerotheca fuliginea. A grape pathogen that can be controlled using such compositions according to the present invention is in particular Uncinula necator and Botrytis cinerea. An apple pathogen that can be controlled using such compositions according to the present invention is in particular Podosphaera leucotricha and Venturia inaequalis. Ornamental pathogens that can be controlled using such compositions according to the present invention are selected in particular from Sphaerotheca fuliginea, Diplocarpon spp., Alternaria spp. and Sclerotinia spp. Banana pathogens that can be controlled using such compositions according to the present invention are selected in particular from Mycosphaerella fijiensis and Mycosphaerella musicola.

According to an embodiment thereof, the present invention relates to the composition of component I, fluxapyroxad and pyrazlostrobin, wherein two of the components are present in a weight ratio of 2: 1 to 1: 2. In particular, the weight ratios for all three components are from Component I to Component II 1: 1 to 2: 1; Component I to Component III 1: 1 to 2: 1 and Component II to Component III 1: 1 to 1: 2. It may be preferred if the components are present in a weight ratio of 1: 1: 1 to 2: 1: 2 or 2: 1: 2 to 2: 1: 1. The components are used in particular in synergistically effective amounts.

In accordance with another embodiment, the present invention relates to the composition comprising component I, fluxapyroxad and fenpropimorph, wherein two of the components are present in a weight ratio of 2: 1 to 1: 2. In particular, the weight ratios for all three components are from Component I to Component II 1: 1 to 2: 1; Component I to Component III 1: 3 to 1: 6 and Component II to Component III 1: 3 to 1: 6. May be preferred if Components are present in a weight ratio of 1: 1: 3 to 1: 1: 6. The components are used in particular in synergistically effective amounts.

A further embodiment refers to three component compositions, comprising a component I, i.e. compound I-3, component II selected from any one of groups A) to K) as defined herein for component II or any embodiment preferred thereof, and component III selected from group O) insecticides.

According to a further specific embodiment, component I is compound I-3, component II is selected from the complex III respiration inhibitors at Q ⁰ as defined herein for component II, in particular selected from the group of strobilurins, and component III is an insecticide, in particular one of the insecticides as defined below. Specifically, component II is selected from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, picoxystrobin, pyraclostrobin, and trifloxystrobin.

Still another specific embodiment relates to three-component compositions, wherein component I is compound I-3, component II is selected from sterols biosynthesis inhibitors (SBI fungicides) as defined herein for component II and Component III is an insecticide, in particular one of the insecticides as defined below. Specifically, component II is selected from the group of C14 demethylase inhibitors (DMI fungicides) as defined here for component II, in particular selected from cyproconazole, diphenoconazole, epoxiconazole, metconazole, propiconazole, protioconazole, tebuconazole, tetraconazole. and triticonazole.

Particularly preferred fungicidal components III used in the compositions of the invention are compounds selected from the group of the following compounds:

l l - l amethoctradin 11-38 fluquinconazole

11-2 amisulbrom 11-39 flusilazol

11-3 azoxystrobin 11-42 fluxapyroxad

11-4 bentiavalícarb

11-43 folpet

11-5 benzovíndiflupir

11-44 fosetil-A l.

11-6 bixafen

11-50 sopirazam

11-7 boscalid

11-51 provalicate

11-8 carbendazim

11-53 kresoxim-methyl

11-11 chlorothalonil

11-54 mancozeb

11-12 ciazofamid

11-60 metconazole

11-13 cyflufenamid

11-61 metiram

11-15 cyproconazole

11-62 Metrafenone

11-16 c¡prodin¡I 11-65 proquinazid

11-21 diphenoconazole 11-66 pyraclostrobin

11-23 dimoxystrobin 11-68 penflufen

11-25 ditianon 11-69 phosphorous acid

11-26 epoxiconazole 11-70 salt potassium

11-27 etaboxam phosphorous acid

11-31 fenpropidin 11-71 phosphorous acid sodium salt

11-32 fenpropímorf

11-33 fluazinam 11-72 pentiopirad

11-34 fludioxonil 11-73 picoxystrobin

11-74 prochloraz

11-35 fIuop¡col¡de

11-76 propiconazole

11-36 fluopi ram

11-78 protioconazole

11-37 fluoxastrobin

11-83 siltiofam

11-84 spiroxamine 11-92 trifloxystrobin

11-85 sulfur 11-93 triticonazole

11-86 tebuconazo 11-97 zoxamide

11-89 thiophanate-methyl

Particularly preferred fungicidal components III are compounds selected from the group of the following compounds:

Particularly preferred three-component compositions are compiled in Table T1, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized three-component composition. According to a specific aspect, these are ternary compositions that each only contains these three components as the active compound. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table T1: Composition of three components comprising a component 1, a component II, a component III.

As detailed above, components I contain chiral centers and therefore may be present as racemic mixtures, as pure enantiomers, or in the two enantiomers of component I may be present in any ratio (S) :( R) .

In accordance with particular embodiments of the invention, the respective component I is present as the (S) enantiomer. The specific compositions of three components comprising the enantiomer (S) of the respective component I are compiled in Table T1s, in which each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition. According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table T1s: Three-component compositions comprising a component I as the (S) enantiomer (abbreviated as (S) -I-3 for the (S) enantiomer of I-3) a component II and a component III, in particular ternary compositions containing the respective component I as (S) enantiomer, II and III as only active ingredients.

According to particular embodiments of the invention, the respective component I is present as the (R) enantiomer. The specific compositions of three components comprising the (R) enantiomer of the respective component I are compiled in Table T1r, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition. According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table T1s: Three-component compositions comprising a component I as the (R) enantiomer (abbreviated as (R) -I-3 for the (R) enantiomer of I-3), a component II and a component III, in particular compositions ternaries containing the respective component I as (R) enantiomer, II and III as only active ingredients

Other particularly preferred compositions are the three-component compositions, where component I is compound I-3 and components II are selected from

Said compositions are compiled in Table T1a, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition of three components. According to a specific aspect, these are ternary compositions that each only contains these three components as the active compound. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table T1a: Additional preferred composition of three components comprising a component I, a component II and a component III.

In Table T1a, according to particular embodiments of the description, the respective component I is present as the (S) enantiomer, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition . According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the enantiomer of the present invention (S). In Table T1a, according to other particular embodiments of the disclosure, the respective component I is present as the (R) enantiomer, where each row corresponds to an embodiment of the compositions according to the disclosure, that is, an individualized composition specific. According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the (R) enantiomer of the present disclosure. Also particularly preferred compositions are the three-component compositions, where component I is compound I-3, component II is selected from

and component III is a growth regulator, selected from:

The particularly preferred compositions of these compositions are compiled in Table T2, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition of three components. According to a specific aspect, these are ternary compositions that each only contains these three components as the active compound. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention. Table T2: Three-component composition comprising a component I, a fungicidal component II and a growth regulator as component III

In Table T2, according to particular embodiments of the invention, the respective component I is present as the (S) enantiomer, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition . According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the enantiomer of the present invention (S).

In Table T2, according to other particular embodiments of the invention, the respective component I is present as enantiomer (R), where each row corresponds to an embodiment of the compositions according to the invention, that is, an individualized composition specific. According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the (R) enantiomer of the present invention.

In Table T3, each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition of three components. According to a specific aspect, these are ternary compositions each of which only contains these three components as the active compound. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table T3: Compositions of three components comprising one component I and two plant growth regulators as component II and component III, where components II and III are different from each other.

In Table T3, according to particular embodiments of the invention, the respective component I is present as the (S) enantiomer, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition . According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the enantiomer of the present invention (S).

In Table T3, according to other particular embodiments of the invention, the respective component I is present as enantiomer (R), where each row corresponds to an embodiment of the compositions according to the invention, that is, an individualized composition specific. According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the (R) enantiomer of the present invention.

Particularly preferred compositions are the three-component compositions, where component I is compound I-3, component II is selected from the following fungicide compounds

-3 azoxystrobin 11-37 fluoxastrobin

-5 benzovindiflupir 11-42 fluxapyroxad

-6 bixafen 11-50 sopirazam

-7 boscalid 11-53 kresoxim-methyl

-11 chlorothalonil 11-60 metconazole

-21 diphenoconazole 11-62 metrafenone

-26 epoxiconazole 11-66 pyraclostrobin

-32 fenpropimorf 11-76 propiconazole

-33 fluazinam 11-78 protioconazole

11-85 sulfur 11-92 trif 1 ox i strob i na

11-86 tebuconazole

and component III is an insecticide selected from

and component III is an insecticide selected from

The particularly preferred compositions of these compositions are compiled in Table T4, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition of three components. According to a specific aspect, these are ternary compositions that each only contains these three components as the active compound. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table T4: Three-component composition comprising a component I, an additional specific fungicidal compound as component II and an insecticide as component III

In Table T4, according to particular embodiments of the invention, the respective component I is present as the (S) enantiomer, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition . According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the enantiomer of the present invention (S).

In Table T4, according to other particular embodiments of the invention, the respective component I is present as enantiomer (R), where each row corresponds to an embodiment of the compositions according to the invention, that is, an individualized composition specific. According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the (R) enantiomer of the present invention.

A further aspect of the present invention are the novel two-component compositions comprising Component II and Component III as listed in Table T4 above, i.e. the compositions given in Table BT4 below, insofar as they are innovative.

Particularly preferred compositions are the three-component compositions, where component I is compound I-3 and component II is

and component III is fipronil (compound II-20c).

The particularly preferred compositions of these compositions are compiled in Table T5, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition of three components. According to a specific aspect, these are ternary compositions that each only contains these three components as the active compound.

Table T5: Three-component compositions comprising a component I, an insecticidal compound as component II and fipronil as component III.

In Table T5, according to particular embodiments of the invention, the respective component I is present as the (S) enantiomer, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition . According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the enantiomer of the present invention (S).

In Table T5, according to other particular embodiments of the invention, the respective component I is present as enantiomer (R), where each row corresponds to an embodiment of the compositions according to the invention, that is, an individualized composition specific. According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the (R) enantiomer of the present invention.

In accordance with a further aspect, the present invention relates to four-component compositions, i.e. compositions comprising component I, i.e. compound I-3, a component II selected from groups A) to O) as here defined for component II, a component III selected from groups A) to O) and a component IV, also selected from groups A) to O), where components II, III and IV are different active ingredients. According to a specific embodiment thereof, exactly four active compounds as defined are present in these compositions (also referred to herein as "quaternary compositions"). The composition can, of course, contain any type of additive or the like as detailed below to provide a formulation suitable for use in agriculture.

In the four-component compositions of the invention, the weight ratio of component I to the first additional active compound (component II) depends on the properties of the active compounds in question. Preferably it is in the range of 1: 3 to 3: 1, in particular from 1: 2 to 2: 1. The weight ratio of compound I to the second additional active compound (component III) can be particularly 1000: 1 to 1: 1000, specifically 500: 1 to 1: 500. It is preferably in the range of 1: 100 to 100: 1, preferably in the range of 1:50 to 50: 1, and in particular in the range of 1:20 to 20: 1. It may be preferable that the weight ratio is in the region of 1:10 to 10: 1, preferably 1: 3 to 3: 1, in particular 1: 2 to 2: 1. The weight ratio of compound I to the third additional active compound (component IV) is preferably in the range of 1: 100 to 100: 1, preferably in the range of 1:50 to 50: 1, and in particular in the range of 1 : 20 to 20: 1. It may be preferable that the weight ratio is in the region of 1:10 to 10: 1, preferably 1: 3 to 3: 1, in particular 1: 2 to 2: 1. The weight ratio of the first additional active compound (component II) to the second additional active compound (component III) can be particularly 1000: 1 to 1: 1000, specifically 500: 1 to 1: 500. It is preferably in the range of 1: 100 to 100: 1, preferably in the range of 1:50 to 50: 1, and in particular in the range of 2:10 to 20: 1. It may be preferable that the weight ratio is in the region of 1:10 to 10: 1, preferably 1: 3 to 3: 1, in particular 1: 2 to 2: 1. The weight ratio of the first additional active compound (component II) to the third additional active compound (component IV) is preferably in the range of 1: 100 to 100: 1, preferably in the range of 1:50 to 50: 1 and in particular in the range of 1:20 to 20: 1. It may be preferable that the weight ratio is in the region of 1:10 to 10: 1, preferably 1: 3 to 3: 1, in particular 1: 2 to 2: 1. The weight ratio of the second additional active compound (component III) to the third additional active compound (component IV) can be particularly 1000: 1 to 1: 1000, specifically 500: 1 to 1: 500. It is preferably in the range of 1: 100 to 100: 1, preferably in the range of 1:50 to 50: 1, and in particular in the range of 1:20 to 20: 1. It may be preferable that the weight ratio is in the region of 1:10 to 10: 1, preferably 1: 3 to 3: 1, in particular 1: 2 to 2: 1.

In accordance with one embodiment, the present invention relates to four-component compositions, comprising a component I, i.e., compound I-3, a component II selected from the groups of groups A) to K) as defined herein for component II, a component III selected from groups A) to K) and a component IV selected from groups A) to K), wherein components II, III and IV are different active compounds.

A specific embodiment refers to four-component compositions, where component I is compound I-3 and component II is selected from group A) of complex III respiration inhibitors in the Qo site as defined here for component II, component III is selected from group B) of sterol biosynthesis inhibitors (SBI fungicides) and component IV is selected from complex II respiration inhibitors. According to a specific embodiment thereof, component II is selected from the group of strobilurins as defined herein for component II. Specifically, component II is selected from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, picoxystrobin, pyraclostrobin, and trifloxystrobin. According to a further specific embodiment thereof, component III is selected from the group of C14 demethylase inhibitors (DMI fungicides), in particular selected from cyproconazole, diphenoconazole, epoxiconazole, fluquinconazole, flusilazole, flutriafol, metconazole, miclobutanil, penconazole, propiconazole, protiozole, triadimefon, triadimenol, tebuconazole, tetraconazole, triticonazole, and prochloraz. According to a further specific embodiment thereof, component IV is selected from the group of carboxamides, in particular selected from benodanil, benzovindiflupir, bixafen, boscalid, carboxin, fenfuram, fluopiram, flutolanil, fluxapiroxad, furametpir, isopirazam, mepronil, oxycarboxin , penflufen, pentiopyrad, sedaxane, tecloftalam, tifluzamide, N- (4'-trifluoromethylthiobiphenyl-2-yl) -3-difluoromethyl-1-methyl-1H-pyrazol-4-carboxamide, N- (2- (1,3, 3-trimethyl-butyl) -phenyl) -1,3-dimethyl-5-fluoro-1H-pyrazol-4-carboxamide, 3- (difluoromethyl) -1-methyl-N- (1,1,3-trimethylindan-4 -yl) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1-methyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 1,3-dimethyl-N- (1 , 1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (Difluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide and 1,3,5-trimethyl-N- (1,1,3- trimethylindan-4-yl) pyrazol-4-carboxamide, in particular selected from benzovindiflupir, bixafen, boscalid, fluopiram, fluxapiroxad, isopirazam, penflufen, pentiopirad, and sedaxane. According to another specific embodiment, these are quaternary compositions that, as active compounds, comprise in each case only the four mentioned active components I, II, III and IV.

A further specific embodiment relates to four-component compositions, where component I is compound I-3 and component II is selected from group A) of complex III respiration inhibitors at site Q ⁰ as defined here for component II, component III is selected from group B) of sterols biosynthesis inhibitors (SBI fungicides) and component IV is selected from inhibitors with multiple site action. According to a specific embodiment thereof, component II is selected from the group of strobilurins as defined herein for component II. Specifically, component II is selected from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, picoxystrobin, pyraclostrobin, and trifloxystrobin. According to a further specific embodiment thereof, component III is selected from the group of C14 demethylase inhibitors (DMI fungicides), in particular selected from cyproconazole, diphenoconazole, epoxiconazole, fluquinconazole, flusilazole, flutriafol, metconazole, miclobutanil, penconazole, propiconazole, protiozole, triadimefon, triadimenol, tebuconazole, tetraconazole, triticonazole, and prochloraz. According to a further specific embodiment thereof, component IV is selected from copper acetate, copper hydroxide, copper oxychloride, copper sulfate, sulfur, copper (tri) basic sulfate, mancozeb, maneb, metiram, propineb, tiram, captafol, folpet, chlorothalonil, dichlorofluanide, dithianon and 2,6-dimethyl-1H, 5H- [1,4] dithinoin [2,3-c: 5,6-c '] dipyrrole-1,3,5 , 7 (2H, 6H) -tetraone, in particular chlorothalonil. According to another specific embodiment, these are quaternary compositions that, as active compounds, comprise in each case only the four mentioned active components I, II, III and IV.

A further specific embodiment relates to four-component compositions, where component I is compound I-3 and component II is selected from group A) of complex III respiration inhibitors at site Q ⁰ as defined here for component II, component III is selected from group B) of complex II respiration inhibitors and component IV is selected from inhibitors with multiple site action. According to a specific embodiment thereof, component II is selected from the group of strobilurins as defined herein for component II. Specifically, component II is selected from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, orystrobin, picoxystrobin, pyrazlostrobin, and trifloxystrobin. According to a further specific embodiment thereof, component III is selected from the group of carboxamides, in particular selected from benodanil, benzovindiflupir, bixafen, boscalid, carboxin, fenfuram, fluopiram, flutolanil, fluxapiroxad, furametpir, isopirazam, mepronil, oxiluboxin , penfifenboxin, penflufoxenbox, pentiopirate, sedaxane, tecloftalam, tifluzamide, N- (4'-trifluoromethylthiobiphenyl-2-yl) -3-difluoromethyl-1-methyl-1 H-pyrazol-4-carboxamide, N- (2- (1 , 3,3-trimethyl-butyl) -phenyl) -1,3-dimethyl-5-fluoro-1 H-pyrazol-4-carboxamide, 3- (difluoromethyl) -1-methyl-N- (1,1,3 -trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1-methyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 1,3-dimethyl- N- (1,1, 3-trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazole- 4-carboxamide, 3- (difluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide and 1,3,5-trimethyl-N- (1, 1,3-trimethylindan-4-yl) pyrazol-4- carboxamide, in particular selected from benzovindiflupir, bixafen, boscalid, fluopiram, fluxapiroxad, isopirazam, penflufen, pentiopyrad and sedaxane. According to a further specific embodiment thereof, component IV is chlorothalonil. According to a further specific embodiment, these are quaternary compositions which, as active compounds, comprise in each case only the four mentioned active components I, II, III and IV.

Another specific embodiment relates to four-component compositions, where component I is as defined above, component II is selected from group A) of complex III respiration inhibitors at the Qo site, component III is selected from group B) of complex II respiration inhibitors and component IV is selected from sterols biosynthesis inhibitors (SBI fungicides), in particular Delta14 inhibitors -reductase. According to a specific embodiment thereof, component II is selected from the group of strobilurins. Specifically, component II is selected from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, orystrobin, picoxystrobin, pyrazlostrobin, and trifloxystrobin. According to a further specific embodiment thereof, component III is selected from the group of carboxamides, in particular selected from benodanil, benzovindiflupir, bixafen, boscalid, carboxin, fenfuram, fluopiram, flutolanil, fluxapiroxad, furametpir, isopirazam, mepronil, oxiluboxin , penfifenboxin, penflufoxenbox, pentiopirate, sedaxane, tecloftalam, tifluzamide, N- (4'-trifluoromethylthiobiphenyl-2-yl) -3-difluoromethyl-1-methyl-1 H-pyrazol-4-carboxamide, N- (2- (1 , 3,3-trimethyl-butyl) -phenyl) -1,3-dimethyl-5-fluoro-1 H-pyrazol-4-carboxamide, 3- (difluoromethyl) -1-methyl-N- (1,1,3 -trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1-methyl-N- (1, 1,3-trimethylindan-4- yl) pyrazol-4-carboxamide, 1,3-dimethyl- N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazole- 4-carboxamide, 3- (difluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide and 1,3,5-trimethyl-N- (1, 1,3-trimethylindan-4-yl) pyrazol-4- carboxamide, in particular selected from benzovindiflupir, bixafen, boscalid, fluopiram, fluxapiroxad, isopirazam, penflufen, pentiopyrad and sedaxane. In accordance with another specific embodiment thereof, component IV is fenpropimorphic. According to another specific embodiment, these are quaternary compositions that, as active compounds, comprise in each case only the four mentioned active components I, II, III and IV.

A further specific embodiment refers to four component compositions, where component I is as defined above, component II is selected from group A) of the complex III respiration inhibitors at site Q ⁰ , component III is selected from group B) of complex II respiration inhibitors and component IV is selected from inhibitors of cell division and cytoskeleton. According to a specific embodiment thereof, component II is selected from the group of strobilurins. Specifically, component II is selected from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, orystrobin, picoxystrobin, pyrazlostrobin, and trifloxystrobin. According to a further specific embodiment thereof, component III is selected from the group of carboxamides, in particular selected from benodanil, benzovindiflupir, bixafen, boscalid, carboxin, fenfuram, fluopiram, flutolanil, fluxapiroxad, furametpir, isopirazam, mepronil, oxiluboxin , penfifenboxin, penflufoxenbox, pentiopirate, sedaxane, tecloftalam, tifluzamide, N- (4'-trifluoromethylthiobiphenyl-2-yl) -3-difluoromethyl-1-methyl-1-pyrazole-4-carboxamide, N- (2- (1, 3,3-trimethyl-butyl) -phenyl) -1,3-dimethyl-5-fluoro-1H-pyrazol-4-carboxamide, 3- (difluoromethyl) -1-methyl-N- (1,1,3-trimethylindan -4-yl) -pyrazole-4-carboxamide, 3- (trifluoromethyl) -1-methyl-N- (1,1,3-trimethylindan-4-yl) -pyrazol-4-carboxamide, 1,3-dimethyl- N- (1, 1,3-trimethylindan-4-yl) pi razol-4-carboxamide, 3- (trifluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazole -4-carboxamide, 3- (difluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide and 1,3,5-trimethyl-N- (1 1,3-trimethylindan-4-yl) pyrazol-4-c arboxamide, in particular selected from benzovindiflupir, bixafen, boscalid, fluopiram, fluxapiroxad, isopirazam, penflufen, pentiopyrad and sedaxane. According to a further specific embodiment thereof, component IV is selected from cell division inhibitors such as tubulin inhibitors such as metrafenone. According to another specific embodiment, these are quaternary compositions that, as active compounds, comprise in each case only the four mentioned active components I, II, III and IV.

Still another specific embodiment relates to four-component compositions, where component I is as defined above, component II is selected from sterols biosynthesis inhibitors (SBI fungicides), in particular C14 demethylase inhibitors ( fungicides DMI), component III is selected from signal transduction inhibitors and component IV is selected from the group of carboxamides, in particular selected from benodanil, benzovindiflupir, bixafen, boscalid, carboxin, fenfuram, fluopiram, flutolanil, fluxapiroxad, furametpir, isopirazam, mepronil, oxycarboxin, penflufen, pentiopyrad, sedaxane, tecloftalam, thifluzamide, N- (4'-trifluoromethylthiobiphenyl-2-yl) -3-difluoromethyl-1-methyl-1H-pyrazol-4-carbox 2- (1,3,3-trimethyl-butyl) -phenyl) -1,3-dimethyl-5-fluoro-1H-pyrazol-4-carboxamide, 3- (difluoromethyl) -1-methyl-N- (1, 1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1-methyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 1,3-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1,5-dimethyl-N- (1, 1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (difluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide and 1 , 3,5-trimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, in particular selected from benzovindiflupir, bixafen, boscalid, fluopiram, fluxapiroxad, isopirazam, penflufen, pentiopyrad and sedaxane. In a specific embodiment, component II is triticonazole, component III is fludioxonil, and component IV is fluxapiroxad.

According to a further embodiment of the four-component compositions, component I is as defined above and components II, III and IV are selected from Group M), growth regulators, in particular selected from chlormequat (chlormequat chloride ), mepicuat (mepicuat chloride), paclobutrazol, prohexadione (prohexadione-calcium), trinexapac-ethyl and uniconazole, where components II, III and IV are different active ingredients.

Particularly preferred four-component compositions are compiled in Table Q1 and Q1a, where each row corresponds to an embodiment of the compositions according to the invention, i.e. a specific individualized four-component composition. According to a specific aspect, these are quaternary compositions that each contain only these four components as an active compound. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table Q1: Four-component composition comprising a component I, a fungicide or growth regulator as components II and III and a fungicide as component IV.

In Table Q1, according to particular embodiments of the invention, the respective component I is present as the (S) enantiomer, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition . According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the enantiomer of the present invention (S).

In Table Q1, according to other particular embodiments of the invention, the respective component I is present as enantiomer (R), where each row corresponds to an embodiment of the compositions according to the invention, that is, an individualized composition specific. According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the (R) enantiomer of the present invention.

Other particularly preferred four-component compositions are compiled in Table Q2, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized four-component composition. According to a specific aspect, these are quaternary compositions that each contain only these four components as an active compound. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table Q2: Composition of four components comprising a component I and fungicidal compounds as components II, III and IV.

In Table Q2, according to particular embodiments of the invention, the respective component I is present as the (S) enantiomer, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition . According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the enantiomer of the present invention (S).

In Table Q2, according to other particular embodiments of the invention, the respective component I is present as enantiomer (R), where each row corresponds to an embodiment of the compositions according to the invention, that is, an individualized composition specific. According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the (R) enantiomer of the present invention.

Other particularly preferred four-component compositions are compiled in Table Q3, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized four-component composition. According to a specific aspect, these are quaternary compositions that each contain only these four components as an active compound. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention.

Table Q3: Compositions of four components that comprise a component I and growth regulators as components II, III and IV.

In Table Q3, according to particular embodiments of the invention, the respective component I is present as the (S) enantiomer, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition . According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Also, also each combination of the individualized compositions in this table represents embodiments of the enantiomer of the present invention (S).

In Table Q3, according to other particular embodiments of the invention, the respective component I is present as enantiomer (R), where each row corresponds to an embodiment of the compositions according to the invention, that is, an individualized composition specific. According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the (R) enantiomer of the present invention.

Other particularly preferred compositions are the four-component compositions, where component I is compound I-3, component II is selected from the following fungicides

and component III selected from the group of the following compounds:

and component IV is fipronil (compound II-20c).

Specifically preferred embodiments of these compositions are compiled in Table Q4, where each row corresponds to one embodiment of the compositions according to the invention, i.e., a specific individualized composition of four components. According to a specific aspect, these are quaternary compositions that each contain only these four components as an active compound. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the present invention. Table Q4: Four component composition comprising a component I, a particular fungicide as component II and specific insecticides as components III and IV.

In Table Q4, according to particular embodiments of the invention, the respective component I is present as the (S) enantiomer, where each row corresponds to an embodiment of the compositions according to the invention, that is, a specific individualized composition . According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the enantiomer of the present invention (S).

In Table Q4, according to other particular embodiments of the invention, the respective component I is present as enantiomer (R), where each row corresponds to an embodiment of the compositions according to the invention, that is, an individualized composition specific. According to a specific aspect, these are ternary compositions that each only contains these two components as active compounds. Furthermore, each combination of the individualized compositions in this table also represents embodiments of the (R) enantiomer of the present invention.

A further aspect of the disclosure is compositions comprising more than four active ingredients, such as, in particular, five-component compositions. In addition to the four components I, II, III and IV as detailed above, these compositions of the invention comprise a component V. Component V is selected from any one of groups A) to O). If desired, any additional active components, such as component V, are added in a ratio of 20: 1 to 1:20, in particular 10: 1 to 1:10, more particularly 3: 1 to 1: 3, to the compound I.

According to an embodiment of the five component compositions, components I, II, III and IV are as defined and preferably defined above, and component V is selected from any one of groups A) to K).

A specific embodiment refers to five component compositions, wherein component I is compound I-3, components II, III and IV are as defined above and preferably defined above, and component V is selected from group A ) of respiration inhibitors. According to an embodiment thereof, component V is selected from the group of complex III inhibitors at site Q ⁰ , in for example, strobilurins Specifically, component V is selected from the group consisting of azoxystrobin, dimoxystrobin, fluoxastrobin, kresoxim-methyl, orystrobin, picoxystrobin, pyrazlostrobin, trifloxystrobin, famoxadone, and fenamidone. According to another embodiment thereof, component V is selected from the group of complex II inhibitors, for example, carboxamides. Specifically, component V is selected from the group consisting of benzovindiflupir, bixafen, boscalid, fluopiram, fluxapiroxad, isopirazam, penflufen, pentiopyrad, and sedaxane. According to another embodiment, component V is selected from the group of ametotradine, ciazofamide, fluazinam, fenthin salts such as fenthin acetate.

A specific embodiment refers to five component compositions, where component I is compound I-3, components II, III and IV are as defined above and preferably defined above, and component V is selected from group B ) of inhibitor sterols biosynthesis (SBI fungicides). According to an embodiment thereof, component V is selected from the group of C14 demethylase inhibitors (DMI fungicides), selected from cyproconazole, diphenoconazole, epoxiconazole, fluquinconazole, flusilazole, flutriafol, metconazole, miclobutanil, penconazole, propiconazole, protioconazole , triadimefon, triadimenol, tebuconazole, tetraconazole, triticonazole, prochloraz, fenarimol, and triforine. According to another embodiment thereof, component V is selected from the group of delta14-reductase inhibitors, in particular dodemorph, fenpropimorph, tridemorph, fenpropidine and spiroxamine. According to a further embodiment thereof, component V is selected from the group of 3-keto reductase inhibitors such as fenhexamide.

According to a further embodiment of the five component compositions, component I is compound I-3, components II, III and IV are as defined above and preferably defined above, and component V is selected from group C) of nucleic acid synthesis inhibitors and particularly selected from metalaxyl, (metalaxyl-M) mefenoxam, ofurace.

According to a further embodiment of the five-component compositions, component I is compound I-3, components II, III and IV are as defined above and preferably defined above, and component V selected from group D) of cell division and cytoskeleton inhibitors, such as benomyl, carbendazim, methyl thiophanate, etaboxam, fluopicolide, zoxamide, metrafenone, pyriophenone, in particular etaboxam, zoxamide and metrafenone.

In accordance with a further embodiment of the five-component compositions, component I is compound I-3, components II, III and IV are as defined above and preferably defined above, and component V is selected from group E ) of amino acid and protein synthesis inhibitors, in particular selected from cyprodinil, mepanipyrim and pyrimethanil.

According to a further embodiment of the five-component compositions, component I is compound I-3, components II, III, and IV are as defined above and preferably defined above, and component V is selected from group F ) signal transduction inhibitors, in particular selected from iprodione, fludioxonil, vinclozolin and quinoxifen.

According to a further embodiment of the five component compositions, component I is compound I-3, components II, III and IV are as defined above and preferably defined above, and component V is selected from group G ) of lipid and inhibitors of membrane synthesis, such as dimetomorph, flumorfo, iprovalicarb, bentiavalicarb, mandipropamid and propamocarb.

According to a further embodiment of the five component compositions, component I is compound I-3, components II, III and IV are as defined above and preferably defined above, and component V is selected from group H ) of multi-site inhibitors, in particular selected from copper acetate, copper (tri) basic sulfate, copper oxychloride, copper sulfate, sulfur, mancozeb, metiram, propineb, tiram, captafol, folpet, chlorothalonil, diclofluanide and ditianon.

According to a further embodiment of the five component compositions, component I is compound I-3, components II, III and IV are as defined above and preferably defined above, and component V is selected from group I ) of cell wall synthesis inhibitors, in particular selected from carpropamid and phenoxanil.

According to a further embodiment of the five component compositions, component I is compound I-3, components II, III and IV are as defined above and preferably defined above, and component V is selected from group J ) of plant defense inducers, in particular selected from acibenzolar-S-methyl, probenazol, tiadinil, fosetil, fosetil-aluminum, phosphorous acid and salts thereof such as phosphorous acid potassium salt, sodium acid salt phosphorous, phosphorous acid calcium salt, phosphorous acid lithium salt and phosphorous acid aluminum salt.

According to a further embodiment of the five component compositions, component I is compound I-3, components II, III and IV are as defined above and preferably defined above, and component V is selected from group K ), in particular selected from cymoxanil, proquinazid and N-methyl-2- {1 - [(5-methyl-3-trifluoromethyl-1H-pi razoM-yl) -acetyl] -piperidin-4-yl} -N- [ (1R) -1,2,3,4-tetrahydronaphthalen-1-yl] -4-thiazolcarboxamide.

In accordance with a further embodiment of the five-component compositions, component I is compound I-3, components II, III and IV are as defined above and preferably defined above, and component V is selected from any one from group L) (plant antifungal and bioactivating biological control agents), in particular selected from Bacillus subtilis strain NRRL No. B-21661, Bacillus pumilus strain NRRL No. B-30087 and Ulocladium oudemansii.

In accordance with a further embodiment of the five-component compositions, component I is compound I-3, components II, III and IV are as defined above and preferably defined above, and component V is selected from any one group M) (growth regulators). According to a specific embodiment, the growth regulator is selected from chlormequat (chlormequat chloride), mepicuat (mepicuat chloride), paclobutrazol, prohexadione (prohexadione-calcium), trinexapac-ethyl and uniconazole.

According to a further embodiment of the five component compositions, the components of compound I of compound I-3 II, III and IV are as defined above and preferably defined above, and component V is selected from any one of the group N) (herbicides).

In accordance with a further embodiment of the five-component compositions, component I is compound I-3, components II, III and IV are as defined above and preferably defined above, and component V is selected from any one group O) (insecticides). According to a specific embodiment, the insecticide is selected from the group of organo (thio) phosphates, in particular selected from the group consisting of acetate, chlorpyrifos, diazinon, dichlorvos, dimethoate, fenitrotion, methamidophos, metidathion, methyl parathion, Monocrotophos, Forate , profenofos and terbufos. According to a further specific embodiment, the insecticide is selected from the group of carbamates, in particular selected from the group consisting of aldicarb, carbaryl, carbofuran, carbosulfan, methomyl and thiodicarb. According to a further specific embodiment, the insecticide is selected from the group of pyrethroids, in particular selected from the group consisting of: biphethrin, cyfluthrin, cypermethrin, alpha-cypermethrin, zeta-cypermethrin, deltamethrin, sphevalerate, lambda-cyhalothrin and tefluthrin . According to a further specific embodiment, the insecticide is selected from the group of insect growth regulators, in particular selected from the group consisting of lufenuron and spirotetramat. According to still another specific embodiment, the insecticide is selected from the group of the nicotine receptor agonists / antagonists, in particular selected from the group consisting of: clothianidin, imidacloprid, thiamethoxam and thiacloprid. According to a further specific embodiment, the insecticide is selected from the group of GABA antagonists, in particular selected from the group consisting of: endosulfan and fipronil. According to a further specific embodiment, the insecticide is selected from the group of macrocyclic lactones, in particular selected from the group consisting of: abamectin, emamectin, spinosad and spinetoram. According to a further specific embodiment, the insecticide is hydramethylnon. According to another specific embodiment, the insecticide is fenbutatin oxide. According to a further specific embodiment, the insecticide is selected from the group consisting of chlorfenapir, indoxacarb, metaflumizone, flonicamid, flubendiamide, ciazipir (HGW86), and cyflomethophen.

The compositions according to the invention are suitable as fungicides. They are distinguished by outstanding efficacy against a broad spectrum of plant pathogenic fungi, including soil-borne fungi, which are especially derived from the classes of Plasmodiophoromycetes, Peronosporomycetes (syn. Oomycetes), Chytridiomycetes, Zygomycetes, Ascomycetes, Basidiomycetes, and Deuteromycetes . Fungi imperfecti). Some are systemically effective and can be used in crop protection as foliar fungicides, seed coating fungicides, and soil fungicides. In addition, they are suitable for controlling harmful fungi, which occur, among others, on wood or plant roots.

Some compositions of the invention are particularly suitable for seed treatment. For example, a three component composition of the invention, wherein component I is as defined above, component II is selected from sterols biosynthesis inhibitors (SBI fungicides) as defined herein for component II, in particular of C14 demethylase inhibitors (DMI fungicides) as defined herein for component II, and component III is selected from signal transduction inhibitors, it is useful for seed treatment, where, in a specific embodiment , component II is triticonazole and component III is fludioxonil.

Furthermore, some four component compositions of the invention are specifically useful for seed treatment. For example, compositions in which Component I is as defined above, Component II is selected from sterol biosynthesis inhibitors (SBI fungicides) as defined herein for Component II, particularly those C14 demethylase inhibitors (DMI fungicides) as defined herein for component II, component III is selected from signal transduction inhibitors and component IV is selected from the group of carboxamides, in particular selected from benodanil , benzovindiflupir, bixafen, boscalid, carboxin, fenfuram, fluopiram, flutolanil, fluxapiroxad, furametpir, isopirazam, mepronil, oxicarboxin, penflufen, pentiopirad, sedaxan-tecloftalam, tifluzamide, N- (4) difluoromethyl-1-methyl-1H-pyrazol-4-carboxamide, N- (2- (1,3,3-trimethyl-butyl) -phenyl) -1,3-dimethyl-5-fluoro-1H-pyrazole-4- carboxamide, 3- (difluoromethyl) -1-methyl-N- (1,1,3-trimethylindan-4-yl) pyrazo l-4-carboxamide, 3- (trifluoromethyl) -1-methyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 1,3-dimethyl-N- (1,1, 3-trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 3- ( difluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide and 1,3,5 -trimethyl-N- (1,1,3-trimethylindan-4 -yl) pyrazole-4-carboxamide, in particular selected from benzovindiflupir, bixafen, boscalid, fluopiram, fluxapiroxad, isopirazam, penflufen, pentiopyrad and sedaxane. In a specific embodiment for seed treatment, component II is triticonazole, component III is fludioxonil and component IV is fluxapiroxad.

The compositions according to the invention are particularly important in the control of a multitude of phytopathogenic fungi in various cultivated plants, such as cereals, for example, wheat, rye, barley, triticale, oats or rice; beets, for example, sugar beets or fodder beets; fruits, such as pommel, stone fruit, or soft fruit, for example, apples, pears, plums, peaches, almonds, cherries, strawberries, raspberries, blackberries, or gooseberries; leguminous plants, such as lentils, peas, alfalfa or soybeans; oleaginous plants, such as rapeseed, mustard, olives, sunflowers, coconut, cocoa beans, castor oil plants, oil palms, ground walnuts or soy; cucurbits, such as pumpkins, cucumbers, or melons; fiber plants such as cotton, flax, hemp or jute; citrus, such as oranges, lemons, grapefruits, or tangerines; vegetables, such as spinach, lettuce, asparagus, cabbage, carrots, onions, tomatoes, potatoes, cucurbits, or paprika; Lauraceae plants, such as avocados, cinnamon or camphor; power plants and raw materials, such as corn, soybeans, rapeseed, sugar cane or oil palm; corn; tobacco; walnuts; coffee; tea; bananas; vines (table grapes and grape juice vines); hop; grass; sweet leaf (also called Stevia); natural rubber plants or ornamental and forest plants, such as flowers, shrubs, broad-leaved trees or evergreen trees, for example conifers and on plant propagation material such as seeds and their growing material plants.

Preferably, the compositions of the invention are used to control a multitude of fungi in field crops, such as potatoes, sugar beets, tobacco, wheat, rye, barley, oats, rice, corn, cotton, soybeans, rapeseed, legumes, sunflowers , coffee or sugar cane; fruits; vines; ornamental; or vegetables, such as cucumbers, tomatoes, beans, or pumpkins.

The term "plant propagation material" is to be understood to denote all generative parts of the plant, such as seeds and vegetative plant material, such as cuttings and tubers (eg, potatoes), which can be used for plant multiplication. This includes seeds, roots, fruits, tubers, bulbs, rhizomes, buds, shoots, and other parts of plants, including seedlings and young plants, that will be transplanted after germination or after soil emergence. These young plants can also be protected before transplanting by means of total or partial treatment by immersion or pouring.

Preferably, the treatment of plant propagation materials with the components of the compositions of the invention and the compositions of the invention, respectively, is used to control a multitude of fungi in cereals, such as wheat, rye, barley and oats; rice, corn, cotton and soy.

The term "cultivated plants" should be understood to include plants that have been modified by genetic improvement, mutagenesis, or genetic engineering, including, but not limited to, agricultural or biotech products on the market or in development (see http: // cera- gmc.org/, see the GM crop database therein). Genetically modified plants are plants, the genetic material of which has been so modified through the use of recombinant DNA techniques that, under natural circumstances, they cannot be readily obtained by crossing, mutating or natural recombination. Typically, one or more genes have been integrated into the genetic material of a genetically modified plant to improve certain properties of the plant. Such genetic modifications also include, but are not limited to, targeted post-translational modification of protein (s), oligo, or polypeptides, for example, by glycosylation or additions of polymers such as prenylated, acetylated, or farnesylated residues or PEG residues.

Plants that have been modified by reproduction, mutagenesis, or genetic engineering, for example, have become tolerant to applications of specific classes of herbicides, such as auxin herbicides such as dicamba or 2,4-D; bleach herbicides such as hydroxyphenylpyruvate dioxygenase (HPPD) inhibitors or phytoene desaturase inhibitors (PDS); acetolactate synthase (ALS) inhibitors such as sulfonylureas or imidazolinones; enolpiruvilshikimate-3-phosphate synthase (EPSPS) inhibitors, such as glyphosate; glutamine synthetase (GS) inhibitors such as glufosinate; protoporphyrinogen-IX oxidase inhibitors; lipid biosynthesis inhibitors such as acetyl CoA carboxylase (ACCase) inhibitors; or oxynyl herbicides (i.e., bromoxynil or ioxynil) as a result of conventional genetic improvement or genetic engineering methods. In addition, plants have become resistant to multiple classes of herbicides through multiple genetic modifications, such as resistance to glyphosate and glufosinate or glyphosate and herbicide of another class, such as ALS inhibitors, HPPD inhibitors, auxin herbicides or ACCase inhibitors. These herbicide resistance technologies are, for example, described in Pest Managem. Sci. 61, 2005, 246; 61,2005, 258; 61,2005, 277; 61, 2005, 269; 61, 2005, 286; 64, 2008, 326; 64, 2008, 332; Weed Sci. 57, 2009, 108; Southern. J. Agricult. Res. 58, 2007, 708; Science 316, 2007, 1185; and references cited therein. Several cultivated plants have become herbicide tolerant by conventional breeding methods (mutagenesis), for example, summer canola Clearfield® (Canola, BASF SE, Germany) is tolerant to imidazolinones, eg imazamox, or Sunflowers ExpressSun ® (DuPont, United States) are tolerant to sulfonylureas, eg, tribenuron. Genetic engineering methods have been used to make cultivated plants, such as soybeans, cotton, corn, beets, and rapeseed, tolerant to herbicides such as glyphosate and glufosinate, some of which are commercially available with Trade names RoundupReady® (glyphosate tolerant, Monsanto, United States), Cultivance® (imidazolinone tolerant, BASF SE, Germany) and LibertyLink® (glufosinate tolerant, Bayer CropScience, Germany).

Furthermore, plants are also covered by the use of recombinant DNA techniques capable of synthesizing one or more insecticidal proteins, especially those known from the bacterial genus Bacillus, particularly from Bacillus thuringiensis, such as endotoxins 5, eg CryIA (b), CryIA (c), CrylF, CryIF (a2), CryIIA (b), CrylIIA, CrylIIB (b1) or Cry9c; vegetative insecticidal proteins (VIP), eg VIP1, VIP2, VIP3 or VIP3A; protein nematode colonizing bacteria insecticides, eg Photorhabdus spp. or Xenorhabdus spp .; animal-produced toxins, such as scorpion toxins, arachnid toxins, wasp toxins, or other specific insect neurotoxins; fungal toxins, such as streptomycete toxins, plant lectins, such as pea or barley lectins; agglutinins; proteinase inhibitors, such as trypsin inhibitors, serine protease inhibitors, patatin, cystatin or papain inhibitors; Ribosome Inactivating Proteins (RIP), such as ricin, corn RIP, abrin, lufin, saporin, or briodine; steroid metabolism enzymes, such as 3-hydroxysteroid oxidase, ecdysteroid-IDP-glycosyltransferase, cholesterol oxidases, ecdysone inhibitors or HMG-CoA-reductase; ion channel blockers, such as sodium or calcium channel blockers; juvenile esterase hormone; diuretic hormone receptors (helicoquinine receptors); stilben synthase, bibenzyl synthase, chitinases or glucanases. In the context of the present invention, these insecticidal proteins or toxins must also be expressly understood as pretoxins, hybrid proteins, truncated or otherwise modified proteins. Hybrid proteins are characterized by a new combination of protein domains (see eg WO 02/015701). Additional examples of such toxins or genetically modified plants capable of synthesizing such toxins are described, for example, in EP-A 374 753, WO 93/007278, WO 95/34656, EP-A 427 529, EP-A 451 878, WO 03/18810 and WO 03/52073. Methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above. These insecticidal proteins contained in genetically modified plants impart to the plants that produce these proteins tolerance to harmful pests of all taxonomic groups of atropods, especially beetles (Coeloptera), two-winged insects (Diptera) and moths. (Lepidoptera) and the nematodes (Nematoda). Genetically modified plants capable of synthesizing one or more insecticidal proteins are, for example, described in the publications mentioned above, and some of which are commercially available, such as YieldGard® (corn cultivars that produce the Cry1Ab toxin), YieldGard® Plus (corn cultivars that produce toxins Cry1Ab and Cry3Bb1), Starlink® (corn cultivars that produce Toxin Cry9c), Herculex® RW (corn cultivars that produce Cry34Ab1, Cry35Ab1 and the enzyme Phosphinotricin-N-Acetyltransferase [PAT]); NuCOTN® 33B (cotton cultivars that produce Cry1Ac toxin), Bollgard® I (cotton cultivars that produce Cry1Ac toxin), Bollgard® II (cotton cultivars that produce Cry1Ac and Cry2Ab2 toxins); VIPCOT® (cotton cultivars that produce a VIP toxin); NewLeaf® (potato cultivars that produce Cry3A toxin); Bt-Xtra®, NatureGard®, KnockOut®, BiteGard®, Protecta®, Bt11 (eg Agrisure® CB) and Bt176 from Syngenta Seeds SAS, France, (maize cultivars that produce Cry1Ab toxin and PAT enzyme), MIR604 from Syngenta Seeds SAS, France (corn cultivars that produce a modified version of the Cry3A toxin, cf.

WO 03/018810), MON 863 from Monsanto Europe SA, Belgium (corn cultivars that produce the Cry3Bb1 toxin), IPC 531 from Monsanto Europa SA, Belgium (cotton cultivars that produce a modified version of the Cry1Ac toxin) and 1507 from Pioneer Overseas Corporation, Belgium (maize cultivars that produce Cry1F toxin and PAT enzyme).

Furthermore, plants are also covered by using recombinant DNA techniques capable of synthesizing one or more proteins to increase the resistance or tolerance of those plants to bacterial, viral, or fungal pathogens. Examples of such proteins are so-called "pathogenesis related proteins" (PR proteins, see eg EP-A 392225), genes for resistance to plant diseases (eg potato cultivars, which express resistance genes that They act against Phytophthora infestans derived from the Mexican wild potato Solanum bulbocastanum) or T4 lysozyme (for example, potato cultivars capable of synthesizing these proteins with greater resistance against bacteria such as Erwinia amylvora). Methods for producing such genetically modified plants are generally known to the person skilled in the art and are described, for example, in the publications mentioned above.

Furthermore, plants are also covered by the use of recombinant DNA techniques capable of synthesizing one or more proteins to increase productivity (for example, biological mass production, grain yield, starch content, oil content, or protein content ), tolerance to drought, salinity or other environmental factors limiting the growth or tolerance to pests and fungal, bacterial or viral pathogens of these plants.

In addition, plants that contain a modified amount of content substances or new content substances are specifically covered by using recombinant DNA techniques, specifically to improve human or animal nutrition, for example, oil crops that produce omega-fatty acids. Long chain 3s that promote health or unsaturated omega-9 fatty acids (eg, Nexera® oilseed rape, DOW Agro Sciences, Canada).

In addition, plants that contain a modified amount of content substances or new content substances are specifically covered by using recombinant DNA techniques specifically to improve the production of raw material, for example potatoes that produce higher amounts of amylopectin (for example potato Amflora®, BASF SE, Germany).

The compositions are particularly suitable for controlling the following plant diseases:

Albugo spp. (white oxide) in ornamental plants, vegetables (for example, A. candida) and sunflowers (for example, A. tragopogonis); Alternaria spp. (Alternaria leaf spot) on vegetables, rapeseed (A. brassicola or brassicae), sugar beet (A. tenuis), fruits, rice, soybeans, potatoes (for example, A. solani or A. alternata), tomatoes (for example, A. solani or A. alternata) and wheat; Aphanomyces spp. in sugar beets and vegetables; Ascochyta spp. in cereals and vegetables, for example, A. tritici (anthracnose) in wheat and A. hordei in barley; Bipolaris and Drechslera spp. (teleomorph: Cochliobolus spp.), for example, southern leaf blight (D. maydis) or northern leaf blight (B. zeicola) on corn, for example, spot (B. sorokiniana) on cereals and eg B. oryzae on rice and grass; Blumeria (formerly Erysiphe) graminis (powdery mildew) on cereals (eg, on wheat or barley); Botrytis cinerea (teleomorph: Botryotinia fuckeliana: gray mold) on fruits and berries (for example, strawberries), vegetables (for example, lettuce, carrots, celery and cabbage), rape, flowers, vines, forest plants and wheat; Bremia lactucae (mildew) on lettuce; Ceratocystis (syn. Ophiostoma) spp. (rot or wilt) on broadleaf and evergreen trees, eg C. ulmi (Dutch elm disease) on elm trees; Cercospora spp. (Cercospora leaf spots) on corn (for example, gray leaf spot: C. zeae-maydis), rice, sugar beets (for example, C. beticola), sugar cane, vegetables, coffee, soybeans (for example , C. sojina or C. kikuchii) and rice; Cladosporium spp. on tomatoes (for example, C. fulvum: leaf mold) and cereals, for example, C. herbarum (black ear) on wheat; Claviceps purpurea (ergot) in cereals; Cochliobolus (anamorph: Bipolaris Helminthosporium) spp. (leaf spots) on corn (C. carbonum), cereals (for example, C. sativus, anamorph: B. sorokiniana) and rice (for example, C. miyabeanus, anamorph: H. oryzae); Colletotrichum (teleomorphic: Glomerella) spp. (anthracnose) on cotton (for example, C. gossypii), corn (for example, C. graminicola: anthracnose stem rot), soft fruits, potatoes (for example, C. coccodes: black spot), beans (for example , C. lindemuthianum) and soybean (for example, C truncatum or C. gloeosporioides); Corticium spp., Eg C. sasakii (pod blight) on rice; Corynespora cassiicola (leaf spots) on soybeans and ornamental plants; Cycloconium spp., For example, C. oleaginum in olive trees; Cylindrocarpon spp. (eg thrush from fruit trees or decreased young vine, teleomorphic: Nectria or Neonectria spp.) on fruit trees, vines (eg C. liriodendri, teleomorph: Neonectria liriodendri: black foot disease) and ornamentals; Dematophora (teleomorphic: Rosellinia) necatrix (root and stem rot) in soybeans; Diaporthe spp., Eg D. phaseolorum (buffer) in soybeans; Drechslera (syn. Helminthosporium, teleomorphic: Pyrenophora) spp. in corn, cereals, such as barley (for example, D. teres, net spot) and wheat (for example, D. tritici-repentis: toasted spot), rice and grass; Esca (regressive death, stroke) in vines, caused by Formitiporia (syn. Phellinus) punctata, F. mediterranea, Phaeomoniella chlamydospora (Phaeoacremonium chlamydosporum anterior), Phaeoacremonium aleophilum and / or Botryosphaeria obtusa; Elsinoe spp., In pome fruits (E pyri), soft fruits (E veneta: anthracnose) and vines (E. ampelina: anthracnose); Entyloma oryzae (dirty leaf) in rice; Epicoccum spp. (black mold) on wheat; Erysiphe spp. (powdery mildew) on sugar beets (E betae), vegetables (eg E pisi), such as cucurbits (eg E cichoracearum), cabbage, rapeseed (eg E. cruciferarum); Eutypa lata (chancre or regressive death of Eutypa, anamorph: Cytosporina lata, syn. Libertella blepharis) on fruit trees, vines and ornamental forests; Exserohilum (syn. Helminthosporium) spp. in corn (for example, E turcicum); Fusarium (teleomorphic: Gibberella) spp. (wilt, root or stem rot) on various plants, such as F. graminearum or F. culmorum (root rot, scab or head blight) on cereals (eg wheat or barley), F. oxysporum in tomatoes, F. solani (f. sp. glycines now syn. F. virguliforme) and F. tucumaniae and F. brasiliense, each of which causes sudden death syndrome in soybeans and F. verticillioides in corn; Gaeumannomyces graminis (takeaway) on cereals (eg, wheat or barley) and corn; Gibberella spp. in cereals (for example G. zeae) and rice (for example G. fujikuroi: Bakanae disease); Glomerella cingulata on vines, pome fruits and other plants, and G. gossypii on cotton; grading complex on rice; Guignardia bidwellii (black rot) on vines; Gymnosporangium spp. in pinkish plants and junipers, for example, G. sabinae (oxide) in pears; Helminthosporium spp. (syn. Drechslera, teleomorphic: Cochliobolus) on corn, cereals and rice; Hemileia spp., Eg H. vastatrix (coffee leaf oxide) in coffee; Isariopsis clavispora (syn. Cladosporium vitis) on vines; Macrophomina phaseolina (syn. Phaseoli) (root and stem rot) on soybeans and cotton; Microdochium (syn. Fusarium) nivale (pink mold) on cereals (eg wheat or barley); Microsphaera diffusa (powdery mildew) on soybeans; Monilinia spp., Eg M. laxa, M. fructicola and M. fructigena (flowering and twig blight, brown rot) on stone fruits and other pinkish plants Mycosphaerella spp. in cereals, bananas, soft fruits and ground nuts, such as, for example, M. graminicola (anamorph: Septoria tritici, Septoria blotch) in wheat or M. fijiensis (black Sigatoka disease) in bananas; Peronospora spp. (mildew) in cabbage (for example, P. brassicae), rapeseed (for example, P. parasitica), onion (for example, P. destructor), tobacco (P. tabacina) and soybeans (for example, P. manshurica) ; Phakopsora pachyrhizi and P. meibomiae (soybean oxide) in soybeans; Phialophora spp. for example, on vines (for example, P. tracheiphila and P. tetraspora) and soybeans (for example, P. gregata: stem rot); Phoma lingam (root and stem rot) in rapeseed and cabbage and P. betae (root rot, leaf spot and wetness) in sugar beet; Phomopsis spp. on sunflowers, vines (for example, P. vitico / a: can and leaf spot) and soybeans (for example, stem rot: P. phaseoli, teleomorphic: Diaporthe phaseolorum); Physoderma maydis (brown spots) on corn; Phytophthora spp. (wilt, root, leaf, fruit and stem root) in various plants, such as paprika and cucurbits (eg P. capsici), soybeans (eg P. megasperma, syn. P. sojae), potatoes and tomatoes ( for example, P. infestans: late blight) and broadleaf trees (for example, P. ramorum: sudden oak death); Plasmodiophora brassicae (stick root) on cabbage, rape, radish and other plants; Plasmopara spp., Eg P. viticola (grapevine mildew) on vines and P. halstedii on sunflowers; Podosphaera spp. (powdery mildew) on pinkish plants, hops, pips and soft fruits, eg P. leucotricha on apples; Polymyxa spp., For example, in cereals, such as barley and wheat (P. graminis) and sugar beet (P. betae), and therefore transmit viral diseases; Pseudocercosporella herpotrichoides (eye spot, teleomorphic: Tapesia yallundae) on cereals, for example, wheat or barley; Pseudoperonospora (downy mildew) on various plants, for example, P. cubensis on cucurbits or P. humili on hops; Pseudopezicula tracheiphila (red fire disease or, rotbrenner ', anamorph: Phialophora) on vines; Puccinia spp. (rust) in various plants, for example P. triticina (brown or leaf oxide), P. striiformis (striped or yellow oxide), P. hordei (dwarf oxide), P. graminis (stem or black oxide) o P. recondita (brown or leaf oxide) in cereals, such as wheat, barley or rye, P. kuehnii (orange oxide) in sugar cane and P. asparagi in asparagus; Pyrenophora (anamorph: Drechslera) tritici-repentis (brown spot) on wheat or P. teres (net spot) on barley; Pyricularia spp., Eg P. oryzae (teleomorphic: Magnaporthe grisea, rice blast) on rice and P. grisea on grass and cereals; Pythium spp. (buffer) on grass, rice, corn, wheat, cotton, rape, sunflowers, soybeans, sugar beets, vegetables, and various other plants (eg, P. ultimum or P. aphanidermatum); Ramularia spp., Eg R. collo-cygni (Ramularia leaf spots, physiological leaf spots) on barley and R. beticola on sugar beets; Rhizoctonia spp. on cotton, rice, potatoes, grass, corn, rape, potatoes, sugar beets, vegetables and other plants, for example R. solani (root and stem rot) on soybeans, R. solani (pod blight) on rice or R. cerealis (Rhizoctonia spring blight) on wheat or barley; Rhizopus stolonifer (black mold, soft rot) on strawberries, carrots, cabbage, vines, and tomatoes; Rhynchosporium secalis (blanched) in barley, rye and triticale; Sarocladium oryzae and S. attenuatum (pod rot) on rice; Sclerotinia spp. (stem rot or white mold) in vegetables and field crops, such as rape, sunflowers (for example, S. sclerotiorum) and soybeans (for example, S. rolfsii or S. sclerotiorum); Septoria spp. in various plants, for example, S. wisteria (brown spot) on soy, S. tritici (Septoria spot) on wheat and S. (syn. Stagonospora) nodorum (Stagonospora spot) on cereals; Uncinula (syn. Erysiphe) necator (powdery mildew, anamorph: Oidium tuckeri) on vines; Setospaeria spp. (leaf blight) on corn (eg S. turcicum, syn. Helminthosporium turcicum) and grass; sphacelotheca spp. (smut) in corn, (for example, S. reiliana: head smut), sorghum and sugar cane; Sphaerotheca fuliginea (powdery mildew) on cucurbits; Spongospora subterranea (crust powder) on potatoes and therefore transmitted viral diseases; Stagonospora spp. in cereals, for example, S. nodorum (Stagonospora spot, teleomorphic: Leptosphaeria [syn. Phaeosphaeria] nodorum) in wheat; Synchytrium endobioticum in potatoes (potato wart disease); Taphrina spp., For example, T. deformans (leaf curl disease) in peaches and T. pruni (plum pocket) in plums; Thielaviopsis spp. (black root rot) in tobacco, pome fruits, vegetables, soybeans and cotton, eg T. basicola (syn. Chalara elegans); Tilletia spp. (common touch or stink) in cereals, such as T. tritici (syn. T. caries, bunt wheat) and T. controversa (dwarf bunt) on wheat; Typhula incarnata (gray snow mold) on barley or wheat; Urocystis spp., For example, U. occulta (dark stem) in rye; Uromyces spp. (oxide) in vegetables, such as beans (for example, U. appendiculatus, syn. U. phaseoli) and sugar beet (for example, U. betae); Ustilago spp. (loose spot) in cereals (for example, U. nuda and U. avaenae), corn (for example, U. maydis: pinch of corn) and sugar cane; Venturia spp. (crust) on apples (eg V. inaequalis) and pears; and Verticillium spp. (wilt) on various plants, such as fruits and ornamental plants, vines, soft fruits, vegetables, and field crops, for example, V. dahliae on strawberries, rapeseed, potatoes, and tomatoes.

The compositions are also suitable for controlling harmful fungi in the protection of stored products or harvest and in the protection of materials. It should be understood that the term "material protection" denotes the protection of technical and non-living materials, such as adhesives, glues, wood, paper and cardboard, textiles, leather, paint dispersions, plastics, lubricants, fibers or fabrics, against infestation and destruction by harmful microorganisms, such as fungi and bacteria. Regarding the protection of wood and other materials, special attention is paid to the following harmful fungi: Ascomycetes such as Ophiostoma spp., Ceratocystis spp., Aureobasidium pullulans, Sclerophoma spp., Chaetomium spp., Humicola spp., Petriella spp. , Trichurus spp .; Basidiomycetes such as Coniophora spp., Coriolus spp., Gloeophyllum spp., Lentinus spp., Pleurotus spp., Poria spp., Serpula spp. and Tyromyces spp., Deuteromycetes such as Aspergillus spp., Cladosporium spp., Penicillium spp., Trichorma spp., Alternaria spp., Paecilomyces spp. and Zygomycetes as Mucor spp., and also in the protection of stored products and harvest, the following yeast fungi are worth mentioning: Candida spp. and Saccharomyces cerevisae.

The treatment method according to the invention can also be used in the field of protection of stored products or harvesting against attack by fungi and microorganisms. In accordance with the present invention, the term "stored products" is understood to denote natural substances of plant or animal origin and its processed forms, which have been taken from the natural life cycle and for which long-term protection is desired. Stored products of cultivated plant origin, such as plants or parts thereof, for example stems, leaves, tubers, seeds, fruits or grains, can be protected in the freshly harvested state or in processed form, such as pre-dried, moistened, crushed , ground, pressed or roasted, a process that is also known as post-harvest treatment. Also included in the definition of stored products is wood, either in the form of raw wood, such as lumber, pylons and barriers, or in the form of finished articles, such as furniture or objects made of wood. Stored products of animal origin are fur, leather, fur, hair, and the like. The combinations according to the present invention can prevent disadvantageous effects such as decomposition, discoloration or mold. Preferably, "stored products" are understood to denote natural substances of plant origin and their processed forms, more preferably fruits and their processed forms, such as pommels, stone fruits, soft fruits, and citrus and their processed forms.

The compositions can be used to improve the health of a plant. The invention also relates to a method of improving the health of the plant by treating a plant, its propagation material and / or the place where the plant is growing or will grow with an effective amount of the components of the composition of the plant. invention or the compositions of the invention, respectively.

The term "plant health" should be understood to indicate a condition of the plant and / or its products that is determined by several indicators alone or in combination with each other, such as yield (eg, biomass increase and / or content increased in valuable ingredients), vigor of the plant (for example, better growth of the plant and / or greener leaves ("green effect"), quality (for example, better content or composition of certain ingredients) and tolerance to abiotic stress and / or biotic The indicators identified above for the health condition of a plant may be interdependent or may be from each other.

The compounds of formula I can be present in different crystal modifications whose biological activity may differ. Compositions comprising such modifications of compounds I are likewise the subject of the present invention.

The compositions are used by treating fungi or plants, plant propagation materials, such as seeds, soil, surfaces, materials, or enclosures to protect from fungal attack with a fungicidally effective amount of the active substances. The application can be carried out both before and after the infection of plants, plant propagation materials, such as seeds, soil, surfaces, materials or enclosures by fungi.

Plant propagation materials can be treated with the components of the compositions of the invention and the compositions of the invention, respectively, prophylactically, either on or before planting or transplanting.

The invention also relates to agrochemical compositions comprising an auxiliary and the components of the composition of the respective invention or the composition of the invention, respectively.

An agrochemical composition comprises a fungicide-effective amount of the components of the compositions of the invention or the composition of the invention, respectively. The term "effective amount" denotes an amount of the composition or components, which is sufficient to control harmful fungi in cultivated plants or in the protection of materials and which does not result in substantial damage to the treated plants. Such quantity can vary in a wide range and depends on several factors, such as the species of fungi to be controlled, the plant or cultivated material treated, the climatic conditions and the specific compound I that I used.

The components of the compositions of the invention or the compositions of the invention, respectively, their N-oxides and salts can be converted into common types of agrochemical compositions, for example, solutions, emulsions, suspensions, sprays, powders, pastes, granules, presses, capsules and mixtures thereof. Examples of composition types are suspensions (for example, SC, OD, FS), emulsifiable concentrates (for example, EC), emulsions (for example, EW, EO, ES, ME), capsules (for example, CS, ZC) , pastes, lozenges, wettable powders or powders (eg WP, SP, WS, DP, DS), pressed (eg BR, TB, DT), granules (eg WG, SG, GR, FG, GG, MG), insecticidal articles (for example LN), as well as gel formulations for the treatment of plant propagation materials such as seeds (for example, GF). These and other types of compositions are defined in the "Catalog of pesticide formulation types and international coding system", Technical Monograph No. 2, 6th Ed. May 2008, CropLife International.

The compositions are prepared in a known manner, as described by Mollet and Grubemann, Formulation technology, Wiley VCH, Weinheim, 2001; or Knowles, New developments in crop protection product formulation, Agrow Reports DS243, T&F Informa, London, 2005.

Suitable auxiliaries are solvents, liquid vehicles, solid vehicles or fillers, surfactants, dispersants, emulsifiers, humectants, adjuvants, solubilizers, penetration enhancers, protective colloids, adhesion agents, thickeners, humectants, repellents, attractants, feed stimulants, compatibilizers. , bactericides, antifreeze agents, antifoaming agents, colorants, adhesives and binders.

Suitable liquid solvents and vehicles are water and organic solvents, such as medium to high boiling point mineral oil fractions, for example, kerosene, diesel; vegetable or animal oils; aliphatic, cyclic and aromatic hydrocarbons, for example, toluene, paraffin, tetrahydronaphthalene, alkylated naphthalenes; alcohols, for example, ethanol, propanol, butanol, benzyl alcohol, cyclohexanol; glycols; DMSO; ketones, eg cyclohexanone; esters, eg lactates, carbonates, fatty acid esters, gamma-butyrolactone; fatty acids; phosphonates; amines; amides, for example, N-methylpyrrolidone, fatty acid dimethylamides; and mixtures thereof.

Suitable solid fillers or vehicles are mineral earths, for example, silicates, silica gels, talc, kaolin, limestone, lime, chalk, clays, dolomite, diatomaceous earth, bentonite, calcium sulfate, magnesium sulfate, magnesium oxide; polysaccharides, eg cellulose, starch; fertilizers, for example ammonium sulfate, ammonium phosphate, ammonium nitrate, ureas; plant-based products, for example, cereal flour, tree bark flour, wood flour, walnut shell flour and mixtures thereof.

Suitable surfactants are surfactant compounds, such as anionic, cationic, nonionic and amphoteric surfactants, block polymers, polyelectrolytes, and mixtures thereof. Such surfactants can be used as emulsifiers, dispersants, solubilizers, humectants, penetration enhancers, protective colloids, or adjuvants. Examples of surfactants are listed in McCutcheon, Vol. 1: Emulsifiers & Detergents, McCutcheon Directory, Glen Rock, United States, 2008 (International Ed. Or North American Ed.).

Suitable anionic surfactants are alkali, alkaline earth, or ammonium sulphonate salts, sulfates, phosphates, carboxylates, and mixtures thereof. Examples of sulfonates are alkylarylsulfonates, diphenylsulfonates, alphaolefin sulfonates, lignin sulfonates, fatty acid sulfonates and oils, ethoxylated alkylphenol sulfonates, alkoxylated arylphenol sulfonates, condensed naphthalenes sulfonates, dodecyl sulfonates and tridecylbenzenes sulfonates, sulfosuccinamates. Examples of sulfates are sulfates of fatty acids and oils, of ethoxylated alkylphenols, of alcohols, of ethoxylated alcohols or of esters of fatty acids. Examples of phosphates are phosphate esters. Examples of carboxylates are alkyl carboxylates and carboxylated alcohol or alkylphenol ethoxylates.

Suitable nonionic surfactants are alkoxylates, N-substituted fatty acid amides, amine oxides, esters, sugar-based surfactants, polymeric surfactants, and mixtures thereof. Examples of alkoxylates are compounds such as alcohols, alkylphenols, amines, amides, arylphenols, fatty acids, or fatty acid esters that have been alkoxylated with 1 to 50 equivalents. Ethylene oxide and / or propylene oxide can be used for alkoxylation, preferably ethylene oxide. Examples of N-substituted fatty acid amides are fatty acid glucamides or fatty acid alkanolamides. Examples of esters are fatty acid esters, glycerol esters or monoglycerides. Examples of sugar-based surfactants are sorbitans, ethoxylated sorbitans, sucrose, and esters of glucose or alkylpolyglucosides. Examples of polymeric surfactants are homo or copolymers or of vinylpyrrolidone, vinyl alcohol or vinyl acetate.

Suitable cationic surfactants are quaternary surfactants, for example quaternary ammonium compounds with one or two hydrophobic groups, or long chain primary amine salts. Suitable amphoteric surfactants are alkyl betaines and imidazolines. Suitable block polymers are block polymers of the type A-B or A-B-A comprising blocks of polyethylene oxide and polypropylene oxide, or of the type A-B-C comprising alkanol, polyethylene oxide and polypropylene oxide. Polyelectrolytes are polyacids or polybases. Examples of polyacids are alkaline salts of polyacrylic acid or comb polymers of polyacids. Examples of polybases are polyvinylamines or polyethyleneamines.

Suitable adjuvants are compounds, which have negligible or even no pesticidal activity, and which enhance the biological performance of compound I at the target. Examples are surfactants, mineral or vegetable oils, and other auxiliaries. Other examples are listed in Knowles, Adjuvants and additives, Agrow Reports DS256, T&F Informa UK, 2006, chapter 5.

Suitable thickeners are polysaccharides (eg, xanthan gum, carboxymethyl cellulose), inorganic clays (organically modified or unmodified), polycarboxylates, and silicates.

Suitable bactericides are bronopol and isothiazolinone derivatives such as alkylisothiazolinones and benzothiazolinones.

Suitable antifreeze agents are ethylene glycol, propylene glycol, urea, and glycerin.

Suitable antifoaming agents are silicones, long chain alcohols, and fatty acid salts.

Suitable dyes (eg, red, blue, or green) are pigments of low water solubility and water soluble dyes. Examples are inorganic dyes (eg, iron oxide, titanium oxide, iron hexacyanoferrate) and organic dyes (eg, alizarin, azo, and phthalocyanine dyes).

Suitable binders or binders are polyvinylpyrrolidones, poly (vinyl acetate), polyvinyl alcohols, polyacrylates, biological or synthetic waxes, and cellulose ethers.

Examples of types of composition and their preparation are (where the active substances denote the respective components (= active ingredients) of the composition of the invention):

i) Water soluble concentrates (SL, LS)

10-60% by weight of active substances and 5-15% by weight of wetting agent (for example, alcohol alkoxylates) are dissolved in water and / or in a water soluble solvent (for example, alcohols) up to 100% by weight. The active ingredient dissolves after dilution with water.

ii) Dispersible concentrates (DC)

5-25% by weight of active substances and 1-10% by weight of dispersant (eg polyvinylpyrrolidone) are dissolved in organic solvent (eg cyclohexanone) up to 100% by weight. Dilution with water gives a dispersion. iii) Emulsifiable concentrates (CE)

15-70% by weight of active substances and 5-10% by weight of emulsifiers (for example, calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in a water-insoluble organic solvent (for example, aromatic hydrocarbon) and 100 % in weigh. Dilution with water gives an emulsion.

iv) Emulsions (EW, EO, ES)

5-40% by weight of active substances and 1-10% by weight of emulsifiers (for example calcium dodecylbenzenesulfonate and castor oil ethoxylate) are dissolved in 20-40% by weight of water-insoluble organic solvent (for example , aromatic hydrocarbon). This mixture is introduced into water up to 100% by weight by means of an emulsifying machine and becomes a homogeneous emulsion. Dilution with water gives an emulsion. v) Suspensions (SC, OD, FS)

In a ball mill with stirring, 20-60% by weight of active substances are crushed with the addition of 2-10% by weight of dispersants and wetting agents (for example, sodium lignosulfonate and alcohol ethoxylate), 0.1-2 Weight% thickener (eg, xanthan gum) and 100% weight water to give a fine suspension of active substance. Dilution with water provides a stable suspension of the active substance. For the FS-type composition, up to 40% by weight of binder (eg polyvinyl alcohol) is added.

vi) Water dispersible granules and water soluble granules (WG, SG)

50-80% by weight of active substances are finely ground with the addition of dispersants and wetting agents (for example, sodium lignosulfonate and alcohol ethoxylate) up to 100% by weight and are prepared as water-dispersible or water-soluble granules by means of technical devices (eg extrusion, spray tower, fluidized bed). Dilution with water provides a stable dispersion or solution of the active substance. vii) Water dispersible powders and water soluble powders (WP, SP, WS)

50-80% by weight of active substances are crushed in a rotor-stator mill with the addition of 1-5% by weight of dispersants (for example, sodium lignosulfonate), 1-3% by weight of wetting agents (per eg, alcohol ethoxylate) and solid vehicle (eg, silica gel) up to 100% by weight. Dilution with water provides a stable dispersion or solution of the active substance.

viii) Gel (GW, GF)

In a ball mill with stirring, 5-25% by weight of active substances are crushed with the addition of 3-10% by weight of dispersants (for example, sodium lignosulfonate), 1-5% by weight of thickener (per example, carboxymethyl cellulose) and water up to 100% by weight until giving a fine suspension of the active substance. Dilution with water provides a stable suspension of the active substance.

iv) Microemulsion (ME)

5-20% by weight of active substances are added to 5-30% by weight of organic solvent mixture (for example, fatty acid dimethylamide and cyclohexanone), 10-25% by weight of surfactant mixture (for example, ethoxylate alcohol and arylphenol ethoxylate) and water up to 100% by weight. This mixture is stirred for 1 h to spontaneously produce a thermodynamically stable microemulsion.

iv) Microcapsules (CS)

An oily phase comprising 5-50% by weight of active substances, 0-40% by weight of organic solvent insoluble in water (for example, aromatic hydrocarbon), 2-15% by weight of acrylic monomers (for example, methacrylate of methyl, methacrylic acid, and a di or triacrylate) are dispersed in an aqueous solution of a protective colloid (eg, polyvinyl alcohol). Radical polymerization initiated by a radical initiator results in the formation of poly (meth) acrylate microcapsules. Alternatively, an oil phase comprising 5-50% by weight of a compound I according to the invention, 0-40% by weight of water-insoluble organic solvent (for example, aromatic hydrocarbon) and an isocyanate monomer (for example , diphenylmethane-4,4'-diisocyanates) are dispersed in an aqueous solution of a protective colloid (eg, polyvinyl alcohol). The addition of a polyamine (eg hexamethylenediamine) results in the formation of polyurea microcapsules. The monomers are 1-10% by weight. % By weight refers to the total composition of CS.

ix) Sprayable powders (DP, DS)

1-10% by weight of active substances are finely ground and intimately mixed with a solid vehicle (eg finely divided kaolin) up to 100% by weight.

x) Granules (GR, FG)

0.5-30% by weight of active substances are finely ground and associated with a solid vehicle (eg silicate) and 100% by weight. Granulation is accomplished by extrusion, spray drying, or fluidized bed.

xi) Ultra Low Volume Liquids (UL)

1-50% by weight of active substances are dissolved in organic solvent (for example, aromatic hydrocarbon) up to 100% by weight.

Compositions of types i) to xi) may optionally comprise other auxiliaries, such as 0.1-1% by weight of bactericides, 5-15% by weight of antifreeze agents, 0.1-1% by weight of antifoaming agents and 0.1-1 % by weight of colorants.

The agrochemical compositions generally comprise between 0.01 and 95%, preferably between 0.1 and 90%, and in particular between 0.5 and 75%, by weight of the active substance. The active substances are used with a purity of 90% to 100%, preferably 95% to 100% (according to the NMR spectrum).

Seed treatment solutions (LS), Suspoemulsions (SE), fluid concentrates (FS), dry treatment powders (DS), water dispersible powders for sludge treatment (WS), water soluble powders (SS), emulsions (ES), emulsifiable concentrates (EC) and gels (GF) are generally used for the treatment of plant propagation materials, particularly seeds. The compositions in question give, after a two to ten-fold dilution, concentrations of active substance of 0.01 to 60% by weight, preferably 0.1 to 40%, in ready-to-use preparations. The application can be carried out before or during planting. Methods of applying Compound I and its compositions, respectively, to plant propagation material, especially seeds, include methods of applying, coating, granulating, dusting, soaking, and furrow application of the propagation material. Preferably, Compound I or the compositions thereof, respectively, are applied to the plant propagation material by a method such that germination is not induced, for example, by seed dressing, granulation, coating and dusting.

When used in plant protection, the amounts of active substances applied are, depending on the type of effect desired, from 0.001 to 2 kg per ha, preferably from 0.005 to 2 kg per ha, more preferably from 0.05 to 0, 9 kg per ha, and in particular from 0.1 to 0.75 kg per ha. 0.1 to 10 kg of active ingredients per 100 kg of seed in the treatment of plant propagation materials such as seeds, for example dusting, coating or soaking seeds, amounts of active substance 0.1 to 10 kg of active substances per 100 kg of seed, particularly 0.1 to 1000 g, preferably 1 to 1000 g, more preferably 1 to 100 g, and most preferably 5 to 100 g are required, per 100 kilograms of plant propagation material (preferably seeds).

When used in the protection of stored materials or products, the amount of active substance applied depends on the type of application area and the desired effect. The amounts usually applied in the protection of materials are from 0.001 g to 2 kg, preferably from 0.005 g to 1 kg, of active substance per cubic meter of treated material.

Various types of oils, humectants, adjuvants, fertilizers or micronutrients, and additional pesticides (for example, herbicides, insecticides, fungicides, growth regulators, protectors) can be added to the active substances or the compositions that comprise them as a premix or, if it is appropriate, not until immediately before use (tank mix). These agents can be mixed with the compositions according to the invention in a weight ratio of 1: 100 to 100: 1, preferably 1:10 to 10: 1.

The user applies the composition according to the invention generally from a pre-dosing device, a knapsack sprayer, a spray tank, a spray plane or an irrigation system. Usually, the agrochemical composition is compounded with water, regulator and / or additional auxiliaries at the desired application concentration and thus the ready-to-use spray liquor or the agrochemical composition according to the invention is obtained. Generally, 20 to 2000 liters, preferably 50 to 400 liters, of the ready-to-use spray liquor are applied per hectare of useful agricultural area.

According to an embodiment, the individual components of the composition according to the invention, such as parts of a kit or parts of composition, can be mixed by the user himself in a spray tank and other auxiliaries can be added, if necessary. appropriate.

In the compositions, the proportions of the components are sometimes advantageously chosen to produce a synergistic effect.

The term "synergistic effect" is understood to refer in particular to that defined by Colby's formula (Colby, S. R., "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds, 15, pp. 20-22, 1967).

The term "synergistic effect" is also understood to refer to that defined by the application of the Tammes method, (Tammes, P.M.L., "Isoboles, a graphic representation of synergism in pesticides", Netherl. J. Plant Pathol.

70, 1964).

The components can be used individually or already mixed partially or completely with each other to prepare the composition according to the invention. They may also be packaged and used as a combination, such as a parts kit.

The fungicidal action of the compositions according to the invention can be shown by the tests described below.

The active compounds, separately or together, are prepared as a stock solution comprising 25 mg of active compound which is prepared up to 10 ml using a mixture of acetone and / or DMSO and the emulsifier Uniperol® EL (wetting agent having an action emulsifier and dispersant based on ethoxylated alkylphenols) in a solvent / emulsifier volume ratio of 99: 1. The mixture is made up to 100 ml with water. This stock solution is diluted with the described solvent / emulsifier / water mixture to give the concentration of the active compound indicated below.

Visually determined percentages of infected leaf areas become efficiencies in% of untreated control.

Efficiency (E) is calculated as follows using the Abbot formula:

a corresponds to the fungal infection of the treated plants in% and

p corresponds to fungal infection of untreated plants (control) in%

An efficiency of 0 means that the infection level of the treated plants corresponds to that of the untreated control plants; an efficiency of 100 means that the treated plants were not infected.

The expected efficiencies of the active compound combinations were determined using the Colby formula (Colby, SR "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds, 15, pp. 20-22, 1967) and compared with the observed efficiencies . Colby's formula:

E expected efficacy, expressed in% of the untreated control, when the mixture of active compounds A and B is used at concentrations a and b

x efficacy, expressed in% of the untreated control, when active compound A is used at concentration a and efficacy, expressed in% of untreated control, when active compound B is used at concentration b.

Micro tests

The active compounds were separately formulated as a stock solution having a concentration of 10,000 ppm in dimethyl sulfoxide.

The orystrobin product was used as a finished commercial formulation and diluted with water to the established concentration of the active compound.

Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a suspension of spores of the respective pathogen in the respective nutrient medium was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

The measured parameters were compared with the growth of the control variant without active compound (100%) and the blank value without fungi and without active compound to determine the relative growth in% of the pathogens in the respective active compounds. These percentages were converted into efficiencies.

The expected efficiencies of the active compound mixtures were determined using the Colby formula [R.S. Colby, "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds 15, 20-22 (1967)] and was compared with the observed efficiencies.

I. Synthesis of the components I:

With due modification of the starting compounds, the procedures shown in the synthesis examples below were used to obtain additional compounds I.

Example 1: Preparation of 2- [4- (4-chloro-phenoxy) -2-trifluoromethyl-phenyl] -1- [1,2,4] triazol-1-yl-propan-2-ol (compound I-3 )

Step 1: 4-fluoro-2- (trifluoromethyl) -acetophenone (35g, 170mmol), 4-chlorophenol (21.8g, 170mmol), potassium carbonate (28.1g, 203mmol) and DMF (284g, 300 ml) were stirred together at about 115 ° C for about five hours. After cooling, the mixture was added to a brine solution and extracted three times with MTBE. The organic phases were combined, washed twice with 10% aqueous LiCl solution and dried. Evaporation of solvents gave intermediate 1- [4- (4-chloro-phenoxy) -2-trifluoromethyl-phenyl] -ethanone (51.4 g, 87%; HPLC Rt = 3.721 min * (conditions A, see below) ).

Step 2: DMSO (154g, 140ml, 1.97mol) was added to a mixture of sodium hydride (0.831g, 33mmol) in THF (53g, 6.0ml) and cooled to approximately 5 ° C. Then trimethylsulf (ox) onium iodide (6.42g, 31.5mmol) in DMSO (80ml) was added dropwise and the mixture was stirred at about 5 ° C for an additional hour. Intermediate 1- [4- (4-chloro-phenoxy) -2-trifluoromethyl-phenyl] -ethanone (5.0 g, 14.3 mol) in DMSO (40 ml) was then added dropwise over a period of approximately five minutes. The mixture was then stirred for 15 minutes, quenched with saturated ammonium chloride solution (150 ml), and extracted three times with MTBE. The organic phases were combined, washed with water, and dried. Solvent evaporation gave 2- [4- (4-chloro-phenoxy) -2-trifluoromethyl-phenyl] -2-methyloxirane as a yellow oil (4.4 g, 89%, HPLC Rt = 3.839 min * (conditions A see below )).

Step 3: A mixture of 2- [4- (4-chloro-phenoxy) -2-trifluoromethyl-phenyl] -2-methyl-oxirane (1.92 g, 4.96 mmol), 1,2,4-triazole (1,715 g, 24.8 mmol), NaOH (0.496 g, 12.41 mmol) and N-methyl pyrrolidone (48 ml) were stirred at about 110 ° C for about one hour, followed by another four hours at about 130 ° C. After cooling to room temperature, saturated ammonium chloride solution was added, and the organic phases were extracted three times with MTBE. The organic phases were combined, washed twice with 10% LiCl solution, and dried. Solvent evaporation followed by diisopropyl ether precipitation gave the final product 2- [4- (4-chloro-phenoxy) -2-trifluoromethyl-phenyl] -1- [1,2,4] triazol-1-yl -propan-2-ol as a white solid (1.55 g, 75%, mp 121-122 ° C, HPLC Rt = 3.196 min * (conditions A see below)).

Example 2: Preparation of 2- [4- (4-chloro-phenoxy) -2-trifluoromethyl-phenyl] -1 [1,2,4] triazol-1-yl-butan-2-ol (compound 1- 7)

Step 1: Bromine (29.6 g, 185 mmol) was added dropwise over three minutes to a solution of intermediate 1- [4- (4-doro-phenoxy) -2-trifluoromethyl-phenyl] -ethanone from step 1 of the example 1, (61.4 g, 185 mmol), in diethyl ether (700 ml). The mixture was stirred at room temperature for approximately 90 minutes, after which a mixture of ice-cold water (1 L) and saturated sodium bicarbonate solution (300 ml) was slowly added with stirring until a pH of 7 to 8 was reached. Organic phases were extracted twice with MTBE and washed with LiCl solution. Drying and evaporation of the solvents gave the intermediate 2-bromo-1- [4- (4-chloro-phenoxy) -2-trifluoromethyl-phenyl] -ethanone as a brown oil (76 g, 83%, HPLC Rt = 3.196 min * (conditions A see below)).

Step 2: 1,2,4-Triazole (3.76 g, 53 mmol) was added slowly and in portions to a mixture of sodium hydride (1.28 g, 53 mmol) in THF (150 mL), and the mixture was stirred at room temperature for about 30 min. To this mixture, the intermediate 2-bromo-1- [4- (4-chloro-phenoxy) -2-trifluoromethyl-phenyl] -ethanone (20.0 g, 40.7 mmol) in THF (100 mL) was added dropwise and stirred at room temperature. for about 150 min. The reaction mixture was cooled to approximately 10 ° C and slowly added to a mixture of ice water and saturated ammonium chloride solution, and the organic components were extracted three times with ethyl acetate. The organic phases were combined, dried and the solvents were evaporated. Recrystallization from diisopropyl ether gave intermediate 1- [4- (4-chloro-phenoxy) -2-trifluoromethyl-phenyl] -2- [1,2,4] triazol-1-yl-ethanone as a white solid (14 , .5 g, 84%; HPLC Rt = 3,225 min * (conditions A see below).

Step 3: Magnesium bromide diethyl etherate (2.65 g, 10.3 mmol) was added to a solution of 1- [4- (4-chloro-phenoxy) -2-trifluoromethyl-phenyl] -2- [1,2, 4] triazol-1-yl-ethanone (2.0g, 5.1mmol) in dichloromethane (DCM, 20ml) and the mixture was stirred at room temperature for 90 minutes. This mixture was then cooled to about -10 ° C and ethylmagnesium bromide (10.3 ml of a 1M solution in THF, 10.3 mmol) was added dropwise. After stirring for about two hours, the mixture was allowed to warm to room temperature and was then quenched by the addition of a saturated solution of ammonium chloride. The organic components were extracted three times with DCM, the organic phases were combined, washed again with saturated ammonium chloride solution, dried, and the solvents were evaporated. The addition of diisopropyl ether resulted in the precipitation of the unreacted starting material, which was filtered. The filtrate was then purified using reverse phase chromatography, to give the final product 2- [4- (4-chloro-phenoxy) -2-trifluoromethyl-phenyl] -1 [1,2,4] triazol-1-yl- butan-2-ol as a light brown solid (130 mg, 5.8%; HPLC Rt = 3,366 min * (conditions A see below); HPLC Rt = 1.21 min, mass = 412 ** (conditions B see below).

Example 3. Preparation of 1- [2- [4- (4-dorophenoxy) -2- (trifluoromethyl) phenyl] -2-methoxy-propyl] -1,2,4-triazole (compound I-9)

To a solution of 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1- (1,2,4-triazol-1-yl) propan-2-ol (33.35 g, 83 mmol) in 400 ml of THF sodium hydride (2.54 g, 100.5 mmol) was added at room temperature. The reaction mixture was then stirred for 30 minutes followed by the addition of methyl iodide (14.24 g, 100.3 mmol) and stirred at 90 ° C for 2 hours. After the addition of an aqueous sodium chloride solution, the mixture was extracted with dichloromethane, dried, evaporated. The crude residue was purified by recrystallization from heptane / ethyl acetate (1: 2) to give the title compound as a colorless solid (34.0 g, 98%; HPLC-MS Rt = 1.26 min; mass = 412 ** (conditions B, see below)).

Example 4. Preparation of 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1- (1,2,4-triazol-1-yl) pent-3-in-2-ol (compound I-14)

Step 1:

1-Bromo-4-fluoro-2- (trifluoromethyl) benzene (2.04 g, 15.9 mmol) was mixed with potassium carbonate (4.18 g) in dimethylformamide and the reaction mixture was heated to 110 ° C. Then 4-chloro-phenol (3.68 g, 15.14 mmol) was added and the resulting mixture was stirred for 5 hours at 110 ° C. After cooling and a water / DCM extraction, the organic layers were washed with an aqueous solution of lithium chloride and then sodium hydroxide, dried, filtered, and evaporated to give 3.14 g of 1-bromo-4- ( 4-chlorophenoxy) -2- (trifluoromethyl) benzene as an oil. 1H-NMR (CDCb; 400 MHz) ■ ■ (ppm) = 6.80 (d, 1H); 6.95 (d, 2H); 7.35 (d, 2H); 7.55 (d, 1H); 7.80 (s, 1H).

Step 2:

To a solution of 1-bromo-4- (4-chlorophenoxy) -2- (trifluoromethyl) benzene (100.0 g, 0.28 mol, 1.0 eq.) In 500 mL of THF, isopropylmagnesium chloride complex was added dropwise lithium (284 ml, 1.3 M in THF) at room temperature and stirred for 2 hours. This mixture was then added dropwise to a solution of acetyl chloride (29.0 g, 0.37 mmol) in 500 ml of THF at room temperature. The resulting reaction mixture was then stirred for 150 minutes and quenched with saturated ammonium chloride solution. After extraction with water / MTBE, the organic solvents were dried and evaporated to give 96.6 g of 1- [4- (4-chlorophenoxy) -2- (trifluoromethyl) -phenyl] ethanone as a yellowish oil. 1H-NMR (CDCb; 400 MHz) ■ ■ (ppm) = 2.6 (s, 3H); 7.0 (d, 2H); 7.10 (d, 1H); 7.30 (s, 1H); 7.37 (d, 2H); 7.50 (d, 1H).

Step 3:

Bromine (29.6 g, 185 mmol) was added dropwise over three minutes to a solution of 1- [4- (4-chloro-phenoxy) -2-trifluoromethyl-phenyl] -ethanone (61.4 g, 185 mmol), in diethyl ether (700 ml). The mixture was stirred at room temperature for approximately 90 minutes, after which a mixture of ice-cold water (1 L) and saturated sodium bicarbonate solution (300 ml) was slowly added with stirring until a pH of 7 to 8 was reached. Organic phases were extracted twice with MTBE and washed with LiCl solution. Drying and evaporation of the solvents gave the intermediate 2-bromo-1 [4- (4-chloro-phenoxy) -2-trifluoromethyl-phenyl] -ethanone as a brown oil (76 g, 83%). 1H-NMR (CDCla; 400 MHz) ■ ■ (ppm) = 4.35 (s, 2H); 7.0 (d, 2H); 7.12 (d, 1H); 7.34 (s, 1H); 7.38 (d, 2H); 7.55 (d, 1H).

Stage 4:

1,2,4-Triazole (3.76 g, 53 mmol) was added slowly and portionwise to a mixture of sodium hydride (1.28 g, 53 mmol) in THF (150 mL), and the mixture was stirred at room temperature for about 30 min. To this mixture 2-bromo-1- [4- (4-chloro-phenoxy) -2-trifluoromethyl-phenyl] -ethanone (20.0g, 40.7mmol) in THF (100ml) was added dropwise and stirred at room temperature for about 150 min. The reaction mixture was cooled to approximately 10 ° C and slowly added to a mixture of ice water and saturated ammonium chloride solution, and the organic components were extracted three times with ethyl acetate. The organic phases were combined, dried and the solvents were evaporated. Recrystallization from diisopropyl ether gave intermediate 1- [4- (4-chloro-phenoxy) -2-trifluoromethylphenyl] -2- [1,2,4] triazol-1-yl-ethanone as a white solid (14.5 g, 84%). 1H-NMR (CDCla; 400 MHz) ■ 5 ■ (ppm) = 5.42 (s, 2H); 7.05 (d, 2H); 7.15 (d, 1H); 7.38 (s, 1H); 7.42 (d, 2H); 7.60 (d, 1H); 8.0 (s, 1H); 8.25 (s, 1H).

Step 5:

1- [4- (4-Chlorophenoxy) -2- (trifluoromethyl) phenyl] -2- (1,2,4-triazol-1-yl) ethanone (0.5g, 1.31mmol) was dissolved in THF (5.0ml) with a solution of LaCl3.2LiCl (2.4 ml, 0.6 M in THF) and stirred for 30 minutes at room temperature. The resulting solution was added dropwise to 1-propynylmagnesium bromide (1.5 ml, 0.5 M in THF) at room temperature. After 30 minutes at room temperature, the resulting mixture was quenched with 10% aqueous HCl solution and extracted with MTBE. The organic phase was washed with brine, dried and evaporated to give after purification on reverse phase chromatography 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1- (1,2, 4-triazol-1-yl) pent-3-in-2-ol as solid (25 mg, HPLC-MS Rt = 1.21 min, mass = 422 ** (conditions B, see below), mp = 137 ° C ).

Example 5. Preparation of 1- [2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -2-methoxy-butyl] -1,2,4-triazole (compound I-13)

To a solution of 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1- (1,2,4-triazol-1-yl) butan-2-ol (4.0 g, 9.71 mmol) in 20 ml THF sodium hydride (294 mg, 11.64 mmol) was added at room temperature. The reaction mixture was then stirred for 30 minutes followed by the addition of methyl iodide (1.67 g, 11.78 mmol) and stirred at room temperature for 10 hours. After the addition of an aqueous sodium chloride solution, the mixture was extracted with dichloromethane, dried, evaporated. The crude residue was purified by flash chromatography on silica gel to give the title compound as a colorless oil (2.42 g, 54%; HPLC-MS Rt = 1.32 min; mass = 426 ** (conditions B, see below) ).

Example 6. Preparation of 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -3-methyl-1- (1,2,4-triazol-1-yl) butan-2-ol (compound I-5)

Step 1:

To a solution of 1-bromo-4- (4-chlorophenoxy) -2- (trifluoromethyl) benzene (450.0 g, 1.15 mol) in 500 ml of THF was added dropwise to the complex of isopropylmagnesium chloride-lithium chloride ( 1,152 L, 1.3 M in THF) at room temperature and stirred for 1 hour. The reaction mixture was then added dropwise over 1.5 hours at 10 ° C to a solution of Isopropyl Carbonyl Chloride (187.9 g, 1.73 mol), LiCI (3.30 g, 0.08 mol), AlCb (4.61 g, 0.03 mol) , CuCl (3.42 g, 0.03 mol) in THF (4 L). After 1 hour at room temperature, the resulting mixture was quenched with an aqueous solution of ammonium chloride at 10 ° C and extracted with MTBE. The organic phase was washed with an aqueous solution of ammonia and then with ammonium chloride, dried and evaporated to give after distillation (bp = 150-155 ° C, P = 0.25 mbar) 1- [4- (4 -chlorophenoxy) -2- (trifluoromethyl) phenyl] -2-methyl-propan-1-one as a yellowish oil (227.0 g, 52%). 1H-NMR (CDCl3; 400 MHz) ■ 5 ■ (ppm) = 1.20 (d, 6H); 3.20 (m, 1H); 7.0 (d, 2H); 7.10 (d, 1H); 7.34 (s, 1H); 7.38 (d, 2H); 7.41 (d, 1H).

Step 2:

DMSO (120 ml) was added to a mixture of sodium hydride (4.43 g, 175.24 mmol) in THF (130 ml) and cooled to approximately 5 ° C. Then trimethylsulfonium iodide (34.97 g, 167.9 mmol) in DMSO (12 ml) was added dropwise and the mixture was stirred at about 5 ° C for an additional hour. Intermediate 1- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -2-methyl-propan-1-one (25.0 g, 72.9 mmol) in DMSO (60 ml) was then added dropwise during a period of about five minutes. The mixture was then stirred overnight at room temperature, then quenched with saturated ammonium chloride solution and extracted three times with MTBE. The organic phases were combined, washed with an aqueous ammonium chloride solution, filtered, and dried. Evaporation of the solvent gave after purification on silica gel 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -2-isopropyl-oxirane as a yellowish oil (24.2 g, 84%, HPLC- MS: Rt = 1,540 min; mass = 356 ** (conditions B see below)).

Step 3:

To 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -2-isopropyl-oxirane (173.0 g, 0.41 mol) dissolved in N-methyl-2-pyrrolidone (1 L), hydroxide of sodium (41.2 g, 1.03 mol) and triazole (145.2 g, 2.06 mol) at room temperature. The mixture was then stirred for 12 hours at 125 ° C. Then a solution of ammonium chloride and ice water was added, the mixture was extracted with MTBE and washed with an aqueous solution of lithium chloride. The crude residue was purified by recrystallization (heptane / MTBE, 1: 1) to give 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -3-methyl-1- (1,2,4- triazol-1-yl) butan-2-ol as a colorless solid (110 g, mp = 114 ° C; HPLC-MS Rt = 1.27 min; mass = 426 ** (conditions B see below)).

Example 7: Preparation of 1- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1-cyclopropyl-2- (1,2,4-triazol-1-yl) ethanol (compound I-4)

Step 1:

To a solution of 1-bromo-4- (4-chlorophenoxy) -2- (trifluoromethyl) benzene (70.0 g, 199 mmol, 1.0 eq.) In 700 ml of THF, isopropylmagnesium chloride complex was added dropwise lithium (199.1 ml, 1.3 M in THF) at room temperature and stirred for 2 hours. The reaction mixture was then added dropwise to a solution of cyclopropane carbonyl chloride (27.05 g, 258 mmol), LiCI (0.5 g, 11.9 mmol), AlCb (0.79 g, 5.9 mmol), CuCl (0.59 g, 5.9 mmol) in THF (700 ml). After 30 minutes at room temperature, the resulting mixture was quenched with an aqueous ammonium chloride solution at 10 ° C and extracted with MTBE. The organic phase was washed with an aqueous ammonia solution, dried, and evaporated to give [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -cyclopropyl-methanone as a brownish oil (66.8 g). 1H-NMR (CDCla; 400 MHz) ■ 5 ■ (ppm) = 1.10 (m, 2H); 1.30 (m, 2H); 2.32 (m, 1H); 7.0 (d, 2H); 7.15 (d, 1H); 7.32 (s, 1H); 7.37 (d, 2H); 7.60 (d, 1H).

Step 2:

To a solution of sodium hydride (10.77 g, 448 mmol) in THF (750 mL) and dry DMSO (250 mL), a solution of trimethylsulfonium iodide (87.62 g, 429 mmol) was added dropwise to argon at 5 ° C. ) in dry DMSO (800 ml). The mixture was stirred 1 hour at 5 ° C followed by a dropwise addition of [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -cyclopropyl-methanone (66.5 g, 195 mmol) in DMSO (500 ml ). The resulting mixture was warmed to room temperature overnight and quenched with an aqueous solution of ammonium chloride and ice water, and then extracted with MTBE. The organic solvents were washed with water, dried and evaporated to give 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -2-cyclopropyl-oxirane as an oil (66.0 g). 1H-NMR (CDCb; 400 MHz) ■ ■ (ppm) = 0.38-0.50 (m, 4H); 1.40 (m, 1H); 2.90-3.0 (dd, 2H); 6.90 (d, 2H); 7.15 (d, 1H); 7.29 (s, 1H); 7.35 (d, 2H); 7.50 (d, 1H).

Step 3:

Sodium hydroxide was added to 2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -2-cyclopropyl-oxirane (866.0 g, 186 mmol) dissolved in N-methyl-2-pyrrolidon (820 mL) (18.6g, 465mmol) and 1,2,4-triazole (64.2g, 930mmol) at room temperature. The mixture was then stirred for 12 hours at 125 ° C. Then a solution of ammonium chloride and ice water was added, the mixture was extracted with MTBE and washed with an aqueous solution of lithium chloride. The crude residue was purified by flash chromatography on silica gel to give 1- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -1-cyclopropyl-2- (1,2,4-triazol-1- yl) ethanol as an oil (64.5 g, HPLC-MS Rt = 1.24 min; mass = 424 ** (conditions B, see below)).

Additional compounds I, in particular the following, have been prepared analogously:

compound I-11 1- [2- [4- (4-chlorophenoxy) -2- (trifluoromethyl) phenyl] -2-cyclopropyl-2-methoxy-ethyl] -1,2,4-triazole; HPLC ** Rt (min): 1.31

* (conditions A): HPLC column: RP-18 column (Chromolith Speed ROD from Merck KgaA, Germany), 50 mm x 4.6 mm with eluent: acetonitrile 0.1% trifluoroacetic acid (TFA) / water 0.1% TFA (gradient 5 : 95 to 95: 5 in 5 min at 40 ° C, flow of 1.8 ml / min)

** (conditions B): HPLC method data for Table I continued:

Mobile phase: A: water + 0.1% TFA, B: acetonitrile; Gradient: 5% B to 100% B in 1.5 min; Temperature: 60 ° C; MS method: ESI positive; mass / area (m / z): 10-700; Flow: 0.8 ml / min to 1.0 ml / min in 1.5 min; Column: Kinetex XB C18 1.7 | j 50 x 2.1 mm; Device: Shimadzu Nexera LC-30 LCMS-2020

Example 8: Preparation of 2- [2-chloro-4- (4-chlorophenoxy) phenyl] -1- (1,2,4-triazol-1-yl) pent-3-in-2-ol (compound I- 1) Intermediate 1- [2-chloro-4- (4-chloro-phenoxy) -phenyl] -2- [1,2,4] triazol-1-yl-ethanone was prepared as described in WO 2010 / 0146114.

To a solution of the aforementioned ethanone (75.5 g, 216.8 mmol) dissolved in THF (450 ml) was added a solution of LaCl3.2LiCl (395.9 ml, 0.6 M in THF) at room temperature and stirred for 1 hour. The resulting solution was added dropwise to 1-propynylmagnesium bromide (650.5 ml, 0.5 M in THF) at room temperature. After 1 hour at room temperature, the resulting mixture was quenched with 10% aqueous HCl solution and extracted with MTBE. The organic phase was washed with brine, dried and evaporated. The crude compound was stirred in a MTBE / diisopropyl ether solution and filtered to remove the starting material. The mother liquor was evaporated and purified on silica gel to give the title compound as a beige solid (31.1 g, HPLC- MS2 Rt = 1.15 min, mass = 388, mp = 137 ° C).

Compound I-2: 1- [2-chloro-4- (4-chlorophenoxy) phenyl] -1-cyclopropyl-2- (1,2,4-triazol-1-yl) ethane 1HPLC2 Rt (min): 1.24; melting point: 110 ° C

Compound I-10: 2- [2-chloro-4- (4-chlorophenoxy) phenyl] -3,3-dimethyl-1- (1,2,4-triazol-1-yl) butan-2-ol: HPLC1 Rt (min): 3,480; HPLC2 Rt (min): 1.38

HPLC1 column: RP-18 column (Chromolith Speed ROD from Merck KgaA, Germany), 50 mm x 4.6 mm with eluent: acetonitrile 0.1% trifluoroacetic acid (TFA) / 0.1% water TFA (gradient from 5:95 to 95: 5 in 5 min at 40 ° C, flow of 1.8 ml / min)

HPLC2 column: column (Kinetex XB C18 1.7 jm), 50 mm x 2.1 mm with eluent: acetonitrile 0.1% trifluoroacetic acid (TFA) / water; (gradient from 5:95 to 95: 5 in 1.5 min at 60 ° C, flow of 1.8 ml / min)

The enantiomers of compound I-3 were isolated by preparative chromatography using the racemic mixture as a starting material.

Preparatory method:

Column: 250x30 mm CHIRALPAK AD-H 5 mm

Mobile phase: carbon dioxide / ethanol 83/17

Flow rate: 100 ml / min

Detection: UV 240nm

Outlet pressure: 130 bar.

Temperature: 25 ° C

Analytical method:

Column: 250x4.6 mm CHIRALPAK IA 5 pm;

Mobile phase: heptane / isopropanol 90/10 (v / v)

Flow rate: 1 ml / min.

Detection: DAD 250 nm

Temperature: 25 ° C

The first eluent enantiomer (analytical method) had a retention time of 11.1 min ([a] = -27.8 °, 0.100 g / 5 mL THF at 20 ° C) while the second enantiomer had a retention time of 12.7 min ( [a] = 22.9, C = 0.080 g / 5 mL M, THF at 20 ° C). The first eluant enantiomer is the (R) enantiomer of I-3. The second eluent enantiomer is the I-3 enantiomer (S).

Examples showing the activity of the compositions of the invention:

The fungicidal activity of the compositions of the invention is demonstrated by the following biological examples. Micro test

The active compounds were separately formulated as a stock solution having a concentration of 10,000 ppm in dimethyl sulfoxide.

1. Activity against early blight caused by Alternaria solani (Alteso)

Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a suspension of Alternaria solani spores in an aqueous solution of biomalt or yeast-bactopeptone-glycerin was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

2. Activity against the late blight pathogen Phytophthora infestans in the microtiter test (Phytin) Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a spore suspension of Phytophtora infestans containing an aqueous nutrient medium based on pea juice or DDC medium was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

3. Pyricularia oryzae rice blast activity in the microtiter plate test (Pyrior) Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water to the indicated concentrations . Then a suspension of Pyricularia oryzae spores in an aqueous solution of biomalt or yeast-bactopeptone-glycerin was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

4. Activity against leaf spot in wheat caused by Septoria tritici (Septtr)

Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a suspension of Septoria tritici spores in an aqueous solution of biomalt or yeast-bactopeptone-glycerin was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

The measured parameters were compared with the growth of the control variant without active compound (100%) and the blank value without fungi and without active compound to determine the relative growth in% of the pathogens in the respective active compounds. These percentages were converted into efficiencies.

The expected efficiencies of the active compound mixtures were determined using the Colby formula [R.S. Colby, "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds 15, 20-22 (1967)] and was compared with the observed efficiencies.

Below, examples not in accordance with the invention are marked with #

Alteso

Product A only

Alteso mix

Phytin

Product A only

Product B only

Phytin mix

Pyrior

Product A only

Product B only

Pyrior mix

Septtr

Product A only

Product B only

Septtr mix

Micro test

The active compounds were separately formulated as a stock solution having a concentration of 10,000 ppm in dimethyl sulfoxide.

Activity against wheat leaf spot caused by Septoria tritici (Septtr)

Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a suspension of Septoria tritici spores in an aqueous solution of biomalt or yeast-bactopeptone-glycerin was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

The measured parameters were compared with the growth of the control variant without active compound (100%) and the blank value without fungi and without active compound to determine the relative growth in% of the pathogens in the respective active compounds. These percentages were converted into efficiencies.

The expected efficiencies of the active compound mixtures were determined using Colby's formula [RS Colby, "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds 15, 20-22 (1967)] and compared with the observed efficiencies.

S o l o p r o d u c t o A

Product B only

2-way mix

Micro test

The active compounds were separately formulated as a stock solution having a concentration of 10,000 ppm in dimethyl sulfoxide.

Activity against wheat leaf spot caused by Septoria tritici (Septtr)

Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a suspension of Septoria tritici spores in an aqueous solution of biomalt or yeast-bactopeptone-glycerin was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

The measured parameters were compared with the growth of the control variant without active compounds (100%) and the blank value without fungi and active compounds to determine the relative growth in% of the pathogens in the respective active compounds. These percentages were converted into efficiencies.

The expected efficiencies of the active compound mixtures were determined using the Colby formula [R.S. Colby, "Calculating synergistic and antagonistic responses of herbicide combinations" Weeds 15, 20-22 (1967)] and was compared with the observed efficiencies.

Product A only

Product B only

Mixes

Micro test

The active compounds were separately formulated as a stock solution having a concentration of 10,000 ppm in dimethyl sulfoxide.

Pyricularia oryzae rice blast activity in the microtiter plate test (Pyrior)

Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a suspension of Pyricularia oryzae spores in an aqueous solution of biomalt or yeast-bactopeptone-glycerin was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

The measured parameters were compared with the growth of the control variant without active compounds (100%) and the blank value without fungi and active compounds to determine the relative growth in% of the pathogens in the respective active compounds. These percentages were converted into efficiencies.

The expected efficiencies of the active compound mixtures were determined using the Colby formula [R.S. Colby, "Calculating synergistic and antagonistic responses of herbicide combinations" ,, Weeds 15, 20-22 (1967)] and was compared with the observed efficiencies.

Product A only

2-way mix

Micro test

The active compounds were separately formulated as a stock solution having a concentration of 10,000 ppm in dimethyl sulfoxide.

Pyricularia oryzae rice blast activity in the microtiter plate test (Pyrior)

Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a suspension of Pyricularia oryzae spores in an aqueous solution of biomalt or yeast-bactopeptone-glycerin was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

The measured parameters were compared with the growth of the control variant without active compounds (100%) and the blank value without fungi and active compounds to determine the relative growth in% of the pathogens in the respective active compounds. These percentages were converted into efficiencies.

The expected efficiencies of the active compound mixtures were determined using Colby's formula [RS Colby, "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds 15, 20-22 (1967)] and compared with the observed efficiencies.

Product A only

S o l o p r o d u c t o B

Mixes

Micro test

The active compounds were separately formulated as a stock solution having a concentration of 10,000 ppm in dimethyl sulfoxide.

Activity against the late blight pathogen Phytophthora infestans in the microtiter test (Phytin) Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a spore suspension of Phytophtora infestans containing an aqueous nutrient medium based on pea juice or DDC medium was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

The measured parameters were compared with the growth of the control variant without active compounds (100%) and the blank value without fungi and active compounds to determine the relative growth in% of the pathogens in the respective active compounds. These percentages were converted into efficiencies. The expected efficiencies of the active compound mixtures were determined using the Colby formula [R.S. Colby, "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds 15, 20-22 (1967)] and was compared with the observed efficiencies.

Product A only

Product B only

2-way mix

Micro test

The active compounds were separately formulated as a stock solution having a concentration of 10,000 ppm in dimethyl sulfoxide.

Activity against the late blight pathogen Phytophthora infestans in the microtiter test (Phytin) Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a spore suspension of Phytophtora infestans containing an aqueous nutrient medium based on pea juice or DDC medium was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

The measured parameters were compared with the growth of the control variant without active compound (100%) and the blank value without fungi and without active compound to determine the relative growth in% of the pathogens in the respective active compounds.

These percentages were converted into efficiencies. The expected efficiencies of the active compound mixtures were determined using the Colby formula [RS Colby, "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds 15, 20-22 (1967)] and compared with the observed efficiencies.

Product A only

Product B only

Mixes

Micro test

The active compounds were separately formulated as a stock solution having a concentration of 10,000 ppm in dimethyl sulfoxide.

Activity against leaf spots in wheat caused by Leptosphaeria nodorum (Leptno)

Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a suspension of Leptosphaeria nodorum spores in an aqueous solution of biomalt or yeast-bactopeptone-glycerin was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

The measured parameters were compared with the growth of the control variant without active compounds (100%) and the blank value without fungi and active compounds to determine the relative growth in% of the pathogens in the respective active compounds.

These percentages were converted into efficiencies. The expected efficiencies of the active compound mixtures were determined using the Colby formula [RS Colby, "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds 15, 20-22 (1967)] and compared with the observed efficiencies.

Product A only

or product B

Micro test

The active compounds were separately formulated as a stock solution having a concentration of 10,000 ppm in dimethyl sulfoxide.

Activity against wheat leaf spot caused by Leptosphaeria nodorum (Leptno)

Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a suspension of Leptosphaeria nodorum spores in an aqueous solution of biomalt or yeast-bactopeptone-glycerin was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

The measured parameters were compared with the growth of the control variant without active compounds (100%) and the blank value without fungi and active compounds to determine the relative growth in% of the pathogens in the respective active compounds.

These percentages were converted into efficiencies.

The expected efficiencies of the active compound mixtures were determined using the Colby formula [R.S. Colby, "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds 15, 20-22 (1967)] and was compared with the observed efficiencies.

Product A only

Product B only

Mixes

Micro test

The active compounds were separately formulated as a stock solution having a concentration of 10,000 ppm in dimethyl sulfoxide.

Activity against gray mold Botrytis cinerea in the microplate test (Botrci)

Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a suspension of Botrci cinerea spores in an aqueous solution of biomalt or yeast-bactopeptone-sodium was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

The measured parameters were compared with the growth of the control variant without active compounds (100%) and the blank value without fungi and active compounds to determine the relative growth in% of the pathogens in the respective active compounds. These percentages were converted into efficiencies.

The expected efficiencies of the active compound mixtures were determined using the Colby formula [R.S. Colby, "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds 15, 20-22 (1967)] and was compared with the observed efficiencies.

Product A only

Product B only

2-way mix

Micro test

The active compounds were separately formulated as a stock solution having a concentration of 10,000 ppm in dimethyl sulfoxide.

Activity against gray mold Botrytis cinerea in the microplate test (Botrci)

Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a suspension of Botrci cinerea spores in an aqueous solution of biomalt or yeast-bactopeptone-sodium was added. The plates were placed in a chamber saturated with water vapor at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

The measured parameters were compared with the growth of the control variant without active compound (100%) and the blank value without fungi and without active compound to determine the relative growth in% of the pathogens in the respective active compounds. These percentages were converted into efficiencies.

The expected efficiencies of the active compound mixtures were determined using the Colby formula [R.S. Colby, "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds 15, 20-22 (1967)] and was compared with the observed efficiencies.

S o lo p r o d u c t o A

Product B only

Mixes

Micro test

The active compounds were separately formulated as a stock solution having a concentration of 10,000 ppm in dimethyl sulfoxide.

Activity against early blight caused by Alternaria solani (Alteso)

Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a suspension of Alternaria solani spores in an aqueous solution of biomalt or yeast-bactopeptone-glycerin was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

The measured parameters were compared with the growth of the control variant without active compound (100%) and the blank value without fungi and without active compound to determine the relative growth in% of the pathogens in the respective active compounds.

These percentages were converted into efficiencies.

The expected efficiencies of the active compound mixtures were determined using the Colby formula [R.S. Colby, "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds 15, 20-22 (1967)] and was compared with the observed efficiencies.

Product A only

Product ^B only

2-way mix

Micro test

The active compounds were separately formulated as a stock solution having a concentration of 10,000 ppm in dimethyl sulfoxide.

Activity against early blight caused by Alternaria solani (Alteso)

Stock solutions were mixed according to the ratio, pipetted onto a microtiter plate (MTP) and diluted with water at the indicated concentrations. Then a suspension of Alternaria solani spores in an aqueous solution of biomalt or yeast-bactopeptone-glycerin was added. The plates were placed in a saturated steam chamber at a temperature of 18 ° C. Using an absorption photometer, MTPs were measured at 405nm 7 days after inoculation.

The measured parameters were compared with the growth of the control variant without active compounds (100%) and the blank value without fungi and active compounds to determine the relative growth in% of the pathogens in the respective active compounds.

These percentages were converted into efficiencies.

The expected efficiencies of the active compound mixtures were determined using the Colby formula [RS Colby, "Calculating synergistic and antagonistic responses of herbicide combinations", Weeds 15, 20-22 (1967)] and compared with the observed efficiencies.

Product A only

Product B only

Mixes

Structures of compounds I:

Claims (6)

1. Compositions that comprise 1) as component I Compound I-3: 2- [4- (4-dorophenoxy) -2- (trifluoromethyl) phenyl] -1- (1,2,4-triazol-1-yl) propan-2-ol; and 2) as component II, an active ingredient selected from: azoxystrobin, dimoxystrobin, fluoxastrobin, isofetamid, kresoxim-methyl, picoxystrobin, pyrazlostrobin, trifloxystrobin, ciazofamide, benzovindiflupir, bixafen, boscalid, fluopirazol, fluxapiroxad, isopirazam, sedaxan, flurazine, sedaxan tetraconazole, triticonazole, fenpropimorph, phenpropidine, metalaxyl, metalaxyl- M (mefenoxam), metrafenone, iprovalicarb, oxatiapiproline, copper oxychloride, sulfur, mancozeb, chlorothalonil, triciclazole, picarbutrazox, Bacillus, Bacillus , T. gamsii, prohexadione-calcium, mepicuat (mepicuat chloride), trinexapac-ethyl, flupiradifurone, thiamethoxam, nitenpyram, wherein the weight ratio of component I to component II is 4: 1 to 1: 4. 2. The compositions of claim 1 further comprising a component III selected from groups A) to O): A) respiration inhibitors - Inhibitors of complex III site Qo (eg strobilurins): azoxystrobin, coumetoxistrobina, coumoxistrobina, dimoxystrobin, enestroburin, fenaminstrobina, fenoxistrobina / flufenoxistrobina, fluoxastrobin, isofetamid, kresoxim-methyl, meto-minostrobina, orysastrobin, picoxystrobin, pyraclostrobin, pirametostrobina , 2- pyroxystrobin, trifloxystrobin, 2- [2- (2,5-dimethyl-phenoxymethyl) -phenyl] -3-methoxy-acrylic and 2- (2- (3- (2,6-dichlorophenyl) -1 -methyl-allylideneaminooxymethyl) -phenyl) -2-methoxyimino-N-methyl-acetamide, pyribencarb, triclopyricarb / chlorodincarb, famoxadone, fenamidone; - Qi site complex III inhibitors: ciazofamide, amisulbrom, [(3S, 6S, 7R, 8R) -8-benzyl-3 - [(3-acetoxy-4-methoxypyridine-2-carbonyl) amino] -6- methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S, 6S, 7R, 8R) -8-benzyl-3 - [[3- (acetoxymethoxy) - 4-methoxy -pyridine-2-carbonyl] amino] -6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S, 6S, 7R, 8R) -8-benzyl-3 - [(3-isobutoxycarbonyloxy-4-methoxy-pyridine-2-carbonyl) amino] -6-methyl-4,9-dioxo-1,5-dioxonan-7-yl] 2-methylpropanoate, [(3S, 6S, 7R, 8R) -8-benzyl-3 - [[3- (1,3-benzodioxol-5-ylmethoxy) -4-methoxy-pyridine-2-carbonyl] amino] -6-methyl-4,9-dioxo- 1,5-dioxonan-7-yl] 2-methylpropanoate; (3S, 6S, 7R, 8R) -3 - [[(3-hydroxy-4-methoxy-2-pyridinyl) carbonyl] amino] -6-methyl-4,9-dioxo-8- (phenylmethyl) -1, 5-dioxonan-7-yl 2-methylpropanoate; - complex II inhibitors (for example, carboxamides): benodanil, benzovindiflupir, bixafen, boscalid, carboxin, fenfuram, fluopiram, flutolanil, fluxapiroxad, furametpir, isopzamine, isopiram, , penflufen, pentiopyrad, sedaxane, tecloftalam, tifluzamide, N- (4'-trifluoromethylthiobiphenyl-2-yl) -3-difluoromethyl-1-methyl-1H-pyrazol-4-carboxamide, N- (2- (1,3, 3-trimethylbutyl) -phenyl) -1,3-dimethyl-5-fluoro-1H-pyrazol-4-carboxamide, 3- (difluoromethyl) -1-methyl-N- (1,1,3-trimethylindan-4-yl ) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1-methyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 1,3-dimethyl-N- (1, 1 , 3-trimethylindan-4-yl) pyrazol-4-carboxamide, 3- (trifluoromethyl) -1,5-dimethyl-N- (1,1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, 1, 3,5-trimethyl-N- (1, 1,3-trimethylindan-4-yl) pyrazol-4-carboxamide, N- (7-fluoro-1, 1,3-trimethyl-indan-4-yl) - 1,3-Dimethyl-pyrazole-4-carboxamide, N- [2- (2,4-Dichlorophenyl) -2-methoxy-1-methyl-ethyl] -3- (difluoromethyl) -1-methyl-pyrazole-4- carboxamide; - other respiration inhibitors (eg complex I, decouplers): diflumethorim, (5,8-difluoroquinazolin-4-yl) - {2- [2-fluoro-4- (4-trifluoromethylpyridin-2-yloxy) - phenyl] -ethyl} -amine; nitrophenyl derivatives: binapacryl, dinobuton, dinocap, fluazinam; ferimzone; organometallic compounds: fenthin salts, such as fenthin acetate, fenthin chloride, or fenthin hydroxide; amethoctradine; and siltiofam; B) Sterols biosynthesis inhibitors (SBI fungicides) - C14 demethylase inhibitors (DMI fungicides): triazoles: azaconazole, bitertanol, bromuconazole, cyproconazole, diphenoconazole, diniconazole, diniconazole-M, epoxiconazole, fenbuconazole, fluquinconazole, flusilazole, flutriafol, hexaconazole, imenconazole, imiphenol, hexaconazole, imiphenolone , paclobutrazole, penconazole, propiconazole, protioconazole, simeconazole, tebuconazole, tetraconazole, triadimefon, triadimenol, triticonazole, uniconazole, 1- [rel- (2S; 3R) -3- (2-chlorophenyl) -2- (2,4-difluorophenyl ) -oxyranylmethyl] -5-thio-cyanate-1H- [1,2,4] triazole, 2- [rel- (2S; 3R) -3- (2-chlorophenyl) -2- (2,4-difluorophenyl) -oxyranylmethyl] -2H- [1,2,4] triazol-3-thiol; imidazoles: imazalil, pefurazoate, prochloraz, triflumizole; pyrimidines, pyridines, and piperazines: fenarimol, nuarimol, pyrifenox, triforine; 3- (4-chloro-2-fluoro-phenyl) -5- (2,4-difluorophenyl) isoxazol-4-yl] - (3-pyridyl) methanol; - Delta14-reductase inhibitors: aldimorph, dodemorph, dodemorph acetate, fenpropimorph, tridemorph, fenpropidine, piperaline, spiroxamine; - 3-keto reductase inhibitors: fenhexamide; C) nucleic acid synthesis inhibitors - acylamino acid phenylamides or fungicides: benalaxyl, benalaxil-M, kiralaxil, metalaxil, metalaxil-M (mefenoxam), ofurace, oxadixil; - others: himexazole, octilinone, oxolinic acid, bupirimate, 5-fluorocytosine, 5-fluoro-2- (p-tolylmethoxy) pyrimidin-4-amine, 5-fluoro-2- (4-fluorophenylmethoxy) pyrimidin-4-amine; D) Cell division and cytoskeleton inhibitors - tubulin inhibitors, such as benzimidazoles, thiophanates: benomyl, carbendazim, fuberidazole, thiabendazole, thiophanate-methyl; triazolopyrimidines: 5-chloro-7- (4-methylpiperidin-1-yl) -6- (2,4,6-trifluorophenyl) - [1,2,4] triazolo [1,5-a] pyrimidine - other inhibitors of cell division: dietofencarb, etaboxam, pencicuron, fluopicolide, zoxamide, metrafenone, pyriophenone; E) Inhibitors of amino acid and protein synthesis - inhibitors of methionine synthesis (anilino-pyrimidines): cyprodinil, mepanipyrim, pyrimethanil; - Protein synthesis inhibitors: blasticidin-S, kasugamycin, kasugamycin hydrochloride-hydrate, mildiomycin, streptomycin, oxytetracycline, polyoxine, validamycin A; F) signal transduction inhibitors - MAP / histidine kinase inhibitors: fluoroimide, iprodione, procymidone, vinclozolin, fludioxonil; - G protein inhibitors: quinoxifene; G) lipid and membrane synthesis inhibitors - Inhibitors of biosynthesis of phospholipids: edifenfos, iprobenfos, pirazofos, isoprotiolano; - lipid peroxidation: dichloran, fifthcene, technacene, tolclofos-methyl, biphenyl, chloroneb, etridiazol; - phospholipid biosynthesis and cell wall deposition: dimethomorphic acid, flumorfo, mandipropamide, pyrimorphic, bentiavalicarb, iprovalicarb, valifenalate and N- (1- (1- (4-cyano-phenyl) ethanesulfonyl) -but-2-yl acid ) carbamic (4-fluorophenyl) ester; - compounds that affect the permeability of the cell membrane and fatty acids: propamocarb, propamocarb hydrochloride; - fatty acid amide hydrolase inhibitors: oxathiapiproline, 1- [4- [4- [5- (2,6-difluorophenyl) -4,5-dihydro-3-isoxazolyl] -2-thiazolyl] -1-piperidinyl ] -2- [5-methyl-3- (trifluoromethyl) -1 H-pyrazol-1-yl] ethanone, 2- {3- [2- (1 - {[3,5-bis (difluoromethyl-1 H- pyrazol-1-yl)] acetyl} piperidin-4-yl) -1,3-thiazol-4-yl] -4,5-dihydro-1,2-oxazol-5-yl} phenyl methanesulfonate, 2- {3 - [2- (1 - {[3,5-bis (difluoromethyl) -1H-pi razol-1-yl] acetyl} piperidin-4-yl) 1,3-thiazol-4-yl] -4,5- dihydro-1,2-oxazol-5-yl} -3-chlorophenylmethanesulfonate; H) Inhibitors with multi-site action - inorganic active substances: Bordeaux mixture, copper acetate, copper hydroxide, copper oxychloride, basic copper sulfate, sulfur; - uncle and dithiocarbamates: ferbam, mancozeb, maneb, metam, metiram, propineb, tiram, zineb, ziram; - organochlorine compounds (for example phthalimides, sulfa drugs, chloronitriles): anilazine, chlorothalonil, captafol, captan, folpet, dichlorofluanide, dichlorophen, flusulfamide, hexachlorobenzene, pentachlorophenols and their salts, phthalide, tolylfluanide, N- (4- nitro-phenyl) -N-ethyl-4-methyl-benzenesulfonamide; - guanidines and others: guanidine, dodine, dodine free base, guazatine, guazatine acetate, iminoctadine, iminoctadine-triacetate, iminoctadine-tris (albesilate), dithianon, 2,6-dimethyl-1H, 5H- [1,4 ] dithine [2,3-c: 5,6-c '] dipyrrole-1,3,5,7 (2H, 6H) -tetraone; I) inhibitors of cell wall synthesis - glucan synthesis inhibitors: validamycin, polyoxin B; melanin synthesis inhibitors: piroquilon, triciclazole, carpropamid, dicyclomet, fenoxanil; J) plant defense inducers - acibenzolar-S-methyl, probenazol, isothianil, tiadinil, prohexadione-calcium; phosphonates: fosethyl, fosetil-aluminum, phosphorous acid and its salts; K) Unknown mode of action - bronopol, cynomethionate, cyflofenamide, cymoxanil, dazomet, debacarb, diclo-mezine, diphenzoquat, diphenzoquatmethylsulfate, diphenylamine, fenpyrazamine, flumetover, flutianil, metasulfocarb, nitrapyrin, nitrotal-isopyl, isopyl-isopyl-isopyl-isopyl-isopyl-isopyl-isopyl-isopyl, , 2- [3,5-bis (difl uoromethyl) -1 H-pyrazol-1-yl] -1- [4- (4- {5- [2- (prop-2-in-1-yloxy) phenyl ] -4,5-dihydro-1,2-oxazol-3-yl} -1,3-thiazol-2-yl) piperidin-1-yl] ethanone, 2- [3,5-bis (difluoromethyl) -1H -pyrazol-1-yl] -1- [4- (4- {5- [2-fluoro-6- (prop-2-in-1-yl-oxy) phenyl] -4,5-dihydro-1, 2-oxazol-3-yl} -1,3-thiazol-2-yl) piperidin-1-yl] ethanone, 2- [3,5-bis (difluoromethyl) -1 H-pyrazol-1-yl] -1 - [4- (4- {5- [2-chloro-6- (prop-2-in-1-yl-oxy) phenyl] -4,5-dihydro-1,2-oxazol-3-yl} - 1,3-thiazol-2-yl) piperidin-1-yl] ethanone, tolprocarb, triazoxide, 2-butoxy-6-iodo-3-propylchromen-4-one, N- (cyclopropylmethoxyimino- (6-difluoro-methoxy) -2,3-difluoro-phenyl) -methyl) -2-phenyl acetamide, N '- (4- (4-chloro-3-trifluoromethyl-phenoxy) -2,5-dimethyl-phenyl) -N-ethyl-N-methyl formamidine, N '- (4- (4-fluoro-3-trifluoromethyl-phenoxy) -2,5-dimethyl-phenyl) -N-ethyl-N-methylformamidine, N' - (2 -methyl-5-trifluoromethyl-4- (3-trimethylsilanil-propoxy) -phenyl) -N-ethyl-N-methylformamidine, N '- (5-difluoromethyl-2-methyl-4- (3-trimethylsilanyl-propoxy) - phenyl) -N-ethyl-N-methylformamidine, 2-methoxy-acetic acid 6-tert-butyl-8-fluoro-2,3-dimethyl-quinolin-4-yl ester, 3- [5- (4-methylphenyl) -2,3-dimethyl-isoxazolidin-3-yl] -pyridine, 3- [5- (4-chloro-phenyl) -2,3-dimethyl-isoxazolidin-3-yl] -pyridine (pyrisoxazole), acid amide N- (6-methoxy-pyridin-3-yl) cyclopropanecarboxylic, 5-chloro-1 - (4,6-dimethoxy-pyrimidin-2-yl) -2-methyl-1 H-benzoimidazole, 2- (4-chlorophenyl ) -N- [4- (3,4-dimethoxy-phenyl) -isoxazol-5-yl] -2-prop-2-ynyloxy-acetamide; ethyl (Z) -3-amino-2-cyano-3-phenyl-prop-2-enoate, tert-butyl N- [6 - [[(Z) - [(1-methyltetrazol-5-yl) -phenyl- methylene] amino] oxymethyl] -2-pyridyl] carbamate, pentyl N- [6 - [[(Z) - [(1-methyltetrazol-5-yl) -phenylmethylene] amino] oxymethyl] -2-pyridyl] carbamate, 2 - [2 - [(7,8-difluoro-2-methyl-3-quinolyl) oxy] -6-fluorophenyl] propan-2-ol, 2- [2-fluoro-6 - [(8-fluoro-2- methyl-3-quinolyl) oxy] phenyl] propan-2-ol, 3- (5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl) quinoline, 3- (4, 4-difluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl) -quinoline, 3- (4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl) quinolone; 9-fluoro-2,2-dimethyl-5- (3-quinolyl) -3H-1,4-benzoxazepine, ethyl (Z) -3-amino-2-cyano-3-phenyl-prop-2-enoate, picarbutrazox , pentyl N- [6 - [[(Z) - [(1-methyltetrazol-5-yl) -phenyl-methylene] amino] oxymethyl] -2-pyridyl] carbamate, 2- [2 - [(7,8- difluoro-2-methyl-3-quinolyl) oxy] -6-fluoro-phenyl] propan-2-ol, 2- [2-fluoro-6 - [(8-fluoro-2-methyl-3-quinolyl) oxy] phen-yl] propan-2-ol, 3- (5-fluoro-3,3,4,4-tetramethyl-3,4-dihydroisoquinolin-1-yl) quinoline, 3- (4,4-difluoro-3, 3-dimethyl-3,4-dihydroisoquinolin-1-yl) quinoline, 3- (4,4,5-trifluoro-3,3-dimethyl-3,4-dihydroisoquinolin-1-yl) quinoline; L) Biopesticides L1) Microbial pesticides with fungicidal, bactericidal, viricidal and / or activating plant defense activity: Ampelomyces quisqualis, Aspergillus flavus, Aureobasidium pullulans, Bacillus amyloliquefaciens, B. mojavensis, B. pumilus, B. simplex, B. solisalsi, B. subtilis , B. subtilis B. subtilis var. amyloliquefaciens, Candida oleophila, C. saitoana, Clavibacter michiganensis (bacteriophages), Coniothyrium minitans, Cryphonectria parasitica, Cryptococcus albidus, Dilophosphora alopecuri, Fusarium oxysporum, Clonostachys rosea f. Catenulate (also called Gliocladium catenulatum), Gliocladium roseum, Lysobacter antibioticus, L. enzymagenes, Metschnikowia fructicola, Microdochium dimerum, Microsphaeropsis ochracea, Muscodor albus, Paenibacillus polymyxa, Pantoea vagans, Phlebiopsis gigantea, Pseudomonas sp., Pseudomonas chloraphis, Pseudozyma flocculosa, Pichia anomala, Pythium oligandrum, Sphaerodes mycoparasitica, Streptomyces griseoviridis, S. lydicus, S. violaceusniger, Talaromyces flavus, Trichoderma asperellum, T. atroviride, T. fertile, T. gamsii, T. harmatum, T. harzianum; mix of T. harzianum and T. viride; mix of T. polysporum and T. harzianum; T. stromaticum, T. virens (also called Gliocladium virens), T. viride, Typhula phacorrhiza, Ulocladium oudemansii, Verticillium dahlia, zucchini yellow mosaic virus (avirulent strain); L2) Biochemical pesticides with fungicidal, bactericidal, viricidal and / or activating plant defense activity: chitosan (hydrolyzed), harpin protein, laminarin, Menhaden fish oil, natamycin, cover protein from plum pox virus, bicarbonate of potassium or sodium, Reynoutria sachlinensis extract, salicylic acid, tea tree oil; L3) Microbial pesticides with insecticidal, acaricidal, molluscic and / or nematicidal activity: Agrobacterium radiobacter, Bacillus cereus, B. firmus, B. thuringiensis, B. thuringiensis ssp. aizawai, B. t. ssp. israelensis, B. t. ssp. galleriae, B. t. ssp. kurstaki, B. t. ssp. tenebrionis, Beauveria bassiana, B. brongniartii, Burkholderia sp., Chromobacterium subtsugae, Cydia pomonella granulosis virus, Cryptophlebia leucotreta granulovirus (CrleGV), Isaria fumosorumia, Heterorhabditis bacteriophora, Lecanicillium longisporum, Lecanicillium longisporum anisopliae var. acridum, Nomuraea rileyi, Paecilomyces fumosoroseus, P. lilacinus, Paenibacillus popilliae, Pasteuria spp., P. nishizawae, P. penetrans, P. ramose, P. reneformis, P. thornea, P. usgae, Pseudomonas fluorescens, Steinernema carpocapsae Sentia S. kraussei; L4) Biochemical pesticides with insecticidal, acaricidal, molluscic, pheromone and / or nematicidal activity: L-carvone, citral, (E, Z) -7,9-dodecadien-1-yl acetate, ethyl formate, (E, Z) -2,4-ethyl decadienoate (pear ester), (Z, Z, E) -7,11,13-hexadecatrienal, heptyl butyrate, isopropyl myristate, lavanulyl senecioate, cis-jasmona, 2-methyl 1- butanol, methyl eugenol, methyl jasmonate, (E, Z) -2,13-octadecadien-1-ol, (E, Z) -2,13-octadecadien-1-ol acetate, (E, Z) -3, 13-octadecadien-1- ol, R-1-octen-3-ol, pentatermanone, potassium silicate, sorbitol actanoate, (E, Z, Z) -3,8,11-tetradecatrienyl acetate, (Z, E ) -9,12-tetradecadien-1-yl acetate, Z-7-tetradecen-2-year, Z-9-tetradecen-1-yl acetate, Z-11-tetradecenal, Z-11-tetradecen-1-ol, black acacia extract, grapefruit and pulp seed extract, Chenopodium ambrosiodae extract, nebeda oil, Neem oil, Quillay extract, Tagetes oil; L5) Microbial pesticides with reduction of plant stress, regulator of plant growth, activity promoting growth of plants and / or improvement of yield: Azospirillum amazonense, A. brasilense, A. lipoferum, A. irakense, A. halopraeferens, Bradyrhizobium sp., B. elkanii, B. japonicum, B. liaoningense, B. lupini, Delftia acidovorans, Glomus intraradices, Mesorhizobium sp., Paenibacillus alvei, Penicillium bilaiae, Rhizobium leguminosarum bv. phaseoli, R. I. trifolii, R. I. bv. viciae, R. tropici, Sinorhizobium meliloti; L6) Biochemical pesticides with plant stress reducing activity, plant growth regulator and / or activity that improves plant performance: abscisic acid, aluminum silicate (kaolin), 3-decen-2-one, formononetin , genistein, hesperetin, homobrassinlide, humates, jasmonic acid or salts or derivatives thereof, lysophosphatidyl ethanolamine, naringenin, polymeric polyhydroxy acid, extract of Ascophyllum nodosum (Norwegian algae, brown algae) and extract of Ecklonia maxima (seaweed); M) Growth regulators abscisic acid, amidochlor, ancimidol, 6-benzylaminopurine, brasinolide, butraline, chlormequat (chlormequat chloride), choline chloride, cyclanilide, daminozide, dikegulac, dimethipine, 2,6-dimethylpuridine, ethephone, flumetralin, flurprimidol, Gibberellic Acid, Inabenfide, Indole-3-Acetic Acid, Maleic Hydrazide, Mefluidide, Mepicuat (Mepicuat Chloride), Naphthaleneacetic Acid, N-6-Benzyladenine, Paclobutrazol, Proheroxadione, Trothiopentool, Triazuron, 2,3,5-triiodobenzoic acid, trinexapac-ethyl and uniconazole; N) herbicides - acetamides: acetochlor, alachlor, butachlor, dimethachlor, dimethenamide, flufenacet, mefenacet, metolachlor, metazachlor, napropamide, naproanilide, pethoxamide, pretilachlor, propachlor, tenylchlor; - amino acid derivatives: bilanafos, glyphosate, glufosinate, sulphosate; - aryloxyphenoxypropionates: clodinafop, cyhalofop-butyl, fenoxaprop, fluazifop, haloxifop, metamifop, propaquizafop, quizalofop, quizalofop-P-tefuril; - Bipyridyls: diquat, paraquat; - (thio) carbamates: asulam, butylate, carbetamide, desmedipham, dimepiperate, eptam (EPTC), esprocarb, molinate, orbencarb, fenmedipham, prosulfocarb, pyributicarb, thiobencarb, trialate; - cyclohexanediones: butroxidim, cletodim, cycloxidim, profoxidim, setoxidim, tepraloxidim, tralcoxidim; - dinitroanilines: benfluralin, etalfluralin, orizaline, pendimethalin, prodiamine, trifluralin; - diphenyl ethers: acifluorfen, aclonifen, bifenox, diclofop, ethoxyphene, fomesafen, lactofen, oxyfluorfen; - hydroxybenzonitriles: bomoxynil, diclobenyl, ioxynil; - imidazolinones: imazametabenz, imazamox, imazapic, imazapir, imazaquin, imazetapir; phenoxyacetic acids: clomeprop, 2,4-didophoenoxyacetic acid (2,4-D), 2,4-DB, dichlorprop, MCPA, MCPA-thioethyl, MCPB, Mecoprop; - pyrazines: chloridazone, flufenpir-ethyl, flutiacet, norflurazon, pyridate; - pyridines: aminopiralid, clopiralid, diflufenican, dithiopyr, fluridoae, fluroxipir, picloram, picolinafen, thiazopir; - sulfonylureas: amidosulfuran, azimsulfuran, bensulfuran, chlorimuron-ethyl, clorsulfuran, cinosulfuran, cyclosulfamuran, ethoxysulfuran, flazasulfuran, flucetosulfuran, flupirsulfuran, foramsulfuran, sulfur, methylsulfuran, meodosulfuran, mesosulfuran, metazosulfuran, meta-sulfur , pirazosulfuran, rimsulfuran, sulfometuran, sulfosulfuran, tifensulfuran, triasulfuran, tribenuran, trifloxisulfuran, triflusulfuran, tritosulfuran, 1 - ((2-chloro-6-propyl-imidazo [1,2-b] pyridazin-3-yl) sulfonyl) -3 (4,6-dimethoxy-pyrimidin-2-yl) urea; triazines: amethrin, atrazine, cyanase, dimethamethrin, etiozin, hexazinone, metamitron, metribuzin, promethrin, simazine, terbutylazine, terbutrin, triaziflam; - ureas: chlorotoluron, daimuron, diuron, fluometuron, isoproturon, linuron, metabenztiazuron, tebutiuron; - other acetolactate synthase inhibitors: bispiribac-sodium, chloransam-methyl, diclosulam, florasulam, flucarbazone, flumetsulam, metosulam, ortosulfamuran, penoxsulam, propoxycarbazone, piribambenz-propyl, piribenzoxim, piriftalid, piriminobac-methyl, pirimisulfan, piritiobac, piroxasulfone, piroxsulam; - other: amicarbazone, aminotriazole, anilophos, beflubutamide, benzonata, bencarbazona, benfluresate, benzofenap, benfluresate, benzofenap, , carfentrazone, cinidon-ethyl, chlorthal, cinmethyline, clomazone, cumiluron, cyprosulfamide, dicamba, difenzocuat, diflufenzopir, Drechslera monoceras, endotal, ethofumesate, etobenzanidine, phenoxasulfone, fluxurazurofluorophenyl, fluorochlorofluorin Isoxaben, Isoxaflutol, Lenacil, Propanil, Propizamide, Quinclorac, Quinmerac, Mesotrione, Methyl Arsonic Acid, Naptalam, Oxadiargil, Oxadiazon, Oxaziclomefone, Pentoxazone, Pyrazlonyl, Pyraflufeno-Ethyl, Pyrarasulfotole, Pirarasulfotole sulfentrazone, terbacillus, tefuryltrione, tremotrione, thiencarbazone, topramezone, this (3- [2-Chloro-4-fluoro-5- (3-methyl-2,6-dioxo-4-trifluoromethyl-3,6-dihydro-2H-pyrimidin-1-yl) -phenoxy acid) ethyl er -pyridin-2-yloxy) -acetic, 6-amino-5-chloro-2-cyclopropyl-pyrimidine-4-carboxylic acid methyl ester, 6-chloro-3- (2-cyclopropyl-6-methyl-phenoxy) - pyridazin-4-ol, 4-amino-3-chloro-6- (4-chlorophenyl) -5-fluoro-pyridine-2-carboxylic acid, 4-amino-3-chloro-6- (4-) methyl ester chloro-2-fluoro-3-methoxy-phenyl) -pyridin-2-carboxylic acid and 4-amino-3-chloro-6- (4-chloro-3-dimethylamino-2-fluorophenyl) -pyridi na- methyl ester 2-carboxylic. O) insecticides - organo (thio) phosphates: acetate, azamethyl, azinphos-methyl, chlorpyrifos, chlorpyriphos-methyl, chlorfenvinphos, diazinon, dichlorvos, dichrotophos, dimethoate, disulfoton, ethion, fenitrothion, fenthion, isoxathion, malathion, methamidophosphomethathione , Monocrotophos, Oxidemeton-methyl, Paraoxon, Parathion, Fentoate, Fosalone, Fosmet, Phosphamidon, Forate, Poxim, Pyrimiphos-methyl, Prophenophos, Protiophos, Sulprofos, Tetrachlorvinphos, Terbuphos, Triazophos, Trichlorphos; -carbamates: Alanicarbium, Albicarbium benfuracarb, carbaryl, carbofuran, carbosulfan, phenoxycarb, furathiocarb, methiocarb, methomyl, oxamyl, pyrimicarb, propoxur, thiodicarb, triazamate; - pyrethroids: alethrin, biphentrin, cyfluthrin, cyhalothrin, cyphenothrin, cypermethrin, alpha-cypermethrin, beta-cypermethrin, zeta-cypermethrin, deltamethrin, sphevalerate, pyrotrothrine, phenvalerate, imipheratrine, phevalerate, -phevaryrin, phenvalerate, pyrrhethrine, phenvalethrin, phenvalerate, phevalerate, phevaletin II, resmethrin, silafluofen, tau-fluvalinate, tefluthrin, tetramethrin, tralometrine, transfluthrin, profluthrin, dimefluthrin; - insect growth regulators: a) inhibitors of chitin synthesis: benzoylureas: chlorfluazuron, ciramazine, diflubenzuron, flucicloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, teflubenzuron, triflumuron; buprofezin, diofenolan, hexitiazole, etoxazole, clofentazine; b) ecdysone antagonists: halofenozide, methoxyphenozide, tebufenozide, azadirachtin; c) juvenoids: pyriproxyfen, methoprene, phenoxycarb; d) lipid biosynthesis inhibitors: spirodichlophene, spiromesifene, spirotetramat; - Nicotinic receptor agonist / antagonist compounds: clothianidin, dinotefuran, flupiradifurone, imidacloprid, thiamethoxam, nitenpyram, acetamiprid, thiacloprid, 1,2-chloro-thiazol-5-ylmethyl) -2-nitrimino-3,5-dimethyl- [1 , 3,5] triazinan; - GABA antagonist compounds: endosulfan, etiprol, fipronil, vaniliprol, pirafluprol, piriprol, 5-amino-1- (2,6-dichloro-4-methyl-phenyl) -4-sulfinamoyl-1H-pi razol- amide 3-carbothioic; - lactone macrocyclic insecticides: abamectin, emamectin, milbemectin, lepimectin, espinosad, espinetoram; - mitochondrial electron transport inhibitors (METI) I acaricides: fenazaquin, pyridaben, tebufenpirad, tolfenpirad, flufenerim; - METI II and III compounds: acequinocyl, fluaciprim, hydramethylnon; - Decouplers: chlorfenapir; - inhibitors of oxidative phosphorylation: cyhexatin, diafentiuron, fenbutatin oxide, propargite; - molting disrupting compounds: cryomazine; - mixed function oxidase inhibitors: piperonyl butoxide; - sodium channel blockers: indoxacarb, metaflumizone; - ryanodine receptor inhibitors: chloranraniliprole, cyanraniliprole, flubendiamide, N- [4,6-dichloro-2 - [(diethyl-lambda-4-sulfanilidene) carbamoyl] -phenyl] -2- (3-chloro-2-pyridyl ) -5- (trifluoromethyl) pyrazol-3-carboxamide; N- [4-chloro-2 - [(dietillambda-4-sulfanilidene) carbamoyl] -6-methyl-phenyl] -2- (3-chloro-2-pyridyl) -5- (trifluoromethyl) pyrazol-3-carboxamide; N- [4-Chloro-2 - [(di-2-propyl-lambda-4-sulfanilidene) carbamoyl] -6-methyl-phenyl] -2- (3-chloro-2-pyridyl) -5- (trifluoromethyl) pyrazole-3-carboxamide; N- [4,6-dichloro-2 - [(di-2-propyl-lambda-4-sulfanilidene) carbamoyl] -phenyl] -2- (3-chloro-2-pyridyl) -5- (trifluoromethyl) pyrazole- 3-carboxamide; N- [4,6-dichloro-2 - [(diethyl-lambda-4-sulfanilidene) carbamoyl] -phenyl] -2- (3-chloro-2-pyridyl) -5- (difluoromethyl) pyrazol-3-carboxamide; N- [4,6-dibromo-2 - [(di-2-propyl-lambda-4-sulfanilidene) carbamoyl] -phenyl] -2- (3-chloro-2-pyridyl) -5- (trifluoromethyl) pyrazole- 3-carboxamide; N- [4-chloro-2 - [(di-2-propyl-lambda-4-sulfanylidene) carbamoyl] -6-cyano-phenyl] -2- (3-chloro-2-pyridyl) -5- (trifluoromethyl) pyrazole-3-carboxamide; N- [4,6-dibromo-2 - [(diethyl-lambda-4-suIfanilidene) carbamoyl] -phenyl] -2- (3-chloro-2-pyridyl) -5- (trifluoromethyl) pyrazol-3-carboxamide; - Others: benclotiaz, bifenazate, cartap, flonicamid, pyridail, pymetrozine, sulfur, thiocyclam, cienopyrafen, flupirazophos, cyflomethophen, amidoflumet, imiciafos, bistrifluron, pirifluquinazon and 1,1 '- [(3S, 4R, 4aS, 4 12R, 12aS, 12bS) -4 - [[((2-cyclopropylacetyl) oxy] methyl] -1,3,4,4a, 5,6,6a, 12,12a, 12b-decahydro-12-hydroxy-4, 6a, 12b-trimethyl-11-oxo-9- (3-pyridinyl) -2H, 11H-naphtho [2,1-b] pyran [3,4-e] pyran-3,6-diyl] ester of cyclopropaneacetic acid . 3. The compositions of any one of claims 1 to 2, further comprising an agrochemical auxiliary. 4. The use of a composition as defined in any one of claims 1 to 3 to combat phytopathogenic fungi. 5. A method of combating plant pathogenic fungi, which comprises treating the fungi or the materials, plants, soil or seeds to be protected against fungal attack with an effective amount of a composition as defined in any of the claims 1 to 3. 6. Seed, coated with components I and II or I, II and III of the compositions as defined in any one of claims 1 to 3, in an amount of 0.1 to 10 kg of active substances per 100 kg of seed.